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Background: Myocardial injury affects up to one in three patients undergoing 
non-cardiac surgery. However, very little is known about the underlying 
pathophysiology. In the general population, patients with elevated resting heart 
rate are at increased risk of cardiac events, mortality, heart failure and 
autonomic dysfunction, while hypertension is a well described risk factor for 
cardiovascular disease. I hypothesised that common abnormalities of heart rate 
or blood pressure were associated with myocardial injury after non-cardiac 
surgery.  
 
Methods: This thesis comprises a series of secondary analyses of data from 
five prospective multi-centre epidemiological studies of surgical patients. The 
main outcome of interest was myocardial injury, defined using objective 
measurement of cardiac troponin. I used logistic regression analysis to test for 
association between exposures and outcomes. 
 
Results: In a large international cohort, patients with high preoperative heart 
rate had increased risk of myocardial injury and patients with very low 
preoperative heart rate had reduced risk of myocardial injury. Patients with 
elevated preoperative pulse pressure had increased risk of myocardial injury, 
independent of existing hypertension or systolic blood pressure. High heart rate, 
or high or low systolic blood pressure during surgery, was associated with 
increased risk of myocardial injury. In a separate study, elevated preoperative 
heart rate was associated with cardiopulmonary and autonomic dysfunction, 
and reduced left ventricular stroke volume, suggestive of heart failure. Finally, 
	 ix 
autonomic dysfunction, identified using cardiopulmonary exercise testing, was 
associated with elevated preoperative heart rate, elevated plasma NT-Pro-BNP 
(indicative of heart failure) and postoperative myocardial injury.  
 
Conclusions: Elevated preoperative heart rate, autonomic dysfunction and 
subclinical heart failure may be part of a common phenotype associated with 
perioperative myocardial injury. Further research is needed to characterise the 
pathological processes responsible for myocardial injury, and to identify 





Myocardial injury affects up to one in three patients undergoing non-cardiac 
surgery. It is predominantly asymptomatic and without ischaemic features, and 
is strongly associated with death. However, very little is known about 
predisposing risk factors for myocardial injury and the underlying 
pathophysiological mechanism. In the general population, patients with elevated 
heart rate, blood pressure and/or pulse pressure are at greater risk of 
cardiovascular complications and death. Elevated heart rate is associated with 
development of heart failure, which is a risk factor for perioperative morbidity 
and mortality, and with autonomic dysfunction, which occurs in one third of 
surgical patients. Blood pressure is routinely checked before surgery, but there 
is uncertainty among anaesthetists and surgeons regarding the management of 
hypertension before surgery, which may result in cancelled procedures. The 
aim of this thesis was to investigate, using epidemiological methods, whether 
abnormalities of heart rate and blood pressure commonly seen in the general 
population were risk factors for perioperative myocardial injury, thus generating 
hypotheses for further translational and interventional research. 
 
Preoperative heart rate 
The first part of this thesis uses data from the international, multi-centre, 
VISION cohort study, which first described perioperative myocardial injury. The 
analysis described in chapter three found that very high preoperative heart rate 
was associated with increased risk of myocardial injury and very low 
preoperative heart rate was associated with reduced risk of myocardial injury. 
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These findings were independent of potential confounding factors such as 
urgency of surgery, age or diagnosis of ischaemic heart disease. 
	
Preoperative blood pressure 
The analysis described in chapter four used data from the VISION study to 
identify an association between preoperative pulse pressure and perioperative 
myocardial injury, independent of previous history of hypertension and 
preoperative systolic blood pressure.  
	
Intraoperative heart rate and systolic blood pressure  
The analysis described in chapter five used data from the VISION study to 
identify that patients with very high heart rate, or very high or low systolic blood 
pressure during surgery were at greater risk of myocardial injury, compared to 
those without heart rate or blood pressure abnormality. Conversely, patients 
with a very low heart rate during surgery were at lower risk of myocardial injury. 
These findings are consistent with the hypothesis that elevated heart rate 
promotes myocardial injury through imbalance between myocardial oxygen 
supply and demand. However, it is also plausible that that elevated heart rate is 
a marker of another pathophysiological mechanism causing myocardial injury. 
	
Sub-clinical heart failure 
In chapter six, I used cardiopulmonary exercise testing to identify 
cardiopulmonary and autonomic impairment in patients in the POM-HR study 
who underwent high-risk non-cardiac surgery. However, only a small proportion 
of these patients had a clinical diagnosis of heart failure. Elevated preoperative 
heart rate was associated with impaired cardiopulmonary and autonomic 
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function, suggestive of heart failure. In a separate cohort of high-risk patients 
from the OPTIMISE and POM-O trials who underwent major abdominal surgery, 
elevated preoperative heart rate was associated with reduced left ventricular 
stroke volume. These findings suggest that elevated preoperative heart rate is a 
marker of subclinical or undiagnosed heart failure. 
 
Parasympathetic dysfunction 
In chapter seven, I used cardiopulmonary exercise testing to identify impaired 
parasympathetic autonomic function in patients in the METS study, a 
prospective international observational cohort study. Parasympathetic 
dysfunction, characterised by impaired heart rate recovery after preoperative 
exercise, was associated with postoperative myocardial injury, elevated resting 
heart rate and elevated preoperative plasma NT pro-BNP, indicative of heart 
failure. These findings suggest that elevated resting heart rate, autonomic 




Elevated heart rate before and during surgery, elevated preoperative pulse 
pressure, high and low systolic blood pressure during surgery, and impaired 
heart rate recovery after preoperative exercise are associated with increased 
risk of perioperative myocardial injury. However, the preoperative phenotype of 
patients at risk of myocardial injury is complex. Elevated preoperative heart 
rate, impaired parasympathetic function and subclinical heart failure are likely to 
be part of the same preoperative phenotype, which may be present in 
approximately 15% of patients undergoing in-patient non-cardiac surgical 
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procedures. Further research is needed to describe the pathological processes 
responsible for myocardial injury, which may include heart failure and 
autonomic dysfunction, and to help target novel therapeutic strategies to those 
patients most at risk. This will require a variety of methodological approaches, 
from hypothesis-generating epidemiology to translational laboratory science 






Each year in the UK approximately 40,000 people die within three months after 
major surgery. The most common causes of death involve the heart, including 
heart attack and heart failure. Several studies since 2012, using simple blood 
tests, have shown that at least one in every ten surgical patients suffer damage 
to their heart muscle (myocardial injury) and are more likely to die after surgery. 
However, we do not understand how or why myocardial injury occurs. In the 
general population, people with elevated heart rate or blood pressure are more 
likely to suffer from heart conditions or die. The aim of my research was to 
investigate whether, in surgical patients, there are relationships between 
abnormal heart rate or blood pressure and myocardial injury after surgery.  
 
Heart rate before surgery 
The first part of my PhD uses data from the VISION study, an observational 
study of 15,000 surgical patients, from eight countries, between 2007 and 2011. 
The research described in chapter three found that very high heart rate (more 
than 96 beats per minute) just before surgery was associated with increased 
risk of myocardial injury, and very low heart rate (less than 60 beats per minute) 
was associated with reduced risk of myocardial injury. 
 
	
Blood pressure before surgery 
There is uncertainty among both anaesthetists and surgeons about how to 
manage high blood pressure before surgery. This may result in cancelled 
operations, even for patients with a normal blood pressure reading in clinic 
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before surgery. Pulse pressure is measured with every standard blood pressure 
measurement. In the general population high pulse pressure is associated with 
increased risk of heart attacks and strokes. In chapter four, using data from the 
VISION study, I identified that elevated pulse pressure before surgery was 
associated with approximately 20% increased risk of myocardial injury. This 
was not influenced by a previous diagnosis of high blood pressure. Therefore, 
patients with elevated pulse pressure may benefit from additional tests before 
surgery, or additional time in the recovery unit after surgery. 
 
Heart rate and blood pressure during surgery 
In chapter five, using data from the same study, I found that patients with very 
high heart rate, or very high or low blood pressure during surgery were at 
greater risk of myocardial injury, compared to patients with normal heart rate or 
normal blood pressure. Patients with very low heart rates during surgery were at 
lower risk of myocardial injury. These findings from the VISION study suggest 
that a high heart rate might cause myocardial injury, perhaps by increased 
requirement for oxygen above that which can be supplied to the heart. 
However, this is unlikely because medications that lower heart rate do not 
reduce the risk of cardiac complications after surgery. Therefore, other, as yet 
unknown, factors are likely to be involved.  
 
Undiagnosed heart failure in surgical patients 
In the general population, elevated heart rate is linked to the development of 
heart failure in later life, which is also a risk factor for complications after 
surgery. In chapter six I used exercise testing to identify impaired function of the 
heart, of breathing (cardiopulmonary function) and of nerves from the brain 
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(autonomic function) in surgical patients. I used data from the POM-HR study, 
an observational study of 1250 surgical patients from Plymouth and London. I 
found that elevated heart rate before surgery was associated with impaired 
cardiopulmonary and autonomic function, which suggests the presence of un-
diagnosed heart failure. This was corroborated by detailed measurements of 
heart function in a separate group of 181 surgical patients from the OPTIMISE 
and POM-O studies. These results suggest that, in people who are going to 
have surgery, elevated heart rate is a marker of undiagnosed heart failure. 
 
Impaired autonomic function 
Data from a previous study of 250 patients suggests that one in three surgical 
patients have impaired autonomic function. In the general population this is 
linked to elevated resting heart rate. In chapter seven, I used exercise testing 
before surgery to identify patients with impaired autonomic function in 1325 
patients from the METS study, an international observational study of surgical 
patients conducted between 2012 and 2016. I found that impaired autonomic 
function was associated with myocardial injury, elevated resting heart rate and 
a blood test suggestive of heart failure. Therefore these preoperative factors 
may be linked and part of the same disease process. 
 
Summary 
I used data from five studies of surgical patients to identify risk factors for 
myocardial injury after surgery. While I could identify risk factors for myocardial 
injury, like elevated heart rate or pulse pressure, the relationship between these 
factors is complex. My results suggests that elevated heart rate, impaired 
autonomic function and undiagnosed heart failure are all part of the same 
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disease process, which occurs in one in six patients having surgery in hospital. 
In other words, out of the 1.5 million major surgical procedures that occur in the 
UK every year, approximately 225,000 patients are at risk of this disease 
process, and neither patient, nor doctor would be aware of it. However, the 
biological mechanisms that might link these factors are uncertain. Therefore, 
further research is needed to describe the biological processes causing 
myocardial injury, which may include heart failure and/or impaired autonomic 
function. This may help identify new treatments or ways to target treatments at 




Statement of contribution 
 
This thesis uses epidemiological methods to analyse five large data sets, 
derived from multi-centre, and predominantly international, research 
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cleaning and preparing the data, performing the statistical analyses and writing 
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submitting protocol amendments to the research ethics committee, preparing 
the annual progress reports, organising shipments of frozen laboratory 
samples, conducting on-site monitoring and chasing up data queries. At an 
international level I was a member of the Trial Steering Committee, which 
involved attending regular teleconference meetings with my supervisor, during 
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which I often provided an update on the study progress in the UK. I was part of 
the writing committee for the published report of study protocol.1 
 
I contributed to the VISION study as a local investigator at the Royal London 
Hospital over a four-year period. This included: screening patients for eligibility, 
obtaining written informed consent, obtaining preoperative and postoperative 
blood samples, collecting data before, during and after surgery both directly 
from patients and from their medical record, completing the paper case report 
forms and conducting telephone follow-up interviews. I liaised with other UK 
sites regarding data collection and blood samples, and with the international 
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1.1 Perioperative morbidity and mortality 
Demand for surgical treatments is increasing.2, 3 Perhaps due to growing global 
population, or as a result of an increasingly inclusive approach to selection of 
candidates, surgical treatments are now routinely offered to patients who, at the 
end of the 20th Century, may have been considered too high-risk for surgery.4-6 
This may be due to improvements in surgical or anaesthetic technique, 
increased healthcare capacity, or evolving views about which patients might 
benefit from surgery. However, the result is a shifting demographic of the 
surgical population toward patients with multiple pre-existing conditions.  
 
1.1.1 The global burden of surgery is increasing 
More than 300 million surgical procedures are performed worldwide each year.2 
This is larger than the global prevalence of malaria (~200 million cases) and 
represents over 4% of total world population.3, 7 However, the incidence of 
morbidity and mortality after surgery is unclear. In developed nations death is 
thought to occur after 0.5-2.0% of surgical procedures.3, 8-14 A recent cohort 
study of 44,000 patients from 27 high/middle/low income countries, found that 
0.5% of elective surgical patients died before hospital discharge. The most 
common causes of postoperative death are cardiovascular in origin, followed by 
multi-organ failure and sepsis.14 Death is more common after emergency 
surgery, compared to elective surgery.10 Estimates of the proportion of patients 
with complications following surgery vary widely between 3-20% of procedures 
	
	 2 
(table 1.1).9, 14-16 Complications range from surgical site infection to myocardial 
infarction, acute kidney injury or pneumonia.17 The presence of any 
postoperative complication is associated with reduced long-term survival.18  
	
	
Complication Incidence (%) 
All complications 15% 
Infectious complications 
Sepsis 5% 
Superficial surgical site 3% 
Pneumonia 2% 
Urinary tract 2% 
Deep surgical site 1% 
Body cavity <1% 
Cardiovascular complications 
Myocardial injury 8% 
Myocardial infarction 3% 
Arrhythmia  3% 
Heart failure 2% 
Pulmonary embolism <1% 
Stroke <1% 
Cardiac arrest <1% 
Other complications 
Postoperative bleed 3% 
Acute kidney injury 2% 
Acute Respiratory Distress Syndrome <1% 
Gastro-intestinal bleed <1% 
  
 
Table 1.1. Approximate incidence of complications after elective surgery. 
Stratified by type of complication: infectious, cardiovascular and other.9, 14-16 
 
Until very recently the number of surgical procedures performed in the United 
Kingdom (UK) was unknown. Estimates of procedure frequency from the Royal 
College of Surgeons of England and the NHS Confederation vary widely, from 
between 5.6 million to 11 million procedures per year (personal 
correspondence). There are few reliable epidemiological data describing the 
surgical population in the UK, which makes it difficult to understand the total 
population at risk of postoperative complications. In a recent time-trend 
ecological study, we used Hospital Episode Statistics to describe the total 
number of hospital procedures performed in the UK each year and the 
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associated postoperative mortality rates. Over the five-year period from 2009 to 
2014, ~40 million hospital procedures were performed, representing ~8 million 
procedures per year, of which 1.5 million procedures would be classed as 
‘major surgery’ by most anaesthetists or surgeons. The crude postoperative 
mortality rate associated with these procedures was 1.5% within 30 days of 
surgery, rising to 2.8% within 90 days of surgery.19  
 
1.1.2 Perioperative cardiovascular complications 
The most common causes of early postoperative mortality are widely held to be 
cardiovascular in origin (table 1.2).8 The incidence of symptomatic myocardial 
infarctions after non-cardiac surgery is ~1% in previously healthy patients 
having elective procedures, rising to ~5% in patients with a pre-existing 
cardiovascular disease.15, 16, 20, 21	 Symptomatic perioperative myocardial 
infarction results in death in one out of five cases.14 However, death and 
symptomatic cardiac events represent only a small proportion of total cardiac 
pathology, since the majority of perioperative cardiac complications are 
asymptomatic. In a large surgical cohort, only ~35% of patients with confirmed 
myocardial infarction reported symptoms of myocardial ischaemia.22 But, the 
reasons for this asymptomatic or ‘silent’ aetiology remain unclear. There is 
growing evidence that asymptomatic myocardial injury, identified by elevation in 
blood concentration of specific biomarkers of cardiac muscle damage (e.g. 
cardiac troponin), is much more common than overt myocardial ischaemia or 
infarction. Furthermore, it is strongly associated with all-cause mortality, 
regardless of the presence or absence of ischaemic symptoms, or the presence 
of electrocardiographic or echocardiographic evidence of myocardial ischaemia 




Cause of death Number of deaths Proportion of deaths (%) 
Cardiovascular causes 435 34 
Mesenteric ischaemia 264 20 
Multi-organ failure 255 20 
Septicaemia 239 18 
Respiratory causes 165 13 
 
Table 1.2. Causes of postoperative deaths. Illustrating the five most common 
causes of death (taken from death certificates) within 48 hours of surgery, 
among 1299 postoperative deaths recorded by the Scottish audit of surgical 
mortality.8 Percentages rounded to the nearest whole number. 
	
	
1.1.3 Some patients are at high-risk of perioperative complications 
Four out of five postoperative deaths occur in a small group (~15%) of ‘high-
risk’ patients,24 who are typically elderly, have pre-existing conditions and/or 
require emergency surgery.24 The physiological phenotype of patients at risk of 
perioperative morbidity and/or mortality has not yet been characterised in detail. 
The current paradigm judges perioperative risk according to patient and 
procedure factors.25, 26 Procedure factors include: intraoperative complications, 
for example, blood loss; procedure length; and surgical or anaesthetic 
technique; all of which may be more significant during emergency surgery.26 
Patient factors comprise pre-existing conditions (co-morbidity), and general 
physical health and/or ability (functional capacity/reserve). The inter-relation of 
these factors is complex,25, 26 with overlap between functional capacity and co-
morbidity since physical illness affects cardiorespiratory fitness, while surgical 
or anaesthetic technique is often influenced by the presence of pre-existing 
conditions.27 Limitation in any of these domains may impact the degree to which 






1.1.4 Preoperative assessment clinics aim to identify high-risk patients 
Preoperative assessment clinics are present in most UK hospitals, visited by at 
least four out of five patients before elective surgery.30 Their introduction was 
driven in part by the findings of the National Confidential Enquiry into 
Perioperative Deaths, which advocates evaluation of all patients before surgery 
in a preoperative clinic,30 the guidelines for the provision of anaesthetic services 
(Royal College of Anaesthetists) and the National Institute for Health and Care 
Excellence (NICE) guidelines for routine preoperative testing.31, 32  The purpose 
of preoperative assessment clinics is to provide opportunities to optimise pre-
existing conditions, assess functional capacity and plan perioperative care.31 
Visits usually include a medical history, clinical examination, electrocardiogram 
and routine blood tests with additional investigations arranged on a case-by-
case basis.33 Risk assessment uses a variety of methods, including: clinical 
(subjective) assessment; risk scores or stratification tools; objective clinical 
measures, for example cardiopulmonary exercise testing; or prognostic 
biomarkers, for example brain natriuretic peptide (BNP).87 Observational 
evidence suggests that patients attending a preoperative assessment clinic 
tend to have a shorter stay in hospital, lower risk of critical care unit admission 
and lower risk of death.30, 33-37 However, there are no interventional studies to 
support the use of preoperative assessment clinics and evidence for specific 
preoperative tests is generally weak (as assessed by NICE).38 
	
	
1.1.5 ‘Fitness’ for surgery and cardiopulmonary exercise testing 
Since Paul Older identified a plausible link between preoperative 
cardiorespiratory capacity and postoperative outcomes in the 1990s,39-44 there 
has been much interest in preoperative ‘fitness’ and how this might be 
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optimised.29, 45 Small studies, most often focused on abdominal surgery, have 
identified association between cardiorespiratory capacity and postoperative 
complications, suggesting that patients with better preoperative ‘fitness’ tend to 
suffer fewer complications.46-50 The widely accepted explanation for this 
observation centres around tissue oxygen delivery51 that patients with poor 
preoperative oxygen consumption are less able to deliver oxygen to respiring 
tissues during periods of physiological stress (like during surgery or the 
immediate postoperative period).47, 52 However, the physiology of this proposed 
mechanism is unclear and it remains uncertain whether preoperative exercise 
training can improve postoperative clinical outcomes.53-56 
 
Cardiopulmonary exercise testing (CPET) is used to objectively measure 
preoperative functional capacity at ~40% of UK hospitals.57 First described in 
the perioperative context in the 1980s, the most common set-up consists of a 
cycle ergometer using an incremental ramp protocol, where the workload 
steadily increases throughout the test. Continuous non-invasive measurement 
of respiratory and cardiovascular function allows multiple parameters to be 
derived. The two most widely used CPET variables are peak oxygen 
consumption (VO2peak) and oxygen consumption at the anaerobic threshold 
(VO2AT), the point where the metabolism switches from predominantly aerobic 
respiration to predominantly anaerobic respiration.48 A number of studies have 
identified associations between preoperative VO2AT,41, 43, 58-65 VO2peak,59, 61, 65-
67 and postoperative clinical outcomes. However, it is unclear which variable is 
superior for predicting postoperative clinical outcomes. Other CPET-derived 
cardiopulmonary and autonomic variables known to be associated with 
postoperative clinical outcomes or cardiovascular morbidity in the general 
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population include: pulse pressure, heart rate recovery and ventilatory 
equivalent for carbon dioxide (VE/VCO2). The original papers detailing the 
prognostic value of these variables are listed in table 1.3. However, the majority 
of studies used to justify preoperative CPET were conducted in single centres 
and in specific groups of patients, which limits their external validity.68 46  
	
CPET variable References 
Oxygen consumption at the 
anaerobic threshold <11 ml.kg-1min-1 
Hennis et al 201146, Older et al 199941, 
Older et al 199343, Wilson et al 201058. 
Peak oxygen consumption ≤14 
ml.kg-1min-1 
James et al 201469, Myers 200870. 
E/ CO2 ratio at anaerobic 
threshold ≥34 
Myers et al 200870, Myers et al 201371, 
Wilson et al 201058. 
Heart rate recovery <12 bpm Myers et al 200870. 
Pulse pressure >53 mmHg Jackson et al 201572. 
	




Cardiovascular complications represent a prominent component of overall 
postoperative morbidity and contribute to the total burden of postoperative 
mortality. It is therefore important to seek ways to identify patients at risk of, and 
subsequently prevent, perioperative cardiovascular morbidity and mortality. 
However, first we must understand the underlying pathophysiology 
mechanisms, which are currently unclear. 
 
 
1.2 Relevant cardiac and autonomic physiology  
Here, I briefly describe the sympathetic and parasympathetic divisions of the 
autonomic nervous system, and the involuntary neural control of heart rate, 





1.2.1 The autonomic nervous system 
The autonomic nervous system (ANS) is part of the peripheral nervous system, 
which innervates organs and smooth muscle that are not under voluntary 
control, for example the heart and endocrine glands.73, 74 It comprises 
parasympathetic and sympathetic divisions.73, 74 Broadly speaking, the 
sympathetic system regulates the stress response, for example by increasing 
blood flow to aerobic muscles through increased rate and force of cardiac 
contraction, and constriction of the splanchnic circulation, diverting blood away 
from the digestive tract. Conversely, the parasympathetic division regulates the 
resting state, for example by diverting blood to the digestive system and 
stimulating urination/defecation. Acetylcholine is the main neurotransmitter in 
the parasympathetic nervous system, whereas the predominant 
neurotransmitter in sympathetic postganglionic neurons is noradrenaline, an 
endogenous catecholamine75 containing a catechol moiety attached to an 
amine side-chain, which is synthesised from the amino acid tyrosine.76 In 
comparison, adrenaline is synthesised in the adrenal medulla and secreted 
directly into the circulation.77 Sympathetic catecholamines stimulate 
adrenoceptors (adreno-receptors),77 which are G-protein-coupled receptors and 
can be divided into alpha- and beta-subtypes.76, 77 They are widely distributed 
throughout and trigger various responses when stimulated (table 1.4).76, 78 The 
heart contains Beta-1 receptors that increase the rate and force of cardiac 
contraction, and therefore cardiac output, when stimulated. 
 Receptor sub-types 
Characteristics alpha-1 alpha-2 beta-1 beta-2 
Blood vessels Constrict Constrict/dilate - Dilate 
Bronchi Constrict - - Dilate 
GI tract Relax Relax - Relax 
Cardiac contraction - - Increase - 
Salivary gland K+ release - Amylase secretion - 
Table 1.4 - Summary of distribution and effects of adrenoceptor subclasses, 
taken from Rang, Dale, Ritter and Moore 2003.76	
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Endogenous catecholamines are non-selective agonists, acting on all 
adrenoceptor sub-types, whereas synthetic agonists/anatagonists can act at a 
range of receptor sub-types (table 1.5). For example, beta-antagonists block the 
beta-receptor, hence ‘beta-blockers’. In this thesis I use the terms beta-blocker 
and beta-antagonist interchangeably. Antagonism of beta-1 receptors in the 
heart reduces rate and force of contraction, thus lowering cardiac output and 
myocardial oxygen demand. However, side effects are not uncommon, 
including: bronchoconstriction;79-81 exacerbation of uncontrolled heart failure;80, 





alpha-1 alpha-2 beta-1 beta-2 
Selective agonist 
 
Phenylephrine Clonidine Dobutamine Salbutamol 











Table 1.5 - Examples of adrenoceptor agonists and antagonists, taken from 
Rang, Dale, Ritter and Moore 2003.76 
	
 
1.2.2 Autonomic control of heart rate 
Cardiac contraction is initiated by the sinoatrial node and a spreading wave of 
depolarisation across the myocardium.75, 83 The heart is innervated by both 
noradrenergic sympathetic nerves from the cervical ganglia of the sympathetic 
chain and cholinergic parasympathetic nerve fibres from the vagus nerve.75  
Contractile rate (chronotropy) and force (inotropy) are modulated by the 
autonomic nervous system.75 Over fifty years ago Jose and colleagues 
investigated the intrinsic rate of contraction of the human heart by injecting 
healthy volunteers with propranolol (beta-antagonist) and atropine (anti-
	
	10 
cholinergic) to obliterate sympathetic and parasympathetic cardiovascular 
control.84, 85 They observed that in the presence of these drugs, heart rate 
increased, and that the intrinsic rate of cardiac contraction was higher than 
resting heart rate under normal circumstances.85 Later experiments in humans 
and animals showed that at rest, the predominant autonomic action was 
parasympathetic, thereby lowering intrinsic heart rate and demonstrating that 
resting heart rate can be marker of parasympathetic activity.86-88 Therefore 
elevated resting heart rate may be the result of autonomic dysfunction: either 
parasympathetic under-activity or sympathetic over-activity. 
 
1.2.3 Parasympathetic autonomic dysfunction  
In the general population, an increasing body of evidence suggests that 
parasympathetic dysfunction is present in approximately one in four people and 
is associated with clinical outcomes. Parasympathetic dysfunction can be 
identified by the degree of reduction in heart rate immediately after the end of 
exercise,85 since in the first few minutes after exercise this is mediated by 
parasympathetic stimulation and thereafter by sympathetic withdrawal.89 Thus 
early heart rate recovery is a measure of parasympathetic function.89 Typically 
heart rate is measured at specific time points after maximal exercise and ‘heart 
rate recovery’ in beats per minute calculated. A study of ~2,500 apparently 
healthy men and women identified that impaired heart rate recovery within the 
first minute after exercise was associated with increased risk of mortality.90 
Similarly, in 9,000 men and women without existing cardiovascular disease, 
prolonged heart rate recovery (≤ 12 beats in the first minute after exercise) was 
associated with increased risk of subsequent mortality.91 These results are 
replicated in longitudinal population cohorts, with average follow-up durations 
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between 14 and 20 years, suggesting that this may represent an as yet un-
recognised chronic underlying pathology.92, 93  
 
 
1.3 Perioperative myocardial injury  
1.3.1 The universal definition of myocardial infarction  
The widely accepted framework for identifying and classifying acute myocardial 
pathology centres on the universal definition of myocardial infarction, derived by 
expert consensus.94 The third iteration defines myocardial infarction as 
“evidence of myocardial necrosis in a clinical setting consistent with myocardial 
ischaemia”.94 In the absence of interventional radiology or post-mortem 
evidence of coronary artery occlusion, myocardial infarction is most commonly 
diagnosed by elevation in a cardiac biomarker >99th centile in addition to one or 
more of the following findings: symptoms of ischaemia; electrocardiographic 
evidence of new ST segment abnormalities, new left bundle branch block or 
new Q waves; or imaging (typically echocardiographic) evidence of regional 
wall motion abnormality or loss of myocardium.94 However, the application of 
the universal definition of myocardial infarction to perioperative patients is not 
straightforward, since the majority of patients with perioperative myocardial 
infarction are asymptomatic. This is further complicated by the high incidence 
(~10%) of perioperative cardiac biomarker elevation in the absence of 
symptoms (~90%) or objective evidence of ischaemia/infarction (~75%).95 
Therefore, asymptomatic perioperative cardiac biomarker elevation is likely to 






1.3.2 The pathophysiology of myocardial injury  
The pathophysiology of perioperative cardiac biomarker elevation (myocardial 
injury) is poorly understood. Landesberg and colleagues describe two separate 
models of perioperative myocardial injury and infarction. Firstly, the occlusive 
model of acute coronary syndrome, characterised by the rupture of unstable 
coronary atherosclerotic plaques with subsequent thrombosis, leading to partial 
or total occlusion of the coronary artery and distal myocardial ischaemia and/or 
infarction (type I). Secondly, prolonged ST-segment depression myocardial 
ischaemia due to oxygen-supply-demand-imbalance in patients with critical, but 
stable, coronary stenosis (type II).96 It is plausible that damage or death of 
cardiac myocytes, and consequent troponin release, could occur as a result of 
both mechanisms.96-98 However, ‘type I’ plaque rupture and thrombosis is 
unlikely to be the predominant biological mechanism underlying perioperative 
myocardial injury for two reasons.99 Firstly, only 4% of patients with 
postoperative troponin elevation show evidence of ST-elevation, Q waves or left 
bundle branch block on electrocardiogram.95 Secondly, standard treatments for 
acute coronary syndrome do not reduce the incidence of perioperative cardiac 
complications when given prophylactically. For example, in the POISE-2 trial, 
prophylactic aspirin did not reduce the incidence of postoperative death or 
myocardial infarction compared to placebo,100 and in the CARP trial, 
prophylactic coronary revascularisation did not reduce the incidence 
postoperative myocardial infarction in patients undergoing vascular surgery.101 
Thus, the aetiology and pathophysiology underlying perioperative myocardial 






1.3.3 Risk factors for perioperative cardiac complications 
Lee and colleagues undertook a study of risk factors for perioperative cardiac 
complications in 1999.20 In a single-centre observational cohort of ~4000 
patients having elective non-cardiac surgery, they identified six preoperative 
risk factors for postoperative cardiac complications, including: high-risk surgery 
(intraperitoneal, intrathoracic or suprainguinal vascular procedures), history of 
ischaemic heart disease, history of congestive heart failure, history of 
cerebrovascular disease, insulin therapy for diabetes and preoperative serum 
creatinine >2.0mg/dL.20 Subsequently, the VISION study investigators identified 
additional preoperative risk factors for myocardial injury after non-cardiac 
surgery (defined by serum troponin), including: age ≥75 years, male gender, 
history of atrial fibrillation, history of diabetes (not limited to insulin therapy), 
history of peripheral vascular disease, estimated glomerular filtration rate ≤60 
ml/min/1.73m2 and emergency surgery. 95  
 
1.3.4 Biomarkers of myocardial injury 
A systematic review of 15 studies identified creatinine kinase brain and muscle 
isoenzyme (CK-MB), troponin-I (TnI) and troponin-T (TnT) as the three most 
commonly used perioperative biomarkers of myocardial injury.102 Elevation in 
any cardiac biomarker within 3 days of surgery is independently associated with 
30-day postoperative mortality.16, 102	 In the context of surgery or trauma, where 
CK-MB is likely to be elevated due to skeletal muscle damage, troponin is a 
more specific biomarker for myocardial injury.102 The majority of subsequent 




Troponin (Tn) is a calcium binding protein consisting of three subunits (I, T and 
C) found in both skeletal and cardiac muscle and is closely associated with 
other muscle proteins: tropomyosin, actin and myosin.83 There are separate 
isoforms of the I and T subunits, which are specific to cardiac muscle (cTnI and 
cTnT).107, 108 In this thesis, further discussion of troponin will relate to cardiac 
troponin unless otherwise stated. The function of troponin is to regulate muscle 
contraction in response to intracellular calcium release, specifically the 
positioning of tropomyosin in relation to actin, and thus the interaction between 
actin and myosin (muscle contraction).83 Troponin is an intracellular protein, 
where ~90% is bound to structural proteins and ~10% is un-bound in the 
cytoplasm.98 Therefore, if troponin is detectable in serum or plasma, it implies 
the release of the cellular contents of cardiac myocytes into the bloodstream.98, 
108 The pathophysiology of troponin release is still under investigation, and while 
the predominant cause of troponin release is thought to be myocyte necrosis, 
several other mechanisms have been suggested, including apoptosis, 
increased cell membrane permeability and release of cellular vesicles 
containing troponin.98 In healthy volunteers, cardiac troponin is not usually 
detectable in blood plasma, therefore measureable concentrations of cTnI/T 
represent sensitive and specific markers of injury to heart muscle (myocardial 
injury).98, 108, 109 Thus, cardiac troponins are routinely used in the identification 
and diagnosis of acute coronary syndromes, including myocardial infarction.110, 
111 However, emerging research using high-sensitivity troponin assays suggest 
that there may be chronic leak of troponin from cardiac myocytes in patients 
with cardiovascular disease, for example undiagnosed hypertension,112 which 




1.3.5 Myocardial injury after non-cardiac surgery 
 ‘Myocardial injury after non-cardiac surgery’ (MINS) was first defined by the 
Vascular events In non-cardiac Surgery cohort evaluatION (VISION) study16 
and has subsequently been adopted by consensus guidelines on perioperative 
outcome measures. MINS is defined as:113 
 
“A peak troponin T (TnT) ≥ 0.03ng ml-1 judged due to myocardial 
ischaemia (i.e. no evidence of a non-ischaemic aetiology causing the 
TnT elevation).”  
	
This definition uses a fourth generation Troponin-T assay, with a reported 
incidence of postoperative myocardial injury between 8% and 15%,95, 104 
although rates of greater than 40% have been reported in high-risk patient 
groups.103, 114, 115 While the Roche Diagnostics TnT assay is very common, not 
all hospitals use it, opting instead for either Troponin-T assays from other 
manufacturers or Troponin-I assays. Therefore the definition may not be 
applicable to all clinical settings. In addition, highly sensitive ‘5th generation’ 
troponin assays are now available, which are increasingly adopted by many 
hospitals.115 In the first published cohort of VISION study - the largest 
epidemiological study of its type, which defined MINS - myocardial injury was 
detected after one in ten non-cardiac procedures.95 On this basis, 
approximately 150,000 cases of postoperative myocardial injury will occur in the 
UK every year, assuming an annual procedure frequency of 1.5 million.19, 24, 95, 
116 Importantly, the majority of these patients will be asymptomatic, yet at much 
higher risk of death compared to patients without myocardial injury. Despite this, 
the clinical significance of myocardial injury remains controversial for four 
principal reasons; firstly, the pathophysiology is poorly understood; secondly, 
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the long-term impact on cardiac function is unclear; thirdly, troponin assays are 
not standardised and a wide variety are used in clinical practice; and fourthly, 
the incidence of myocardial injury in the general (non-surgical) population is 
unknown. Therefore, treatments have not yet been developed, leaving clinicians 
unclear about how best to manage a patient with myocardial injury.117 Research 
is urgently needed to understand postoperative myocardial injury and develop 
new treatments.16, 95, 102, 104 
 
 
1.4 Pathophysiology of heart disease in the wider population 
The single leading cause of death worldwide is ischaemic heart disease, with 
deaths from cardiovascular diseases accounting for ~13% of deaths among 
men and ~11% of deaths among women.118 In the United Kingdom, cancers 
and cardiovascular diseases account for 28% and 26% of all deaths 
respectively.119 In men aged 50 years or older, ischaemic heart disease is the 
leading cause of death.120 
 
1.4.1 Ischaemic heart disease  
The aetiology of ischaemic heart disease is complex. The principal underlying 
pathophysiological mechanism is atherosclerosis leading to coronary artery 
stenosis, impaired myocardial blood supply and myocardial ischaemia, which 
clinically manifests as angina. Rupture of atherosclerotic plaques and 
thrombosis results in sudden partial or complete coronary artery occlusion, 
which presents as an acute coronary syndrome of unstable angina or 
myocardial infarction.94 The seminal epidemiological study in this field is the 
Framingham Heart study; an observational cohort study of ~5000 men and 
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women from Framingham, Massachusetts, which started in the late 1940s and 
continues today.121 122 Analyses of the Framingham cohort identified key risk 
factors for ischaemic heart disease,123 including: hypertension,124-126 diabetes 
mellitus,127, 128 hypercholesterolaemia,129, 130 and cigarette smoking.131, 132 
	
	
1.4.2 Heart failure  
Heart failure is a clinical syndrome of signs and symptoms including: 
paroxysmal nocturnal dyspnoea, cardiomegaly, central venous congestion and 
neck vein distension, basal crepitations on auscultation of the chest, peripheral 
oedema, shortness of breath on exertion, hepatomegaly and pleural effusion.133 
Clinical heart failure syndrome is strongly associated with death; in the 
Framingham cohort the median survival from diagnosis was 3.2 years for 
women and 1.7 years for men.134 Despite improvements in the identification, 
treatment and prevention of ischaemic heart disease, the prevalence of heart 
failure has stayed relatively stable.135 In the USA, the annual incidence of 
clinical heart failure syndrome is 1% in people aged over 65 years,136 which 
increases with increasing age.137 The pathophysiological mechanisms 
underlying heart failure are poorly understood. There are common risk factors 
with ischaemic heart disease (e.g. hypertension and diabetes mellitus). 
However, the dissociation between decreasing mortality from ischaemic heart 
disease and stable mortality from heart failure suggests two separate 
aetiologies.135, 136 This is complicated by the clinically subjective nature of the 
predominant definition/classification of heart failure (New York Heart 
Association classification),138 which is based on exercise tolerance and does 
not take into account emerging functional sub-types of heart failure, for 
	
	18 
example, heart failure with reduced ejection fraction, versus heart failure with 
preserved ejection fraction.135 
 
1.4.3 Hypertension 
Hypertension, typically defined as systolic blood pressure ≥140mmHg or 
diastolic blood pressure ≥90mmHg, is a modifiable risk factor for cardiovascular 
diseases in the general population, including ischaemic heart disease, heart 
failure and stroke.139, 140 In the UK, clinical management of hypertension is 
based on measured blood pressure, age, ethnicity and predicted ten-year risk 
of cardiovascular complications.139 Treatment includes lifestyle interventions 
(diet and exercise) and pharmacological therapy to a target blood pressure of 
≤140/90mmHg.139 However, new evidence suggests that a target of systolic 
blood pressure ≤120mmHg is associated with reduced incidence of 
cardiovascular morbidity and mortality.141, 142  
 
Components of blood pressure change with normal ageing; for example, 
elevated mean arterial pressureA appears more common in younger men, while 
elevated pulse pressureB is more common in older women.143 Pulse pressure is 
the arithmetic difference between systolic and diastolic blood pressure, which 
reflects the compliance of large arteries (stiffness), arterial resistance, 
myocardial contractility and left ventricular filling.144-146 Elevations in systolic, 
diastolic, mean arterial and pulse pressures are differentially associated with 
various cardiovascular diseases;140 arterial pulse pressure may be a superior 
predictor of cardiovascular disease than systolic or diastolic blood pressures 
alone. In the prospective PROCAM study of >5,000 healthy men, pulse 
																																																								
A Mean arterial pressure (MAP) = Diastolic blood pressure + ⅓ systolic blood pressure 
B Pulse pressure = systolic blood pressure – diastolic blood pressure 
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pressure was more strongly associated with ischaemic heart disease than 
systolic or diastolic blood pressure, independently of hypertension status.147 
Similarly, elevated pulse pressure was associated with increased incidences of 
cardiovascular events and mortality in a registry study of ~45,000 patients with 
atherosclerosis,148 a cohort study of ~120,000 men and a systematic review and 
meta-analysis.149-151 
 
1.4.4 Resting heart rate  
Elevated resting heart rate is associated with early mortality in both 
hypertensive and non-hypertensive cohorts, independently of gender or pre-
existing cardiovascular disease.152, 153 In a Portuguese study of patients with 
acute coronary syndrome, heart rate >82 beats per minute was associated with 
reduced survival to hospital discharge,154 and elevated heart rate was 
associated with other cardiovascular risk factors in a large Italian cohort of 
hypertensive patients.155 This relationship is not limited to patients with pre-
existing cardiovascular disease. In a Finish cohort of ~22,000 healthy men and 
women, elevated resting heart rate was independently associated with 
increased risk of subsequent cardiovascular disease.156 While a similar study in 
Denmark identified a relationship between elevated resting heart rate and 
mortality, independent of physical fitness.157  
 
Elevated resting heart rate is also independently associated with the 
development of clinical heart failure syndrome. In the EPIC-Norfolk cohort study 
of ~22,000 men and women without pre-existing disease, increasing risk of 
heart failure was strongly associated with increasing heart rate.158 This 
relationship was also observed in a smaller study of ~5,000 men and women 
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from Rotterdam, where each 10 beat per minute increase in resting heart rate 
was associated with a 16% increase in the risk of developing heart failure.159 
 
 
1.5 Heart rate in the perioperative period 
It is plausible that tachycardia could cause myocardial injury via a mechanism 
of myocardial oxygen supply-demand imbalance.96, 97, 102, 160 However, there is 
little clinical evidence to support this hypothesis. Here, I consider the evidence 
to support or refute potential associations between perioperative heart rate and 
clinical outcomes. This includes studies of heart rate before and during surgery, 
studies of cardiac and non-cardiac surgery and studies of heart rate during and 
after preoperative exercise testing.  
 
1.5.1 Heart rate before surgery 
Heart rate before cardiac surgery is associated with postoperative morbidity and 
mortality. In two observational cohorts of patients undergoing coronary artery 
bypass grafting (CABG), preoperative tachycardia, defined as either heart rate 
>130 or >80 beats per minute respectively, was associated with postoperative 
mortality.161, 162 The difference in heart rate threshold could be due to variation 
in sample size or the unadjusted influence of confounding factors. In a different 
cohort, resting heart rate at hospital admission as a continuous variable was 
associated with postoperative myocardial infarction, and stroke, corrected for 
potentially confounding factors.163 Patients with a complication had a mean 
heart rate that was five beats per minute higher than those patients without a 




In patients undergoing non-cardiac surgery there is less evidence to support a 
relationship between preoperative heart rate and postoperative outcomes. 
Preoperative heart rate is reported in only a small proportion of the trials of 
perioperative beta-blockade and, where it is reported, is subject to confounding 
by drug therapy. Evidence from two small trials suggests that heart rates lower 
than 65 or 70 beats per minute are associated with improved clinical 
outcome.39, 44 Similarly, a retrospective study reported that patients treated with 
beta-blockers who later died had higher preoperative heart rate compared to 
those that survived. However, it is impossible disentangle the confounding 
effect of beta-blocker therapy, since patients without treatment were not 
described.40 Furthermore, there is insufficient data to determine the degree of 
beta-receptor antagonism for individual patients receiving beta-blockers, which 
could confound an observed relationship between heart rate and clinical 
outcome.39, 40, 44 
 
Only three studies have described resting heart rate before non-cardiac surgery 
in the absence of beta-blockade. In 172 patients with ischaemic heart disease, 
increasing preoperative heart rate was associated with increasing risk of 
postoperative mortality and cardiovascular morbidity.164 In contrast, in a 
separate cohort of 181 patients undergoing vascular or orthopaedic surgery, 
elevated preoperative heart rate was not associated with increased risk of 
myocardial infarction.165 These studies were similar in size and patient group. 
However, the contradictory results leave uncertainty about whether elevated 
preoperative heart rate is associated with postoperative clinical outcome. The 
largest study to examine preoperative heart rate is a secondary analysis of 
~4,000 placebo group patients in the POISE trial. The investigators found that 
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each 10 beats per minute increase in preoperative heart rate was associated 
with a 29% increase in the risk of postoperative myocardial infarction.22 
However, there were several limitations of this analysis. Firstly, it is not clear 
when heart rate was measured, for example in the preoperative assessment 
clinic or in the anaesthetic room before the induction of anaesthesia.22, 166, 167 
Secondly, the analysis does not test whether there is a particular heart rate 
threshold above or below which patients are at greater risk of postoperative 
morbidity. Thirdly, the outcome measures were subjective and clinically defined, 
which has the potential to introduce observer bias and measurement error. 
Biochemical myocardial injury has not been investigated in this context.  
 
1.5.2 Heart rate during surgery 
Early studies reported association between intraoperative tachycardia and 
myocardial ischaemia, but did not define ‘tachycardia’.168-170 Subsequently, 
three cohort studies identified association between heart rates >100 beats per 
minute during non-cardiac surgery and postoperative morbidity and mortality.171-
173 However, these used a priori heart rate thresholds and non-comparable 
composite outcome measures, including: mortality, intensive care unit 
admission or prolonged hospital stay;171 “negative surgical outcome”, consisting 
of postoperative hospital stay >10 days or death;173 and “cardiovascular 
complications”, consisting of ischaemic symptoms, myocardial infarction, 
cardiac dysrhythmia or new heart failure.172 In contrast, an observational study 
of the surgical APGAR score did not identify a relationship between 
intraoperative tachycardia and the development of any one of 17 postoperative 
complications or mortality.174 On balance, it is likely that intraoperative 
tachycardia is associated with postoperative complications. However, there is 
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insufficient evidence of association between tachycardia and specific outcome 
measures, for example myocardial infarction or myocardial injury. Furthermore, 
it is unclear how to numerically define ‘tachycardia’ and whether there are 
specific heart rate thresholds at which the risk of morbidity is increased. 
 
1.5.3 Heart rate recovery after preoperative exercise  
Exercise testing is increasingly used to assess appropriateness for surgery. 
However, research has focused on biomarkers of ventilation or gas exchange. 
Few studies have investigated heart rate or blood pressure during preoperative 
exercise testing. In a study of 177 elderly patients, the risk of postoperative 
morbidity was greater for those unable to raise their heart rate over 99 beats 
per minute during preoperative exercise, compared to controls.175 Similarly, 
evidence from a small study (n=32) suggests that the magnitude of change in 
heart rate from rest to maximum may predict postoperative morbidity.60  
 
The cardiac response to exercise is affected by increased sympathetic activity 
and decreased parasympathetic activity. Thus recovery of heart rate after 
exercise can be used to evaluate the autonomic nervous system, where 
prolonged heart rate recovery in the first minute after exercise suggests 
parasympathetic dysfunction. However, heart rate recovery after preoperative 
exercise has been subject to only limited investigation. In two small studies 
delayed heart rate recovery was associated with increased risk of mortality after 
paediatric heart transplantation, and intraoperative hypotension in intermediate-
risk adults.176, 177 New evidence suggests that parasympathetic dysfunction, 
reflected by impaired baroreflex sensitivity, is associated with clinically defined 
cardiovascular and infectious complications after major surgery.178  
	
	24 
In the context of autonomic control of heart rate and potential association 
between abnormal heart rate and cardiovascular morbidity, autonomic nervous 
system dysfunction may form part of the mechanism of perioperative 
myocardial injury. Parasympathetic autonomic dysfunction is associated with 
multiple risk factors for cardiovascular disease, including: diabetes mellitus,179 
ischaemic heart disease,180 cardiac failure,181 renal impairment182 and stroke.183, 
184 Parasympathetic dysfunction has been implicated in the development of 
cardiovascular disease in the general population, due to the loss of cardio-
protective vagal activity which is known to increase production of nitric oxide 
and anti-inflammatory cytokines, inhibit the renin-angiotensin axis and inhibit 
cardiac dysrhythmia formation.185 In the perioperative setting, two out of five 
high-risk surgical patients have parasympathetic impairment.178, 186 However, 
further research is needed to determine whether parasympathetic dysfunction is 
associated with biochemical myocardial injury after surgery. 
 
 
1.6 Arterial pressure in the perioperative period 
It is widely believed that changes in blood pressure during the perioperative 
period could cause or contribute to cardiovascular morbidity, through either 
oxygen supply-demand imbalance secondary to hypotension and low 
myocardial perfusion pressure, or as a result of existing cardiovascular disease 
and left ventricular strain in response to hypertension. However, the clinical 
blood pressure thresholds associated with organ injury remain unclear. This is 
important, given the apparent disconnect between haemodynamic variables 
and blood pressure, where in healthy volunteers, more than 25% of circulating 
blood volume must be lost before measureable changes in blood pressure 
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become apparent.187 The majority of existing research into perioperative blood 
pressure is limited to observational studies of intraoperative hypotension, using 
subjective clinical outcome measures, rather than objective biomarkers of organ 
injury. Few studies have investigated blood pressure before surgery, as 
highlighted in recent consensus guidelines.188 Here, I discuss the current 
evidence for association between perioperative blood pressure and 
postoperative morbidity and mortality. 
 
1.6.1 Arterial pressure before surgery 
As many as half of all patients undergoing high-risk non-cardiac surgery have 
pre-existing hypertension.16 Evidence from two large cohort studies and a meta-
analysis suggests that pre-existing hypertension is associated with increased 
risk of morbidity and mortality after non-cardiac surgery (table 1.6). However, 
hypertension is most often defined according to an existing diagnosis, rather 
than objective measurement of blood pressure before surgery. Therefore, the 
risk associated with elevated blood pressure on the day of surgery remains 
unclear, and it is not uncommon for surgery to be postponed or cancelled due 
to uncertainty about how to manage elevated preoperative blood pressure.189, 
190 Recent consensus guidelines suggest that surgery can proceed safely if the 
blood pressure is below 180/110mmHg in the preoperative assessment clinic, 
or less than 160/100mmHg in general practice.188,	 191 However, this guidance 
varies internationally192 and is mainly derived from expert opinion, since there 
are only a limited number of small studies in this field, all of which use 





Study Sample size Key findings 
Howell et al 
1996195 
152 Retrospective case-control study. Pre-existing 
hypertension was strongly associated with 
postoperative cardiovascular death within 30 
days of surgery. However, the absolute value of 
systolic of diastolic blood pressure was not 
associated with outcome. 
 
Howell et al 
1997196 
183 Prospective observational cohort study. Pre-
existing hypertension was associated with 
increased risk of postoperative silent myocardial 
ischaemia. 
 
Howell et al 
1998197 
230 Case-control study. Pre-existing hypertension 
was associated with cardiovascular death within 
30 days of elective surgery.  
Howell et al 
1999198 
146 Case-control study. Pre-existing hypertension 
was not associated with cardiovascular death 
within 30 days of urgent or emergency surgery. 
 
Basali et al 2000199 207 Matched case-control study of intracranial 
haemorrhage after craniotomy. Preoperative 
hypertension was not associated with 
postoperative intracranial haemorrhage.  
Howell et al 
2004200 
13671 Meta-analysis of 30 studies between 1971 and 
2001. Hypertensive disease was associated with 
postoperative cardiovascular complications. 
 
Sanders et al 
2012201 
429509 Retrospective cohort study using hospital episode 
statistics. Existing diagnosis of hypertension was 
associated with mortality following total knee 
replacement but not AAA repair. 
 
Mathis et al 
2013202 
244397 Retrospective cohort study. Existing diagnosis of 
hypertension was associated with a composite 
outcome of mortality and morbidity with 72 hours 
of day case surgery. 
 
 
Table 1.6. Summary of previous studies of preoperative hypertension. Two large 
retrospective cohort studies suggest that a diagnosis of hypertension is associated with 
mortality after day-case total knee replacement surgery. A meta-analysis of 30 small 
studies suggests that hypertension is associated with postoperative mortality and 
morbidity. Five smaller studies show weaker and inconsistent evidence of an 
association between hypertension and postoperative outcome. 
 
1.6.2 Arterial pressure during surgery 
The incidence of intraoperative hypotension is unknown, largely due to the 
absence of a consistent definition. Bijker et al reviewed 130 studies of 
intraoperative hypotension and identified 140 different definitions.203 When 
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these were applied to an observational cohort of ~15,000 patients, the 
incidence of hypotension was between 5% and 99% of the sample, depending 
of the definition used.203 However, numerous studies have identified association 
between intraoperative hypotension and perioperative mortality. One of the 
largest studies found that intraoperative hypotension was among the 
commonest cited factors contributing to deaths related to anaesthesia.204 In the 
POISE trial, “clinically significant hypotension” was independently associated 
with perioperative mortality and stroke,166 while numerous other studies have 
identified systolic hypotension and low mean arterial pressure as risk factors for 
perioperative mortality.205-207 Similarly, several studies have identified 
association between intraoperative hypotension and cardiovascular 
complications after surgery.208, 209 However, these use subjective clinically 
defined outcome measures, rather than objective biomarkers of organ injury. 
 
Intraoperative hypertension is comparatively under-researched. The majority of 
published articles are case reports/series of patients undergoing endocrine or 
vascular surgery. In two observational cohort studies of cataract surgery and 
thyroid surgery the incidence of hypertension was between 10% and 60%.210, 211	
However, whether intraoperative hypertension is associated with adverse 
postoperative outcomes is unclear. Further research is needed to understand 
intraoperative hypertension and the potential association with postoperative 
morbidity and mortality. 
	
 
1.6.3 Arterial pulse pressure before surgery 
In the general population arterial pulse pressure is associated with 
cardiovascular morbidity, independent of existing hypertension.147, 148, 212, 213 
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Data from the Framingham heart study suggests that as age increases, pulse 
pressure becomes the main blood pressure related risk factor for incident 
cardiovascular events.143 This finding is replicated in other longitudinal 
cohorts.147 It seems intuitive that pulse pressure should be a more instructive 
physiological biomarker than systolic or diastolic pressures alone. Blood 
pressure is regulated by feedback from baroreceptors in the carotid sinus, aortic 
arch and atrial wall.75 Baroreceptors are stretch receptors and the degree of 
arterial stretch is dictated by pulse pressure. Elevated pulse pressure is 
associated with increased aortic wall stiffness,214 which influences sympathetic 
baroreflex sensitivity in elderly men and women.215 Impaired baroreflex 
sensitivity is associated with cardiovascular morbidity after major surgery.178 
Alternatively, pulse pressure could combine pathophysiological processes 
usually associated with either elevated systolic pressure or reduced diastolic 
pressure, for example left ventricular hypertrophy secondary to systolic 
hypertension, leading to end-systolic myocardial stress,216, 217 or poor coronary 
perfusion as a result of low diastolic pressure relative to left ventricular end-
diastolic pressure, causing myocardial ischaemia.218 
 
In this context, preoperative pulse pressure may be a superior predictor of 
perioperative cardiovascular outcomes compared to systolic blood pressure or 
pre-existing diagnoses of hypertension. However, the majority of existing 
studies of preoperative pulse pressure are restricted to patients undergoing 
cardiac surgery (table 1.7). Two observational studies identified association 
between preoperative pulse pressure >70-80mmHg and cardiovascular 
morbidity and mortality of patients undergoing coronary artery bypass grafting 
(CABG).163, 219 These findings were replicated in a separate retrospective 
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cohort.220 In contrast, only two retrospective studies have investigated pulse 
pressure before non-cardiac surgery (table 1.8), neither of which identified 
association between pulse pressure and postoperative outcomes.221, 222 
However, these studies have several limitations. They were retrospective in 
design and had small sample sizes, which limits the statistical power. In keeping 
with the majority of research in this field, they used subjective clinical outcome 
measures.  
Study Sample size Key findings 
Benjo et al 2007223 703 Retrospective cohort study of patients having 
coronary artery bypass grafting. Preoperative 
pulse pressure was associated with 
postoperative stroke. 
 
Aboyans et al 
2008163 
1022 Prospective cohort study of patients 
undergoing coronary artery bypass grafting. 
Preoperative pulse pressure >70mmHg was 
associated with mortality, myocardial 
infarction, stroke or TIA with 30 days of 
surgery. 
 
Fontes et al 2008219 4801 Prospective cohort study of patients 
undergoing coronary artery bypass surgery. 
Preoperative pulse pressure >80mmHg was 
associated with cardiac complications and 
death from a cardiac cause. 
 
Nikolov et al 
2010220 
973 Retrospective cohort study of patients 
undergoing coronary artery bypass grafting. 
Elevated preoperative pulse pressure was 
associated with reduced long-term survival 
(mean follow-up 7.3 years). 
Mazzeffi et al 
2012222 
556 Retrospective cohort study of patients having 
infrainguinal arterial bypass surgery. No 
association between preoperative pulse 
pressure and 30-day or 1-year mortality. 
 
Asopa et al 2012221 412 Retrospective cohort study of patients 
undergoing lower extremity bypass surgery. 
Preoperative pulse pressure is not associated 
with postoperative cardiovascular events. 
 
 
Table 1.7. Summary of previous studies of preoperative pulse pressure. Four 
studies demonstrate association between preoperative pulse pressure and 
postoperative outcomes in patients undergoing cardiac surgery. The remaining two 
retrospective cohort studies did not identify association between preoperative pulse 
pressure and postoperative mortality or cardiovascular events inpatients undergoing 
vascular surgical procedures.  
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Thus there is evidence of association between preoperative pulse pressure and 
postoperative morbidity and mortality after cardiac surgery, but it is unclear if 
this is the same for non-cardiac surgery. Furthermore, it is unclear if 
preoperative pulse pressure is associated with perioperative myocardial injury 
defined using cardiac biomarkers, or if there is a pulse pressure threshold 
above or below which the risk of morbidity or mortality increases. Further 
research is needed to evaluate these unanswered questions. 
 
 
1.7 Perioperative beta-blockade 
Until recently, beta-blockers were widely used to reduce cardiovascular 
complications after surgery. However, growing evidence over the past decade 
suggests that the clinical benefit of perioperative beta-blocker therapy may be 
outweighed by harmful side effects.224 Despite over thirty years of research in 
this area,145, 146, 156, 157, 165, 166, 169-174 very little is known about the 
pathophysiology of perioperative myocardial infarction and myocardial injury,166, 
225-235 or how beta-blockade might exert a cardio-protective effect.236 The 
presumed mechanism of action is that beta-blockers reduce tachycardia, which 
could plausibly contribute to myocardial injury via a mechanism of myocardial 
oxygen supply-demand imbalance.96, 97, 102, 160 However, there is little evidence 
to support this. Thus it remains controversial whether there is any place for 
perioperative beta-blockers in contemporary anaesthetic practice.  
 
If tachycardia does contribute to perioperative myocardial injury then it is 
plausible that other negatively chronotropic agents, for example non-
dihydropyridine calcium channel antagonists or ivabradine, may prevent 
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perioperative cardiovascular complications.237, 238 However, since beta-blockade 
has been the prevailing focus of research and clinical activity in this field for 
over thirty years, I have restricted my analysis to beta-blockade. 
 
1.7.1 Beta-blocker therapy for cardiovascular disease  
Given the observation that elevated heart rate is associated with the 
development of heart failure in the general population, it seems intuitive that 
beta-adrenoceptor antagonists (beta-blockers) are used to treat heart failure, in 
addition to the negative inotropic benefits. Two randomised controlled trials by 
the Carvedilol Heart Failure Study Group in the late 1990s, found that 
compared to placebo, treatment with Carvedilol was associated with reduced 
mortality in patients with mild/moderate or severe heart failure.239, 240 One trial 
was stopped early after the independent data monitoring committee found the 
risk of mortality was 65% lower in the beta-blocker group at the interim 
analysis.239 Another randomised trial by the same group of investigators 
identified a reduction in both symptoms and the number and duration of hospital 
admissions for heart failure associated with beta-blocker treatment in patients 
with severe heart failure.241 Other clinical trials have shown that beta-blocker 
therapy can reduce the risk of death after acute myocardial infarction,242 and 
the subsequent risk of re-infarction.243 
 
1.7.2  Perioperative beta-blockade: early evidence of clinical benefit 
Until recently beta-blockers were commonly used to prevent perioperative 
morbidity and mortality.244, 245 The American Heart Association recommended 
beta-blocker treatment for several patient groups, largely based on the results 
of the DECREASE I trial,228, 229 including: vascular surgery patients with 
	
	32 
preoperative myocardial ischaemia; patients with a history of ischaemic heart 
disease; or with risk factors for ischaemic heart disease or hypertension.246 
However, the evidence supporting perioperative beta-blockade became 
increasingly conflicted. In 2005 two meta-analyses were published, which 
supported beta-blockade to differing degrees (table 1.8).  
	
Table 1.8. Summary of trials included in meta-analyses by McGory and 
Devereaux.226, 244 
§ Wallace 1998 used the same dataset as Mangano 1996. Ψ Yang et al. initially 
published this analysis as a supplement in the Canadian Journal of Anesthesia in 
2004, and subsequently re-published in 2006 in the American Heart Journal. 
 
One meta-analysis by McGory et al included data from six randomised 
controlled trials and supported beta-blockade, citing reductions in mortality and 
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Yang 2004253 Ψ 496 Metoprolol Composite of cardiac 
death, atrial fibrillation or 
ventricular arrhythmia, 
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cardiovascular complications associated with treatment.169, 228, 229, 250-252 
However, the other much larger meta-analysis by Devereaux et al found that 
beta-blockade was only associated with reduced risk of a composite outcome of 
myocardial infarction, non-fatal cardiac arrest or death, but that the results were 
not replicated when each outcome was considered individually.229, 247-253 An 
accompanying power calculation suggested that a definitive clinical trial would 
need at least 6,000 participants, compared to the majority of existing studies, 
which had sample sizes of less than 100 participants.225 
 
1.7.3  The influence of bias and research misconduct 
The Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress 
Echocardiography (DECREASE) studies had a prominent influence on 
guidelines and clinical practice in favour of perioperative beta-blocker use.229, 254 
224, 246, 255 However, it later emerged that the principal investigator was 
responsible for several breaches of academic integrity, described as ‘negligent 
conduct’, including: fabricating data and methods, pretending to use 
adjudication committees and failing to obtain informed consent.256-258 Given the 
concerns about the integrity of the DECREASE studies and the methods and 
sample sizes of the early beta-blocker trials, the influence of bias on the 
evidence in support of beta-blockers is likely to be high.259, 260 One meta-
analysis concluded that the majority (21/34) of available trials were at a high-
risk of bias.225 When these were excluded, the previously observed cardio-
protective effect of beta-blockade was diminished (table 1.9).225 Bouri et al. 
performed a meta-analysis of ‘secure trials’, excluding data from the high-bias 
trials like DECREASE, which found that beta-blockade was associated with 




Outcome Low bias trials 
[OR (95% CI)] 
High bias trials 
[OR (95% CI)] 
Low & high bias 




0.72 (0.59 – 0.87) 0.19 (0.19 – 0.39) 0.65 (0.54 – 0.79) 
Myocardial 
Ischaemia 
0.42 (0.27 – 0.65) 0.31 (0.20 – 0.49) 
 
0.36 (0.26 – 0.50) 
Table 1.9. The effect of peri-operative beta-blockade on post-operative cardiac 




1.7.4 The POISE trial 
The Peri-operative Ischaemia Evaluation (POISE) trial is the largest trial of peri-
operative beta-blockade.227 Over 8,000 patients were randomised to receive 
either metoprolol succinate or placebo at 190 hospitals in 23 countries over five 
years. Treatment with metoprolol was associated with a lower risk of myocardial 
infarction, non-fatal cardiac arrest (hazard ratio 0.84, 95% CI: 0.7 to 0.99) within 
30 days of surgery. However, metoprolol was also associated with an increased 
risk of death (hazard ratio 1.33, 95% CI: 1.03 to 1.74) and stroke (hazard ratio 
2.17, 95% CI: 1.26 to 3.74).166 Thus, the beneficial effect of beta-blockade was 
outweighed by greater risk of harm.225 Mortality in the beta-blocker group was 
associated with hypotension. Therefore, it is possible that stroke and death 
could be caused by reduced cardiac output, secondary to beta-blockade, 
manifest as hypotension.166 The trial used a fixed dose of metoprolol for all 
patients, irrespective of age or co-morbidity, which was withheld only if the 
blood pressure or heart rate were very low.227  Recent guidelines suggest 
titrating beta-blocker dose to a heart rate between 60-80 beats per minute. 
However, there is little evidence to support targeting specific heart rates and it is 





1.7.5 Summary of perioperative beta-blockade 
Current evidence suggests that perioperative beta-blockade is associated with 
reduced risk of perioperative myocardial infarction, but increased risk of stroke 
and death. Consequently, the routine use of beta-blockers in patients 
undergoing surgery is no longer recommended.261 The pathophysiological 
mechanism by which beta-blockers might confer benefit or cause harm is poorly 
understood. Chiefly, there is little evidence of association between perioperative 
heart rate (or specific values of heart rate) and postoperative cardiovascular 




The most common causes of postoperative mortality are cardiovascular in 
origin. However, symptomatic cardiac events represent only a small proportion 
of postoperative cardiovascular morbidity. Myocardial injury, identified by a 
transient rise in cardiac biomarkers, is predominantly asymptomatic and occurs 
after one in ten non-cardiac surgical procedures. It is strongly associated with 
mortality, but the pathophysiological mechanism(s) for this relationship is 
unclear. The majority of existing research uses clinical outcome measures, but 
these are subjectively defined and at risk of bias. In contrast, myocardial injury 
is an objective, biomarker-defined outcome measure at lower risk of bias.  
 
Beta-blocker therapy reduces the risk of perioperative myocardial infarction. 
One potential explanation is that lower heart rate prevents myocardial injury by 
reducing rate-related myocardial ischaemia. This treatment was routinely used 
until the results of the POISE trial suggested that perioperative beta-blockade 
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may be harmful due to the increased risk of stroke and death. However, this trial 
used a standard dosage regime for all patients and did not titrate drug dosage 
to heart rate, which may have resulted in inappropriate dosing for some 
patients, potentially explaining some of the observed harm. Currently, there is a 
lack of evidence to support association between perioperative heart rate and 
cardiac complications. Thus, evidence-based heart rate thresholds, which could 
be used to target rate-controlling therapy, are not available. 
 
Several observational studies identified that intraoperative tachycardia was 
associated with clinically defined cardiac complications after surgery. However, 
these studies did not quantitatively define ‘tachycardia’. Other observational 
studies have identified association between preoperative heart rate and cardiac 
complications after both cardiac and non-cardiac surgery, but not biochemical 
myocardial injury. The largest study was a secondary analysis of the POISE 
trial. However, again, quantitative heart rate thresholds that could be used 
clinically were not identified. Limited data from pilot studies suggest that 
impaired heart rate recovery after preoperative exercise, a marker of 
parasympathetic autonomic dysfunction, may be associated with postoperative 
clinical outcome. While evidence from the general population suggests that 
elevated resting heart rate is a poor prognostic indicator in patients with heart 
failure. However, this has not been investigated in surgical patients. 
 
Elevated blood pressure is an accepted risk factor for cardiovascular disease in 
the general population. Growing evidence suggests that, particularly in elderly 
patients, pulse pressure may be more strongly associated with clinical 
outcomes than systolic or diastolic pressure. It is plausible that very high or very 
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low blood pressure in the perioperative period could cause myocardial injury, as 
a result of oxygen supply-demand imbalance. However, the majority of 
perioperative blood pressure research has focused on intraoperative 
hypotension, rather than preoperative blood pressure or intraoperative 
hypertension. As a result, many clinicians are uncertain about how to deal with 
elevated blood pressure on the day of surgery, leading to postponed or 
cancelled surgical procedures. Research is needed to determine whether 
abnormal blood pressure before or during surgery is a risk factor for myocardial 
injury. 
 
1.9 Research aims 
1. To investigate the relationship between preoperative heart rate and 
myocardial injury after non-cardiac surgery. 
	
2. To investigate the relationship between preoperative pulse pressure and 
myocardial injury after non-cardiac surgery. 
	
3. To investigate the relationship between intraoperative heart rate and 
blood pressure, and myocardial injury after non-cardiac surgery. 
	
4. To investigate the relationship between preoperative heart rate and 
cardiopulmonary and autonomic function. 
	
5. To investigate the relationship between parasympathetic autonomic 
dysfunction, identified by impaired heart rate recovery after preoperative 






Chapter two  
Methods 
2.1  Methodology 
In this thesis I use epidemiological methods to identify cardiovascular risk 
factors for perioperative myocardial injury. Epidemiology is the study of the 
frequency, distribution and causes of disease.262 Its origins date back to the 19th 
Century when William Farr systematically recorded causes of death in England 
in 1839 and when John Snow identified contaminated water as a vector for 
cholera transmission in London in 1854.262, 263 The epidemiological paradigm is 
based on two core assumptions, that disease “does not occur at random” and 
“has causal and preventative factors”.262 Epidemiology relies on the observation 
and measurement of association between exposures and outcomes, to identify 
risk factors for disease and build evidence of causal mechanism, in samples of 
subjects from defined populations. Health Services Research (HSR) 
encompasses clinical research drawing on a range of disciplines, which involve 
patients and the health services and systems that serve them.265-267 
 
2.1.1 Research using existing data 
Health Services Research falls into two broad categories according to the data 
source: research using primary data and secondary analyses of existing 
data.268 Research using existing data is increasingly common in critical care, 
and perioperative medicine,269 and provision for data sharing to bona fide 
researchers is often a mandatory condition of research council or charity funded 
research grants in the UK.270 The main advantage is that secondary analyses 
maximise the utility of the data and at a much lower cost than collecting a 
	
	39 
similar data set de novo. For large data sets, which are often required for 
complex statistics, or where a long follow-up period is needed, secondary 
analyses may be the most financially and logistically efficient way to answer a 
research question, compared to a new, multi-centre study.269 
	
	
2.1.2 Strategies for analysis 
The purpose of analytic epidemiology is to identify association between 
exposures and outcomes, in order to identify causal risk factors for (and thus 
prevent) disease. There are two broad strategies for analysing observational 
data: explanatory (‘causal’) and predictive (‘data-driven’) modelling, where 
‘modelling’ means to define a mathematical relationship between exposure(s) 
and outcome(s).271 Predictive modelling seeks to identify variables within a data 
set that are associated with an outcome, which often develops into a prediction 
rule or scoring system where constituent factors are weighted according to 
association with the outcome. These models include a large number of 
variables and it is common practice to examine the data before planning the 
analysis.268 In contrast, explanatory modelling aims to identify association 
according to a priori hypotheses, which usually include adjustment for potential 
confounding. The number of variables included in an explanatory model is 
usually less than for a predictive model. The ultimate aim of explanatory 
modelling is to identify factors that could cause disease. However, association 









2.1.3 Methodological approach and rationale for this thesis 
The overarching aim of this thesis is to investigate potential cardiovascular risk 
factors for perioperative myocardial injury. Specifically, whether extremes of 
heart rate or blood pressure are associated with perioperative myocardial injury 
in patients undergoing non-cardiac surgery. I used explanatory modelling to 
analyse five existing data sets to answer a series of linked research questions. 
Data from three studies that were already complete were supplemented with 
data from two further studies where I was actively involved in data collection. I 
played a leading role in one study as the UK national co-ordinator, in addition to 
recruiting patients and collecting data at my own hospital over four years. This 
approach has several benefits. Firstly, using data from large studies provided a 
sufficiently large number of cases to make adjustments for potential 
confounding factors. This provided an important opportunity for training in 
epidemiological methods and statistical analysis of large data sets, which would 
not otherwise be possible. Secondly, using data from three studies that were 
already completed reduced the risk of non-completion through lack of data. 
Thirdly, playing a central role in an international multi-centre observational 
cohort study was a unique opportunity to manage a large multi-centre research 
project, including consenting and recruiting patients.  
 
2.1.4 Data sources and data collection 
The data for this thesis is derived from five epidemiological studies. Two 
international cohort studies: the ‘Vascular events In non-cardiac Surgery 
patIents cOhort evaluatioN’ (VISION) and the ‘Measurement of Exercise 
Tolerance for Surgery’ (METS) studies; one UK cohort study: the ‘Peri-
Operative Morbidity – Heart Rate’ (POM-HR); and two multi-centre randomised 
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controlled trials: the ‘Opimisation of perioperaTive cardIovascular Management 
to Improve Surgical outcomE’ (OPTIMISE) and the ‘Post Operative Morbidity - 
Oxygen’ (POMO) trial. In all studies, surgical patients were enrolled according 
to clearly defined eligibility criteria and data were collected using standardised 
case report forms, with clear definitions exposure and outcomes, which were 
compatible between studies. I describe each study in further detail below.  
 
	
2.2 The Measurement of Exercise Tolerance before Surgery 
(METS) study 
I performed secondary analyses of the METS study as described in chapter 
seven. The methods of the study have been published previously.1 
 
2.2.1 Primary aim of the METS study 
Cardiopulmonary fitness is thought to be an important risk factor for morbidity 
and mortality after surgery. The METS study aimed to compare preoperative 
cardiopulmonary exercise testing, a standardised questionnaire (Duke Activity 
Status Index) and physician judgement for predicting cardiovascular morbidity 
and mortality after non-cardiac surgery.1 
 
2.2.2 Study design 
International, multi-centre, prospective, observational cohort study in 23 
hospitals in the United Kingdom, Canada, Australia and New Zealand. I was the 






Participants were aged 40 years or older, undergoing elective non-cardiac 
surgery, with an anticipated overnight stay in hospital and at least one of the 
following risk factors: coronary artery disease, heart failure, cerebrovascular 
disease, diabetes mellitus, estimated glomerular filtration rate 
<60ml/min/1.73m2, peripheral arterial disease, hypertension, smoking within the 
previous one year, age of 70 years or more, or intermediate- or high-risk 
surgery. Patients were excluded if there was: inadequate time to feasibly 
complete cardiopulmonary exercise testing at least 24 hours in advance of 
surgery, planned use of cardiopulmonary exercise testing for preoperative risk 
stratification independent of the METS study, planned surgery performed 
exclusively using an endovascular technique, presence of an automated 
implantable cardio-defibrillator, known or suspected pregnancy, previous 
enrolment in the METS study, active cardiac conditions,224 absolute 
contraindications to cardiopulmonary exercise testing (American Thoracic 
Society and American College of Chest Physicians guidelines)272 or conditions 
expected to preclude cardiopulmonary exercise testing (e.g. lower limb 
amputation), or systolic blood pressure of 180mmHg or more or diastolic blood 
pressure of 100mmHg or more at the time of study recruitment. 
 
2.2.4 Study conduct and data collection 
All patients enrolled in the study underwent preoperative cardiopulmonary 
exercise testing, between February 2013 and March 2016. Researchers at each 
site collected data from patients and their medical record before, during and 
after surgery using a standardised case report form, with standardised 
definitions. These data were entered on to a secure web-based data entry 
platform. All patients underwent a preoperative symptom-limited 
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cardiopulmonary exercise test, the protocol for which is explained below. Blood 
samples and electrocardiograms were collected before surgery and on the first, 
second and third postoperative days. In the United Kingdom, blood samples 
were centrifuged and serum extracted for freezing, to facilitate analysis at the 
central laboratory. The laboratory measured preoperative and postoperative 
troponin I (TnI). At 30 days and one year after surgery, researchers contacted 
participants on the telephone to conduct a short interview using a standardised 
questionnaire. 
 
2.2.5 Research ethics approval and sponsorship 
Research ethics committee/board approval for the METS study was obtained 
for each hospital before starting the study. Ethics approval for the UK was 
granted by the South East Coast (Surrey) Research ethics committee 
(reference: 13/LO/0135). The study was sponsored by St. Michael’s Hospital, 
Toronto, Canada, with Queen Mary University of London acting as the 
Sponsor’s representative in the United Kingdom. The study was conducted in 




2.3 The Vascular events In non-cardiac Surgery patIent 
cOhort evaluatioN (VISION) study 
I performed secondary analyses of the prospective international observational 
cohort study, the Vascular Events in Non-cardiac Surgery Cohort Evaluation 
(VISION) study as described in chapters three, four and five.16 The methods of 




2.3.1 Primary aim of the VISION study 
The VISION study aimed to determine whether postoperative cardiac troponin T 




2.3.2 Study design 
International, multi-centre, prospective, observational cohort study of patients 
undergoing non-cardiac surgery.  
 
2.3.3 Participants 
Participants were aged 45 years or older, undergoing non-cardiac surgery using 
a general or regional anaesthetic technique and were anticipated to require at 
least an overnight hospital admission after surgery. Patients were excluded if 
they had previously been enrolled in the study. All participants or their 
designates provided written informed consent to take part in the study. Eight 
hospitals used deferred consent for patients who were unable to provide 
consent and had no next of kin available. Where it was not possible to approach 
the patient before surgery (e.g. emergency surgery), they were approached for 
written consent within 24 hours after the procedure. 
 
2.3.4 Data collection 
The data included in this thesis is derived from the first cohort of ~15,000 
patients, recruited from 12 hospitals in eight countries in Asia, Australia, Europe 
and North/South America between 6th August 2007 and 11th January 2011. 
Researchers at each hospital collected data from patients and their medical 
record before, during and up to one year after surgery. Data were collected 
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using a standardised and detailed case report form, with standardised 
definitions of exposures and outcomes. At 30 days after surgery, researchers 
contacted participants on the telephone to conduct a short interview regarding 
postoperative complications.  
 
2.3.5 Outcome measures 
The VISION study defined myocardial injury after non-cardiac surgery (MINS) 
as: serum Troponin T (TnT) ≥0.03ng/mL within 30 days after surgery, 
adjudicated as due to an ischaemic pathology.95, 113 Blood samples were 
obtained before surgery, 6-12 hours after the end of surgery and then on 
postoperative days one, two and three. In addition, investigators were 
encouraged to take additional blood samples if participants experienced an 
ischaemic symptom within the 30-day postoperative period. Serum was tested 
for troponin T using a Roche 4th generation Roche ElecsysTM assay. For 
patients with postoperative troponin ≥0.04ng/mL, the accepted laboratory 
threshold at the start of the study, an electrocardiogram was performed and 
subsequently an echocardiogram in the absence of dynamic 
electrocardiographic changes.  For each TnT measurement ≥0.03ng/mL, one of 
15 independent adjudicators reviewed the clinical information, including the 
medical record, electrocardiograms and echocardiograms, and decided if there 
was evidence of a non-ischaemic cause of the TnT elevation (e.g. pulmonary 
embolus, sepsis, renal failure etc.). Patients with a serum troponin elevation 
<0.04ng/mL were not investigated for evidence of myocardial ischaemia.  
 
The VISION study defined myocardial infarction using the third universal 
definition; serum troponin elevation in the presence of at least one of: ischaemic 
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symptoms; the development of new or presumed new Q waves, ST segment or 
T wave changes, or left bundle branch block on the electrocardiogram; or the 
finding of a new or presumed new regional wall motion abnormality on 
echocardiography.94 
 
2.3.6 Research ethics approval and sponsorship 
Research ethics committee/board approval for the VISION study was obtained 
for each hospital before starting the study. Ethics approval for UK hospitals was 
granted by North Wales Research ethics committee (reference: 10/WN/0325). 
The research was conducted in accordance with the Declaration of Helsinki and 
the Research Governance Framework. The study was sponsored by McMaster 
University, Hamilton, Canada, with Queen Mary University of London acting as 
the Sponsor’s representative in the United Kingdom. The study was registered 
with clinicaltrials.gov (NCT00512109). 
 
	
2.4 The Post Operative Morbidity-Heart Rate (POM-HR) study 
I performed secondary analyses of POM-HR study as described in chapter six. 
The methods of study have been published previously.277, 278 
 
2.4.1 Primary aim of the POM-HR study 
The POM-HR study aimed to demonstrate that parasympathetic autonomic 
dysfunction (as reflected by heart rate response to exercise) was associated 






2.4.2 Study design 
Prospective observational cohort study of patients undergoing major surgery, 




Participants were aged 45 years or more, scheduled for major surgery predicted 
to last for more than two hours, and were referred for cardiopulmonary exercise 
testing (CPET) as part of their routine preoperative assessment. Patients 
provided written informed consent before taking part in the study (prior to 
exercise testing). Patients were excluded if there was: a history exercise 
induced angioedema, pregnancy, or any contraindication to cardiopulmonary 
exercise testing.272 These criteria are very similar to the eligibility criteria for the 
VISION study.16 
 
2.4.4 Study conduct 
The POM-HR study included 1,572 patients undergoing major non-cardiac 
surgery at five UK centres between March 2013 and March 2015. All 
participants underwent cardiopulmonary exercise testing as part of their routine 
preoperative assessment. Researchers at each site collected data before, 
during and after surgery using a standardised case report form.  
 
2.4.5 Research ethics approval and sponsorship 
The study was approved by the National Research Ethics Committee London 
(Camden & Islington; 12/LO/0453) and registered with Controlled Trials 
(ISRCTN88456378). The study was sponsored by University College London 
Hospitals NHS Foundation Trust. 
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2.5 The Optimisation of perioperaTive cardIovascular 
management to Improve Surgical outcomE (OPTIMISE) trial 
I performed secondary analyses of OPTIMISE trial as described in chapter six. 
The methods of study have been published previously.279  
 
2.5.1 Primary aim of the OPTIMISE trial 
The OPTIMISE trial aimed to determine whether cardiac output monitor guided 
(goal directed) intravenous fluid therapy and inotropes according to a 
standardised treatment algorithm was superior to usual clinical care.279 
 
2.5.2 Study design 
Multi-centre randomised controlled trial of perioperative cardiac output-guided 
haemodynamic therapy according to a standard treatment algorithm for 
intravenous fluid therapy and dopexamine (inotrope) infusion during surgery 
and for six hours after surgery, compared to usual clinical care in patients 
undergoing major gastrointestinal surgery.  
	
2.5.3 Participants 
Adults undergoing major gastrointestinal surgery with expected duration greater 
than 90 minutes that also satisfied the following criteria: aged 65 years or over, 
or; aged 50-64 years, and one of the following: non-elective surgery, acute or 
chronic renal impairment defined as serum creatinine ≥130μmol/l, diabetes 
mellitus or the presence of a risk factor for cardiac or respiratory disease.280 
Patients were excluded if they: refused to provide informed consent, received 
palliative treatment only (likely to die within 30 days), had acute myocardial 
ischaemia (within the 30 days prior to randomisation), had acute pulmonary 
oedema (within 7 days prior to randomisation), had septic shock, had 
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thrombocytopenia (platelet count <50 x 109/l), received monoamine oxidase 
inhibitors, had a phaeochromocytoma, had severe left ventricular outlet 
obstruction e.g. due to hypertrophic obstructive cardiomyopathy or aortic 
stenosis, had hypersensitivity to dopexamine hydrochloride or disodium 
edelate, were participating in another randomised controlled trial, or were 
pregnant at the time of enrolment. 
 
2.5.4 Study conduct 
The OPTIMISE trial included 734 patients undergoing major gastrointestinal 
surgery at 17 UK hospitals, between June 2010 and November 2012. 
Participants in the intervention group were commenced on the treatment 
algorithm at the induction of anaesthesia and continued until six hours after 
surgery. Cardiac output monitoring was conducted using LidCo Rapid (Lidco, 
London, UK) cardiac output monitors (see section 2.10). Researchers at each 
site collected data before, during and after surgery using a standardised case 
report form. Researchers collecting outcome data were blinded to treatment 
group allocation where possible.  
	
2.5.5 Research ethics approval and sponsorship 
Research ethics approval was granted by the East London and City Research 
Ethics Committee (09/H0703/23). The trial was approved by the Medical and 
Healthcare Products Regulatory Agency. The trial was sponsored by Queen 
Mary University of London. The study was coordinated by the Intensive Care 





2.6 The Post Operative Morbidity-Oxygen (POMO) trial 
I performed secondary analyses of POM-O trial as described in chapter six. The 
methods of study have been published previously.281  
 
2.6.1 Primary aim of the POM-O trial 
The POM-O trial aimed to determine whether oxygen-delivery targeted 
haemodynamic therapy would reduce postoperative morbidity in high-risk 
surgical patients.281 
 
2.6.2 Study design 
Multi-centre, randomised, double-blinded controlled trial of an intravenous fluid 
protocol with or without dobutamine, targeted to achieve individual preoperative 
oxygen delivery, compared to standard perioperative care in adults undergoing 
major elective surgery.  
 
2.6.3 Participants 
Eligible patients were those undergoing major surgical procedures (abdominal 
or oesophageal or hepatic or gynaecological or urological reconstructive) with a 
high risk of postoperative morbidity and who met the following criteria:282 
American Society of Anesthesiologists risk score 3 or 4, age greater than 50 
years, and more than three cardiovascular risk factors according to the Revised 
Cardiac Risk Index.20 The exclusion criteria were:282 current lithium therapy, 






2.6.4 Study conduct 
The POM-O trial recruited 204 patients from four UK hospitals between 20th 
May 2010 and 12th February 2014. Participants were allocated to treatment 
groups using a concealed envelope system, with the allocation sequence 
generated using STATA (Statacorp, USA). Participants in the intervention group 
were commenced on treatment alogorithm once they reached the critical care 
unit after surgery. Cardiac output monitoring was conducted throughout the 
surgical procedure using a LidcoPlus (Lidco, London, UK) cardiac output 
monitor (see section 2.10), which required the insertion of a radial artery 
catheter before the induction of anaesthesia. The intervention continued until 
six hours after the completion of surgery. Participants in the control group 
received usual postoperative care. Researchers collected detailed data before, 
during and after surgery using a standardised case report form until hospital 
discharge.  
 
2.6.5 Research ethics approval and sponsorship 
Research ethics approval was granted by the South London Research Ethics 
Committee (09/H0805/58). The trial was sponsored by University College 




2.7  Literature review 
As part of the preliminary work for this thesis I conducted a review of the 
existing literature. I searched the following databases: MEDLINE; EMBASE; 
and Web of Science. I used the following search terms: heart rate; non-cardiac 
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surgery; pre-operative heart rate; resting heart rate; baseline heart rate; peri-
operative mortality; post-operative mortality; surgical mortality; surgical 
outcome; morbidity; surgery; pulse-pressure; pre-operative pulse-pressure; pre-
operative arterial pulse-pressure; cardiopulmonary exercise test; CPET; CPX; 
CPEX; pre-operative cardiopulmonary exercise test; pre-operative beta 
blockade; peri-operative beta-blockade; pre-operative beta-blocker; peri-
operative beta-blocker; beta-blocker; perioperative myocardial injury; MINS; 
perioperative myocardial infarction. I reviewed the reference lists of the relevant 
journal articles to generate further papers to review. I collated and managed 
journal articles using Papers version 2.8.3 (BV Mekentosj, Dordrecht, The 
Netherlands). I managed references using EndnoteTM version X6 (Thomson 
Reuters, New York, USA). 
 
 
2.8 Patient and public involvement 
The patient representative for this research was David Hepworth, who reviewed 
the scientific content of this thesis and provided advice during the writing of the 
lay summary. During the preliminary stages of planning this project, the Patient 
and Public Involvement (PPI) Group of the Royal College of Anaesthetists 
Health Services Research Centre (HSRC) reviewed and provided feedback on 
the initial project proposal. They felt that there was clear potential for patient 
benefit from this and subsequent research. Their feedback helped me to 









2.9 Cardiopulmonary exercise testing (CPET) 
I used cardiopulmonary exercise test (CPET) data from the POM-HR and METS 
studies. Here I provide an overview of preoperative CPET with specific details 
of the experimental approaches used in the METS and POM-HR studies. 
 
2.9.1 Overview of preoperative CPET 
Physiologists have measured cardiopulmonary responses to exercise for over a 
century.283 There are many methods for evaluating cardiovascular performance. 
However, the cardiopulmonary exercise test is the only method for 
simultaneous assessment of cardiovascular and respiratory performance, 
particularly the quantitative measurement of oxygen consumption.284, 285 
Treadmill exercise tests, developed by Bruce286 and Ellestad,287 are routinely 
used to detect exercise-induced myocardial ischaemia.284 However, these 
protocols only utilise electrocardiogram and blood pressure monitoring and do 
not measure ventilatory parameters. Multiple other tests can be employed to 
evaluate cardiovascular fitness,284 including: the Harvard Step Test,288 the 600-
yard Run-Walk,284 the 12-minute field test,289 the 12-minute walk test290 and six-
minute walk test.291 However, these tests estimate cardiovascular fitness by 
measuring function (e.g. distance walked) rather than a quantitative 
physiological variable.  
 
Cardiopulmonary exercise testing is most often performed using a cycle 
ergometer and continuously measures the electrocardiogram, heart rate, pulse-
oximetry, minute ventilation, oxygen uptake and carbon dioxide production, as 
well as intermittent non-invasive measurement of arterial blood pressure.292 
CPETs most commonly follow an incremental ramp protocol, where the 
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workload increases gradually throughout the test.284 Cardiopulmonary exercise 
testing was not used as part of preoperative assessment until after Older and 
Smith’s work of the 1990s, which identified a link between measurable 
cardiopulmonary performance, namely anaerobic threshold, and clinical 
outcome after surgery.41-43 At the Royal London Hospital, CPET is routinely 
used as part of preoperative assessment for high-risk patients undergoing 
vascular, hepatobiliary and some colorectal surgery.  
 
CPETs for the METS and POM-HR studies were conducted in accordance with 
the American Thoracic Society and American College of Chest Physicians 
(ATS/ACCP) guidelines on exercise testing and the individual study 
protocols.272, 278, 293 
	
 
2.9.2 Laboratory environment and equipment 
CPETs were conducted in an appropriate clinical area, with ready access to 
resuscitation equipment.292 At the Royal London Hospital this was in the 
preoperative assessment clinic. Participants underwent incremental ramp 
protocol symptom-limited CPET using an electromagnetically-braked cycle 
ergometer, which allowed the precise control of work rate.272 Researchers at 
each hospital used commercially available CPET machines, typically consisting 
of an airflow or volume transducer, a gas analyser with a high sampling rate for 
breath by breath oxygen and carbon dioxide measurement, pulse-oximeter, 
electrocardiogram, non-invasive arterial blood pressure measurement and a 
computer.272 Software for analysing and presenting CPET data varies between 
manufacturers. Equipment was checked and calibrated before each test and 
decontaminated after each test. 
	
	55 
At the Royal London Hospital, the CPET equipment was provided and serviced 
by NSpire Health (Hertford, UK) and consisted of a pneumotachometer airflow 
transducer, a gas analyser consisting of a ‘fuel cell’ oxygen analyser and an 
infrared carbon dioxide analyser, and a 12-lead electrocardiogram (figures 2.1 
and 2.2). The analysis software was ‘Zan’ (NSpire Health, Hertford, UK), using 
30-second data averaging.272 Before each test, the gas analyser was calibrated 
using calibration gas containing known concentrations of oxygen, carbon 
dioxide and nitrogen. The airflow sensor was calibrated with a cylinder of known 
volume, using both high and low flows. Calibrations were corrected for 
barometric pressure, temperature and relative humidity. The equipment was 
regularly serviced by the manufacturer, including testing the oxygen fuel cell. 
Emergency equipment was available in the preoperative assessment clinic and 

















Figure 2.1 –  Photograph of CPET equipment showing cycle ergometer, 





















Figure 2.2 – Photograph of CPET equipment showing cycle ergometer display, 
blood pressure cuff, flow sensor and electrocardiogram wires. 
	
 
2.9.3 Protocol for CPET using an incremental ramp 
The majority of preoperative CPETs follow the same standard protocol; thus the 
conduct of CPETs for POM-HR and METS study were very similar. I will briefly 
describe the CPET protocol for the METS study. 
 
Before starting the test, informed consent and patient suitability was confirmed. 
Patients were asked to attend the clinic wearing appropriate loose clothing, not 
to drink caffeinated drinks on the day of the test and not to undertake vigorous 
exercise in the 24 hours before the test. Electrocardiogram (ECG) electrodes 
were placed on the patient’s chest. At the Royal London we used 12-lead ECG 
monitoring. An appropriately sized blood pressure cuff was placed on the upper 
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arm at the level of the heart and a pulse-oximeter probe on a finger of the 
opposite hand. A tight-fitting facemask, or a mouthpiece with a bite block and 
nose clip, was fitted. The airflow meter was fitted to the mask or mouthpiece. In 
the seated position, resting heart rate, blood pressure and pulse-oximetry was 
measured. Lung function tests, including forced inspiration, expiration and 
spirometry was performed. If FEV1 was less than 30% of age and gender 
predicted values then testing was discontinued.272 The cycle ergometer was 
adjusted to the patient, including seat height, handlebar height and handlebar 
angle, and that participant was seated comfortably on the bike. 
 
The exercise test proper consisted of five phases: rest, unloaded cycling (warm 
up), incremental workload exercise, recovery and rest. Before starting exercise, 
baseline measurements of ventilation, gas exchange, heart rate and blood 
pressure were taken during three minutes of rest. Next, the patient was 
instructed to start pedalling, aiming to meet a target pedal rate of 60 revolutions 
per minute (RPM). During this phase the resistance to pedalling was set at 0 
watts.C After three minutes of unloaded cycling, the workload was progressively 
increased in an incremental fashion at a constant rate according to a pre-
determined ‘ramp’.272 The participant was encouraged to continue pedalling at 
60RPM for as long as they were able to continue. At the end of loaded 
pedalling, the workload was reduced to 20 watts and pedalling continued for 
five minutes at 60RPM. This helped to reduce the incidence of dizziness or 
syncope due to abrupt cessation of high intensity exercise.284 During this period 
																																																								
C Depending on the manufacturer of the CPET equipment, some centres may not have been 
able to set the resistance to 0 watts. Where this was the case they set the resistance to the 
lowest setting possible during warm-up. 
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the full set of respiratory and cardiovascular variables was recorded. At the end 
of the recovery period, the participant dismounted from the ergometer and 
monitoring equipment was removed. The participant was invited sit in the 
laboratory and rest until they felt ready to leave the clinic. During this time a 
brief interview was conducted in order to identify any adverse symptoms that 
may have occurred during exercise and to complete fatigue and dyspnoea 
ratings according to the BORG scale.1 
 
The aim of the incremental rate of workload increase (ramp) is for the 
participant to reach peak exercise capacity after eight to twelve minutes of 
incremental exercise.272, 284 The recommended method for determining the 
ramp is based on the expected maximal oxygen consumption (VO2), calculated 
as follows:294 
 
1. Predicted VO2 unloaded (ml/min) = 150 + (6 x weight [kg]) 
2. Predicted peak VO2 (ml/min) = height (cm) – age (years) x constantD 
3. Work rate increment (W/min) = Predicted peak VO2 – predicted unloaded 
VO2 / 100 
 
For the METS study, which was a pragmatic study the clinical effectiveness of 
preoperative CPET, the rate of workload increase (ramp) was selected 
according to the subjective judgement of the investigator: 10W/minute in 
untrained individuals, 20-30W/minute in trained participants or those who 
regularly undertook physical activity.295 Contraindications to CPET, reasons for 
stopping a test, and adverse events are listed in the appendix. 
																																																								
D Constant = 20 for men and 14 for women 
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2.9.4 Interpreting a cardiopulmonary exercise test 
After the CPET is complete, the test is interpreted and a report compiled. This 
includes a global assessment of all cardiovascular and respiratory data as well 
as detailed assessment of specific parameters, including oxygen 
consumption/work rate relationship, anaerobic threshold, peak oxygen 
consumption, oxygen pulse, ventilatory equivalents for carbon dioxide and 
oxygen, and heart rate and blood pressure responses to exercise.296 Typically, 
interpretation of a CPET will start with the inspection of summary screen 
displaying a ‘nine panel plot’ (figure 2.3),297, 298 before moving to inspect specific 
plots in more detail, as well as reviewing the raw cardiorespiratory data in 
numerical format. The typical interpretation strategy for preoperative CPET has 










2.9.5 Anaerobic threshold 
Anaerobic threshold and ventilatory threshold are broadly equivalent and the 
terms are often used interchangeably.285 Anaerobic threshold is the value of 
oxygen consumption or work rate at which the concentration of blood lactate 
begins to increase during incremental exercise (lactate threshold), theoretically 
signalling a conversion from a predominantly aerobic cellular metabolism to a 
predominantly anaerobic cellular metabolism, via anaerobic glycolysis.299, 300 
Since it is impractical to obtain serial blood gas samples to measure changing 
concentrations of blood lactate, non-invasive estimation of the lactate threshold, 
using ventilatory gas analysis, is common.301 The principle of the ventilatory 
threshold is that during aerobic metabolism carbon dioxide production is 
equivalent to oxygen consumption. However, during anaerobic metabolism 
carbon dioxide production exceeds oxygen consumption due to the shift in 
respiratory substrate. The relative changes in carbon dioxide production and 
oxygen consumption can be used to infer a specific ventilatory threshold, which 
is broadly equivalent to anaerobic threshold, which is in turn, broadly equivalent 
to lactate threshold.301 The standardised approach to identifying the anaerobic 
threshold in the METS study, adapted from Gaskill and colleagues,302 was 
threefold:303 
	
1. Modified V-Slope method. On a plot of VCO2 against VO2 the anaerobic 






Figure 2.4 – Example plot of VO2 (x-axis) and VCO2 (y-axis) with points in red. 
Black lines show the modified V-slope with Anaerobic threshold (AT) shown as 







2. Ventilatory equivalents method. On a plot of ventilatory equivalents for 
oxygen (VE/VO2) and ventilatory equivalents for carbon dioxide 
(VE/VCO2) against time, the anaerobic threshold is the point at which the 
(VE/VO2) rises without a simultaneous increase in (VE/VCO2), i.e. a 




Figure 2.5 – Plot of ventilatory equivalents for oxygen (blue) and carbon dixoide 
(red), incremental increase in workload in watts (grey) against time. Anaerobic 






3. The excess carbon dioxide method. The point at which there is excess 
production of carbon dioxide, calculated as (VCO2)2/(VO2).305 (figure 2.6). 
 
Figure 2.6 – Plot of oxygen consumption (blue) and carbon dixoide production 
(red) on y-axes, time (minutes) on the x-axis, incremental increase in workload in 
watts (grey) against time. Anaerobic threshold shown as red vertical line. 
 
2.9.6 Peak and maximal oxygen consumption  
Wasserman and colleagues define maximal oxygen consumption as the 
“highest oxygen consumption achievable as evidenced by failure of oxygen 
consumption to increase despite increasing work rate.”298 By contrast peak 
	
	64 
oxygen consumption is the highest oxygen consumption achieved when “the 
subject has reached his or her maximum tolerable work rate”.298 In practice 
maximal oxygen consumption is rarely measured in the clinical setting since it 
requires the subject to exercise for a sustained period at their maximal capacity 
in order to demonstrate static oxygen consumption in the presence of 
increasing workload, which can be unpleasant or uncomfortable. Peak oxygen 
consumption is usually expressed as a 10 - 60 second average depending on 
the protocol being used.285 In the METS study peak oxygen consumption was 
calculated as the mean oxygen consumption during the last twenty seconds of 
the incremental phase of exercise before reaching the limit of exercise 
tolerance.303 This was adapted from the approach described by Ferguson and 
colleagues.306 
 
2.9.7 Oxygen pulse 
Oxygen pulse is the ratio of oxygen consumption to heart rate at any given 
time.285 It is equivalent to the amount of oxygen taken up by the pulmonary 
circulation during the period of one heart beat and is calculated by dividing 
oxygen consumption by heart rate at any given time point.298 The modified Fick 
equation describes the relationship between oxygen pulse (VO2/HR) and left 
ventricular stroke volume (SV), where C(a-v)O2 is the difference between 
arterial and mixed-venous oxygen content.272  
	
VO2/HR = SV x C(a-v)O2 
 
Thus, oxygen pulse provides a non-invasive estimate of left ventricular stroke 




2.9.8 Ventilatory equivalent for carbon dioxide (VE/VCO2) and slope 
At rest and during exercise, minute ventilation (VE) and carbon dioxide 
production (VCO2) are tightly coupled, such that VE increases in proportion to 
VCO2 in a linear fashion at work rates below the anaerobic threshold, regulating 
arterial carbon dioxide concentration and hence arterial pH.307-309 The 
ventilatory equivalent for carbon dioxide is the ratio of VE to VCO2 at any given 
point in time and reflects the relative ventilatory response to carbon dioxide 
production.272 The VE/VCO2 typically drops to a low point around the anaerobic 
threshold and subsequently increases in response to elevated minute 
ventilation as a result of anaerobic respiration, lactic acid production and 
associated metabolic acidosis.272 Abnormalities of instantaneous VE/VCO2 ratio 
have been observed in patients with heart failure and patients undergoing 
preoperative assessment. Time to VE/VCO2 nadir is shorter in patients with 
heart failure compared to healthy controls.310 In patients undergoing major 
surgery, VE/VCO2 ratio at the anaerobic threshold >34 is associated with 
postoperative mortality.58 An alternative measure of VE and VCO2 coupling is 
the VE/VCO2 slope, which is the rate of increase of VE for increasing values of 
VCO2.301 Typically this is calculated using linear regression (i.e. y=mx + c, 
where m=slope) and reflects ventilatory efficiency throughout exercise.71 Both 
VE/VCO2 slope and VE/VCO2 slope ≥34 are associated with mortality in patients 
with heart failure.71 However, there is no consensus regarding whether the 
instantaneous VE/VCO2 ratio at a given point during exercise or the VE/VCO2 
slope throughout incremental exercise should be used as the principal measure 
of VE and VCO2 coupling. In the METS study the VE/VCO2 ratio at the anaerobic 




2.9.9 Heart rate during exercise 
Increasing heart rate during exercise is typically related to increasing oxygen 
consumption in a linear fashion, facilitated by both withdrawal of 
parasympathetic tone and an increase in sympathetic activity as oxygen 
requirement increases.272, 298 Heart rate reserve is the arithmetic difference 
between age predicted maximal heart rate and achieved maximal heart rate at 
the end of exercise.272 In the METS study, heart rate was measured at rest in 
the sitting position before starting exercise, at peak oxygen consumption, at the 
end of incremental exercise and at one, three and five minutes into the recovery 
period after the end of incremental exercise.295 Reduction in heart rate after the 
cessation of exercise is mediated initially by increased parasympathetic activity, 
followed subsequently by reduced sympathetic activity.89 Heart rate recovery is 
calculated by subtracting heart rate during the recovery period from the 
maximum heart rate achieved at the end of exercise. 
 
2.10 Cardiac output monitoring 
I used cardiac output monitor data from the OPTIMISE and POM-O trials to test 
for association between preoperative heart rate and preoperative left ventricular 
stroke volume. The OPTIMISE trial used the LiDCOTM rapid cardiac output 
monitor and the POM-O trial used the LiDCOTM Plus cardiac output monitor 
(Lidco, London UK). The LiDCOTM plus and LiDCOTM rapid systems use the 
‘PulseCOTM’ algorithm to calculate stroke volume and heartbeat duration from 
the arterial pulse pressure waveform.311 This estimate of cardiac output is 
calibrated using lithium dilution for the LiDCOTM plus system. However, the 
LiDCOTM rapid system is un-calibrated. Heart rate is calculated on a beat-by-
beat basis according to the heartbeat duration. The manufacturers report that 
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the LiDCOTM method of estimating cardiac output is at least as accurate as 
thermodilution.312 Whilst there are many studies evaluating both calibrated and 
non-calibrated cardiac output monitors, none have compared pulse contour 




2.11 Collection, preparation and processing of blood samples 
Collection of blood samples for troponin testing was performed in both the 
VISION and METS studies and followed a standardised process, which was 
similar for both studies. For the VISION study, blood samples were collected 
between six and twelve hours after the completion of surgery and then again on 
postoperative days one, two and three.16 For the METS study, blood samples 
were collected before surgery at the time of routine preoperative blood sampling 
and then again on postoperative days one, two and three. For both studies, 5-
10mls of blood was sampled into a plain vacuum tube (i.e. clotted sample) and 
only sampled when patients were in hospital.313 For the VISION study, blood 
samples were analysed in the local hospital laboratories, where the troponin 
assay was Troponin-T (Roche 4th generation ElecsysTM assay – Roche 
Diagnostics, Basel, Switzerland). For the METS study, participating hospitals in 
Canada and Australia sent blood samples to their local hospital laboratory for 
analysis. However, in the United Kingdom, the analysis of laboratory samples 
was carried out in a single, central laboratory, where the troponin assay was 
ultra Troponin-I (Siemens Centaur analyser – Siemens Healthcare Diagnostics 
Inc. Frimley, United Kingdom). Hospitals in Canada and Australia used 
whichever assay was available in the local hospital laboratory (chapter seven). 
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2.12 Statistical and data methods 
A large part of my work on this thesis was data management, data processing 
and statistical analysis. Consequently, important learning and development has 
been in epidemiological, data handling and statistical methods. For this thesis, 
the purpose of statistical analysis was to identify association between 
exposures and outcomes, and to determine whether any observed effects were 
likely to be due to chance, confounding or bias. I took a ‘research question’ 
driven approach, rather than a ‘data driven’ approach, planning each analysis 
prospectively before looking at the data.268  
 
2.12.1  Software packages 
I used Microsoft Excel (Microsoft, Redmond, USA) for data manipulation and 
processing. I used SPSS version 22 (IBM, Armonk, USA) and STATA version 
14 (Statacorp, College Station, USA) to analyse the data. 
 
2.12.2  Data management, exploration and cleaning 
I received the data sets for the VISION study and OPTIMISE trials in a semi-
cleaned format. I received the data sets for the METS and POM-HR studies and 
the POM-O trial in an un-cleaned format. The preliminary data cleaning for 
these data sets in Microsoft Excel included:  
• Checking the data against the study case report form 
• Renaming/recoding variables and creating or amending data dictionaries 
• Formatting the type of data field for each variable (e.g. continuous or 
categorical) and checking this was consistent for all cells for any given 
variable 
• Checking units and decimal places for continuous data 
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• Coding or recoding categorical data using a number coding system 
• Checking for missing data and coding this with a consistent missing data 
value 
• Preparing an analysis data set by removing variables that were not required 
 
The data cleaning in the statistics software package included: 
• Importing the Microsoft Excel data into the statistics package 
• Assigning variable names 
• Assigning data types (continuous, categorical nominal, categorical ordinal) 
• Assigning numbers of decimal places 
• Setting the missing data values 
• Running sense checks on each variable, including: number of cases, 
number of missing values, mean, standard deviation, median and 
histograms (for continuous data) 
• Checking categorical variable coding and adding category labels 
• Generating any new variables required for an analysis 
 
The data from cardiac output monitors from the OPTIMISE and POM-O trials 
were in a raw data format. These were very large Microsoft Excel documents, 
with 20 to 50 columns and 20,000 to 80,000 rows. Due to the beat-by-beat 
nature of data generated from the arterial catheter and the pulse-contour 
analysis, there were often artefacts in the Microsoft Excel data, for example, a 
between beat change in heart rate of 300 beats per minute or interruptions due 
to positioning of the arterial catheter or transducer. It was not possible to rely on 
a computer program or macro to consistently remove these aberrations, so this 
required manual checking of each of the 178 files (figure 2.7). This took 
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approximately five hours per file or ~1000 hours in total. To perform a statistical 
analysis I required summary data from each cleaned cardiac output monitor file 
in a single spreadsheet, with rows representing patients and columns 
representing summary variables. In collaboration with Aaron Lee 
(Bioinformatics, William Harvey Research Institute), I used a bespoke PythonE 
program to extract summary data from each cardiac output monitor file and 




Figure 2.7 – An example of a cleaned cardiac output monitor data file showing 
haemodynamic variables as columns and measurements (beats) as rows. 
	
																																																								




Figure 2.8 – An example of Python code using the Jupyter notebook platform, 
which was used to generate a single summary data set for statistical analysis. 
 
2.12.3  Descriptive statistics 
Normally distributed continuous data were presented as mean with standard 
deviation and non-normally distributed continuous data were presented as 
median with inter-quartile range. Categorical data were presented as absolute 
numbers (n) and a percentage. The acceptable type one error rate, or threshold 
for statistically significant results of hypothesis testing, was pre-specified as 5% 
(p≤ 0.05). Where effect estimates were presented, crude event rates for the 
outcome(s) of interest were also presented. 
 
2.12.4  Regression analysis 
Regression analysis attempts to describe the relationship between a dependent 
(outcome) variable and one or more independent (predictor) variables, using a 
mathematical equation called a model. Univariable analysis models one 
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independent variable against a single dependent variable. Multivariable analysis 
models multiple independent variables against a single dependent variable. 
Linear regression analysis models a continuous dependent variable (y), with a 
constant (intercept, β0) and regression coefficients (β1,2,3…n) for each 
independent variable (x1,2,3…n):314 
 
y = β0 + β1x1 + β2x2 + β2x2 …….+ βnxn 
 
Logistic regression analysis, along with Poisson and Cox regression, is one of a 
group of statistical techniques called ‘generalised linear models’ (GLM).315 In 
contrast to linear regression analysis, GLMs model a transformation of the 
dependent variable. For logistic regression, where the dependent variable is 
binary, the analysis models the log of the odds of the outcome, i.e. log-linear: 
 
Log odds (y) = β0 + β1x1 + β2x2 + β2x2 …….+ βnxn 
	
Here, the regression coefficient (β1,2,3…n) represents the change in log odds 
(logit) of the dependent variable per unit increase in the independent variable 
(x1,2,3…n).315 The effect estimate for a logistic regression model is expressed as 
an odds ratio, which is the exponential of the regression coefficient (β1,2,3…n) for 
each independent variable.316 The odds ratio is the likelihood of having the 
outcome of interest versus not having the outcome of interest.316 Logistic 
regression analysis can be used to model categorical variables, grouped 
continuous variables and continuous variables.315 A principal assumption for all 
GLMs is that the relationship between exposure and outcome (or transformed 




In this thesis, I modelled binary outcome measures, e.g. mortality or myocardial 
injury, using logistic regression analysis. I used multivariableF modelling to 
adjust for the effect of potentially confounding factors. Results were presented 
as odds ratios with 95% confidence intervals. I used the Wald chi-squared test 
for hypothesis testing of individual covariates in any given model.314, 316 
 
2.12.5  Modelling non-linear independent variables 
Linear regression and generalised linear models assume that the dependent 
variable (or log of the dependent variable) is related to the independent 
variable(s) in a linear fashion, as shown above.317 However, this is not always 
the case. In such a case, linear modelling may under- or over-estimate the 
strength of association between variables, which may bias the interpretation of 
the observation.317 
 
The commonest, and most widely accepted, approach is to stratify a continuous 
independent variable and transform it into an ordered categorical variable, for 
example by sorting the sample according to the variable of interest and dividing 
into strata (for example quartiles), which would be handled as discrete data 
rather than continuous data in the model.318 I used this strategy in all of my 
analyses. 
 
A second approach is to use non-linear modelling, where the independent 
variable is not transformed into a categorical variable, but kept in the model as 
a continuous variable. The two commonest approaches are to use regression 
splines or polynomial regression. Regression splines are a type of basis 
																																																								
F Multivariable analysis models multiple independent variables. Multivariate analysis models 
multiple dependent variables. See Medical Statistics by Kirkwood & Sterne 2003, page 106. 
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function, meaning that the relationship between independent and dependent 
variables are modelled separately over different regions of the independent 
variable. Thus, several different models might apply over different regions.319 
Polynomial regression fits polynomial functions to the independent variables, 
which in contrast to regression splines, applies a “global structure on the non-
linear function of” the independent variables.319 This is preferable because a 
single model describes the relationship between independent and dependent 
variables over the full range of data. The general form of a polynomial function 
is:319 
	
y = β0 + β1x1+ β2x22…….+ βnxnn 
 
Royston and Altman320 developed this further to include a defined “family of 
parametric models”,321 fractional polynomials, where the polynomial functions 
are limited to a specific set of values: -2, -1, -0.5, 0.5, 1, 2, 3 and log(x).321 A 
method for including fractional polynomial terms in a multivariable model was 
first described by Sauerbrei and Royston, called multivariable fractional 
polynomial regression analysis.322 This combined a “function selection 
procedure” with standard backwards elimination for the selection of variables.323 
Likelihood ratio statistics (chi-squared) are used for variable selection and for 
determining the fit of functions in the function selection procedure.323 This 
process was later developed into a standard algorithm, which is included in the 
statistical package STATA and, which can be applied to various types of 
regression models.324 The output is the best fitting model, which may or may 




In this thesis, I handled continuous exposure variables by ranking the sample 
according to the variable of interest and then dividing into strata, for example 
deciles or quintiles, and treating them as categorical data. Where I was 
concerned that a relationship might not be linear, for example between 
preoperative heart rate and postoperative myocardial injury, I used multivariable 
fractional polynomial logistic regression analysis. 
 
2.12.6  Variable selection for inclusion in statistical models 
I used an explanatory modelling strategy throughout this thesis. Analyses were 
pre-specified and based on a priori hypotheses of association between 
exposure and outcome. Analyses were conducted according to prospective 
analysis plans. Covariates were selected for inclusion in multivariable models 
based on subject matter knowledge, derived from previous evidence of 
association with the outcome measures and plausible association with the 
exposure.325 This is particularly pertinent where the number of variables is 
small.326 In the analyses of the VISION study data, where the sample size was 
very large, I was able to adjust the analyses for multiple confounding factors. 
Variables were not selected for inclusion based on univariable association 
alone.325 Pre-specified covariates were included in models, even in the absence 
of statistical significance,317 since individually some variables may not exert 
much confounding until they are considered collectively with other factors.327 I 
used forced simultaneous entry (all candidate variables included in the model) 
as opposed to automated stepwise selection, because simulation studies 
suggest increased risk of over-fitting with the latter approach.328, 329 In the 
analyses of the METS and POM-HR data, the comparatively smaller sample 
size limited the total number of variables I was able to include in multivariable 
	
	76 
models, according to the ‘rule of seven’.16 Therefore I used backwards-stepwise 
selection to identify variables for inclusion in the final multivariable models, with 




Chapter three   
Preoperative heart rate 
 
Preoperative heart rate and myocardial injury after non-cardiac 
surgery. A secondary analysis of data from a prospective 








At least 1.5 million major surgical procedures are carried out in the United 
Kingdom every year. Observational data suggest that one in ten patients have 
elevated concentrations of cardiac troponins in the blood after surgery. 
Conventional wisdom attributes this to myocardial ischaemia and infarction as a 
result of atherosclerotic plaque rupture in coronary arteries and subsequent 
thrombosis.330 However, fewer than one tenth of patients with troponin elevation 
(myocardial injury) after surgery experience ischaemic symptoms and <25% 
have objective evidence of myocardial ischaemia or infarction.16, 95 Evidence-
based treatments for acute coronary syndrome in the non-operative setting, 
such as aspirin or coronary angioplasty, do not reduce the risk of myocardial 
injury when given prophylactically before surgery.100, 101 So while coronary 
artery thrombosis may cause perioperative myocardial injury in some instances, 
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it is unlikely to be the predominant pathophysiological process in the majority of 
cases. 
 
Epidemiological studies in general population cohorts have consistently 
demonstrated that resting heart rate is associated with cardiovascular morbidity 
and mortality.156, 331-333 However, the explanation for this relationship is 
uncertain. Elevated heart rate is associated with multiple cardiovascular risk 
factors, so resting tachycardia could be a marker of co-existing cardiovascular 
disease.156 However, the association between heart rate and cardiovascular 
morbidity and mortality appears independent of underlying pathology.156, 331-334 
The prevailing perioperative paradigm is that of oxygen supply-demand 
imbalance driven myocardial injury, which could be induced by tachycardia. 
Alternatively, elevated resting heart rate could indicate autonomic nervous 
system imbalance, either by up-regulation of sympathetic or down-regulation of 
parasympathetic activity, which has been implicated as a casual factor in 
several cardiovascular pathologies.178, 181, 335-337 Consequently, there has been 
widespread interest in treatments to control heart rate, in both general medical 
and perioperative patients.258, 334 
 
Multiple trials have demonstrated that treatment with beta-blockers, to lower 
heart rate, can reduce the risk of perioperative myocardial infarction,166, 258 but 
at the expense of increased risk of mortality.166 Consequently, it has been 
suggested that the optimum dose of beta-blocker may vary from person to 
person, and that preoperative heart rate may be used to determine the 
appropriate individualised dosage.227 However, this remains controversial since 
the relationship between preoperative heart rate and postoperative cardiac 
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complications has been subject to only limited investigation.22, 171-173 Previous 
studies have not measured cardiac biomarkers to identify myocardial injury, and 
statistical analyses used arbitrary pre-defined heart rate thresholds.171-173 
Therefore it remains unclear whether or not preoperative heart rate is 
associated with myocardial injury after non-cardiac surgery, or if there is a heart 
rate threshold at which the risk of postoperative myocardial injury increases and 
that could be used to identify patients at risk of postoperative morbidity.  
 
The aim of this analysis was to assess the relationships between preoperative 
heart rate and cardiovascular outcomes, as has previously been described in 
the general population. I hypothesised that elevated preoperative heart rate is 
associated with increased risk of myocardial injury, myocardial infarction (MI) 




This was a secondary analysis of prospectively collected data from the Vascular 
Events in Non-cardiac Surgery Patients Cohort Evaluation (VISION) study. The 
study is described in chapter two and full details of the methods and previous 
analyses have been published before.16, 95, 273, 275 Briefly, the study cohort 
consists of patients aged 45 years or older undergoing non-cardiac surgery 
under regional or general anaesthesia at one of twelve participating hospitals in 
eight countries.16, 95 Patients were excluded if they refused consent or if they 
had been previously enrolled in the study. Researchers collected a detailed and 
standardised dataset from patients and their medical notes before and up to 30 
days after surgery.  
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3.2.1 Exposure of interest 
The exposure of interest was preoperative heart rate, defined as the last heart 
rate measurement, as part of routine care, recorded before induction of 
anaesthesia.   
 
3.2.2 Outcome measures 
The primary outcome measure was myocardial injury after non-cardiac surgery 
(MINS), defined as TnT ≥0.03 ng/mL using a Roche 4th generation ElecsysTM 
assay, adjudicated as due to an ischaemic pathology within 30 days after 
surgery. This was the definition used in the original report of the VISION 
study.95, 113 The adjudication process and blood sampling regime are described 
in chapter two (methods) and have been published previously.16, 95, 273, 275 
 
Secondary outcome measures were myocardial infarction and death within 30 
days of surgery. Myocardial infarction was defined according to the third 
universal definition (troponin elevation in the presence of at least one of: 
ischaemic symptoms; the development of new or presumed new Q waves, ST 
segment or T wave changes, or left bundle branch block on the 
electrocardiogram; the finding of a new or presumed new regional wall motion 
abnormality on echocardiography).113, 273 Patients with a troponin elevation 
<0.04 ng/mL were not investigated for evidence of ischaemia.273  
 
3.2.3 Primary statistical analysis 
I planned the analysis before taking custody of the data. The data were 
analysed using SPSS version 22 (IBM, New York, USA). Patients with missing 
data were handled by list-wise deletion. The sample was ranked according to 
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integer values of preoperative heart rate and divided the sample into deciles, 
using cut-points closest to each 10th percentile. Ten groups that contained an 
approximately equal number of cases were produced and differences in 
baseline characteristics for each group were compared. Multivariable logistic 
regression models for heart rate against each outcome measure were 
constructed, considering each decile as a categorical variable. To avoid 
isolating any particular heart rate decile as a reference category, I used 
deviation contrasts to compare each decile to the un-weighted average effect 
for the whole cohort.338, 339 Each multivariable model was corrected for 
covariates that were previously associated with MINS, cardiac events (including 
MI) or mortality in other perioperative epidemiological research: age (45-64, 65-
75, >75 years), current atrial fibrillation, diabetes, hypertension, heart failure, 
coronary artery disease, peripheral vascular disease, previous stroke or 
transient ischaemic attack, estimated glomerular filtration rate (eGFR <30, 30-
44, 45-60, >60 ml/min), chronic obstructive pulmonary disease, neurosurgery, 
major surgery and urgent/emergency surgery were considered as categorical 
variables in the multivariable models.16, 20, 21, 95 The results of multivariable 
logistic regression analyses were presented as odds ratios (OR) with 95% 
confidence intervals. Normally distributed data were expressed as mean +/- 
standard deviation (SD) and non-normally distributed data were expressed as 




3.2.4 Secondary analysis 
Previous studies have investigated heart rate as a risk factor for cardiac 
complications using pre-defined heart rate thresholds. To allow comparisons 
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between my findings and other research, I repeated my analysis using two 
heart rate thresholds that were previously associated with MI or mortality in the 
general medical literature (>70 beats per minute [bpm]) and the perioperative 
literature (>104 bpm).97, 237 I dichotomised the sample according to each heart 
rate threshold and constructed multivariable logistic regression models for each 
outcome measure, corrected for the previous covariates. Heart rate above the 
threshold was considered as a categorical variable.  
	
3.2.5 Sensitivity analyses 
The conventional approach to regression analysis using multi-level categorical 
variables is to isolate one group as the reference category.314 To make my 
analysis comparable to other research, I repeated the multivariable logistic 
regression analyses using a single heart rate decile as the reference category. 
To determine the influence of preoperative atrial fibrillation, the commonest 
perioperative dysrhythmia, I excluded all patients with a previous history of atrial 
fibrillation and repeated the primary analysis.340 To determine the influence of 
emergency surgery, which is an independent risk factor for postoperative 
morbidity and mortality, I excluded all patients undergoing emergency surgery 
and repeated the primary analysis.10, 16 It is plausible that an observed 
relationship between heart rate and one or more of the outcome measures 
could be confounded by the use of medications that influence heart rate. The 
most relevant agents in clinical practice are beta-adrenoceptor antagonists 
(beta-blockers) and the negatively chronotropic calcium channel blockers, 
diltiazem and verapamil.167, 258, 341 To determine the influence of these agents, I 
conducted a post-hoc analysis by excluding patients that received a beta-
blocker and/or a rate limiting calcium channel blocker within 24 hours before 
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surgery and repeated the primary analysis. In a study of patients undergoing 
coronary artery bypass grafting, the investigators observed a non-linear 
relationship between preoperative heart rate and postoperative mortality.162 To 
investigate the possibility of a non-linear relationship between heart rate and 
myocardial injury in more depth, I conducted a post-hoc analysis using 
multivariable fractional polynomial regression.342 I have described this 
technique in chapter two (methods). 
	
 
3.3  Results 
16,079 patients were recruited to the VISION study from twelve hospitals in 
eight countries between 6th August 2007 and 11th January 2011.95  I excluded 
cases with missing data describing preoperative heart rate or patient outcomes. 
1,197/15,087 patients (7.9%) sustained MINS, 454/16,007 patients (2.8%) 
sustained MI and 315/16,037 patients (2.0%) died, within 30 days of surgery.  
Participants that were missing pre-defined covariates were excluded from 
multivariable analyses (figure 3.1). I have presented the baseline characteristics 
in table 3.1. The incidences of the outcome measures is greater for heart rates 
>96 bpm compared to the other heart rate deciles. The highest decile was 
associated with increased incidences of preoperative atrial fibrillation (p<0.01), 
diabetes (p<0.01), peripheral vascular disease (p<0.01), previous stroke or 
transient ischaemic attack (p<0.01), chronic obstructive pulmonary disease 







Figure 3.1. STROBE diagram showing the number of cases included and 
excluded from each analysis.343 
	
Cases included in multivariable 
analyses: 
Myocardial injury: 13,963  
Myocardial infarction: 14,836  
Mortality: 14,866 
16,079 patients recruited into 
study 
16,055 cases with resting 
preoperative heart rate recorded 
Excluded 24 cases without resting preoperative heart 
rate  
Heart rate and outcomes 
available: 
Myocardial injury: 15,087 
Myocardial infarction: 16,007 
Mortality: 16,037 
Cases with missing outcome data were excluded from 
respective analyses: 
Myocardial injury:  968 cases excluded 
Myocardial infarction: 48 cases excluded 
Mortality:  18 cases excluded 
Cases with other missing variables were excluded from 
multivariable analyses: 
Myocardial injury:  1,124 cases excluded 
Myocardial infarction:  1,171 cases excluded 




Table 3.1. Baseline patient characteristics. Descriptive data stratified by preoperative heart rate decile, presented as frequencies with percentages (%) or 
means with standard deviations (SD). Data rounded to nearest whole number. Heart rate (beats per minute), systolic blood pressure and pulse pressure (mmHg). 
 
Preoperative resting heart rate deciles (bpm) Whole 
cohort 
<60 60-64 65-68 69-71 72-74 75-79 80-82 83-87 88-96 >96 
Number of cases (n) 16055 1515 1676 1579 1464 1318 2019 1649 1352 1989 1494 
Mean age (SD) 65 (12) 66 (11) 66 (11) 66 (12) 64 (12) 65 (12) 65 (12) 65 (12) 65 (12) 65 (13) 65 (13) 
Sex  
          Male (%) 7739 (48) 915 (60) 888 (53) 795 (50) 704 (48) 634 (48) 914 (45) 784 (48) 578 (43) 871 (44) 667 (45)
Female (%) 8316 (52) 600 (40) 788 (47) 784 (50) 760 (52) 684 (52) 1105 (55) 865 (52) 774 (57) 1118 (56) 827 (55) 
Mean preoperative heart rate (SD) 77 (15) 54 (5) 62 (2) 67 (1) 70 (1) 73 (1) 77 (1) 81 (1) 85 (1) 91 (3) 107 (11) 
Mean preoperative systolic blood pressure (SD) 140 (24) 137 (24) 138 (24) 137 (24) 136 (22) 140 (23) 139 (23) 141 (24) 140 (23) 144 (23) 145 (25) 
Mean preoperative pulse pressure (SD) 61 (19) 62 (20) 62 (20) 61 (20) 59 (19) 61 (19) 60 (19) 61 (19) 60 (19) 62 (19) 61 (20) 
Comorbid disorder (%)  
          Atrial fibrillation 545 (3) 46 (3) 44 (3) 39 (2) 46 (3) 32 (2) 56 (3) 67 (4) 39 (3) 79 (4) 97 (6)
Diabetes  3153 (20) 258 (17) 294 (18) 281 (18) 278 (19) 243 (18) 411 (20) 341 (21) 264 (20) 422 (21) 355 (24) 
Hypertension 8171 (51) 808 (53) 887 (53) 791 (50) 693 (47) 636 (48) 1031 (51) 848 (51) 686 (51) 1006 (51) 771 (52) 
Coronary artery disease 1947 (12) 284 (19) 256 (15) 227 (14) 182 (12) 133 (10) 215 (11) 172 (10) 145 (11) 175 (9) 153 (10) 
Peripheral vascular disease 858 (5) 71 (5) 106 (6) 87 (6) 77 (5) 59 (5) 116 (6) 78 (5) 56 (4) 106 (5) 102 (7) 
Previous stroke or transient ischaemic attack 1167 (7) 123 (8) 121 (7) 107 (7) 101 (7) 89 (7) 134 (7) 108 (7) 77 (6) 164 (8) 140 (9) 
Chronic obstructive pulmonary disease 1337 (8) 116 (7) 128 (8) 118 (7) 120 (8) 108 (8) 156 (8) 147 (9) 112 (8) 180 (9) 149 (10) 
Active cancer 2031 (13) 176 (12) 213 (13) 193 (12) 188 (13) 195 (15) 234 (12) 231 (14) 180 (13) 218 (11) 199 (13) 
Preoperative eGFR, ml/min/1.73m2 (%)  
          <30  564 (4) 50 (4) 48 (3) 38 (3) 41 (3) 45 (4) 65 (4) 59 (4) 38 (3) 87 (5) 93 (7)
30-44  831 (5) 81 (6) 81 (5) 76 (5) 71 (5) 55 (4) 111 (6) 72 (5) 64 (5) 114 (6) 104 (7) 
45-60  1579 (10) 166 (12) 165 (11) 176 (12) 145 (11) 106 (9) 175 (9) 166 (11) 135 (11) 198 (11) 145 (10) 
>60  11938 (74) 1105 (79) 1267 (81) 1157 (80) 1108 (81) 1020 (83) 1505 (8) 1216 (80) 1014 (81) 1467 (79) 1060 (76) 
Surgical procedure category (%)  
          Elective 13745 (86) 1377 (91) 1530 (91) 1413 (89) 1304 (89) 1149 (87) 1776 (88) 1409 (85) 1118 (83) 1585 (80) 1084 (73)
Urgent 483 (3) 28 (2) 35 (2) 28 (2) 33 (2) 30 (2) 45 (2) 44 (3) 51 (4) 80 (4) 109 (7) 
Emergency 1826 (11) 110 (7) 111 (7) 138 (9) 126 (9) 139 (11) 198 (10) 196 (12) 183 (14) 324 (16) 301 (20) 
Major surgery (%) 9576 (60) 868 (57) 946 (56) 905 (57) 817 (56) 798 (61) 1202 (60) 980 (59) 846 (63) 1253 (63) 969 (65) 
Outcome measures (%)  
          Myocardial injury 1197 (8) 103 (7) 105 (7) 100 (7) 100 (7) 70 (6) 131 (7) 117 (8) 119 (9) 169 (9) 177 (13)
Myocardial infarction 454 (3) 35 (2) 34 (2) 39 (3) 43 (3) 25 (2) 53 (3) 45 (3) 39 (3) 55 (3) 84 (6) 
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3.3.1  Primary analysis 
The results of multivariable logistic regression analyses for preoperative heart 
rate deciles as categorical variables against MINS, MI, and mortality within 30 
days of surgery are reported in table 3.2 and figure 3.2. Most of the 
associations observed on univariable analysis remained significant on 
multivariable analysis. In particular, heart rates in the highest decile (>96 bpm) 
were associated with MINS (OR 1.48 [1.23 – 1.77]; p <0.01), MI (OR 1.71 [1.34 
– 2.18]; p <0.01) and mortality (OR 3.16 [2.45-4.07]; p <0.01). Heart rates in the 
ninth decile (88-96 bpm) were also associated with mortality (OR 1.46 [1.08 – 
1.97]; p=0.01), but not with MINS or MI. Heart rates in the 8th decile (83-87 
bpm) and 5th decile (73-74 bpm) were associated with MINS (OR 1.36 [1.11-
1.66]; p<0.01 and OR 0.71 [0.55-0.91]; p=0.01, respectively), but not MI or 
mortality. Heart rates in the lowest decile (<60 bpm) were associated with lower 
mortality rates than other deciles (OR 0.50 [0.29 – 0.88]; p=0.02), but this group 
was not associated with MINS or MI (figure 3.2). For comparison, I present the 
results of univariable logistic regression analysis of heart rate deciles against 
the outcome measures, showing un-adjusted odds ratios in table 3.3. 
 
3.3.2  Secondary analysis 
I repeated the multivariable analysis for two binary heart rate thresholds. 
Preoperative heart rate >104 bpm was associated with MINS (OR 1.38 [1.21-
1.57]; p<0.01), MI (OR 1.35 [1.14-1.61]; p<0.01) and mortality (OR 1.89 [1.60-
2.24]; p<0.01), as shown in table 3.4. Heart rate >70 bpm was associated with 
MINS (OR 1.09 [1.01-1.17]; p=0.02) and mortality (OR 1.52 [1.30-1.77]; 







Figure 3.2. Forest plot showing the odds ratios for myocardial injury, myocardial infarction and mortality by each heart rate (HR) decile 




Table 3.2. Multivariable logistic regression models for preoperative heart rate deciles. Dependent variables are myocardial injury, myocardial 
infarction and mortality within 30 days of surgery. Each heart rate decile was compared to the un-weighted average heart rate for the whole sample.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years)       
45-64 (reference) - - - - - - 
65-75 1.08 (0.90-1.30) 0.43 1.16 (0.87-1.55) 0.30 1.64 (1.17-2.30) <0.01 
>75 2.08 (1.74-2.48) <0.01 1.90 (1.45-2.49) <0.01 2.41 (1.73-3.35) <0.01 
Male sex 1.40 (1.22-1.61) <0.01 1.04 (0.85-1.28) 0.70 1.27 (0.99-1.63) 0.06 
History of atrial fibrillation 1.53 (1.18-2.00) <0.01 1.29 (0.90-1.85) 0.17 0.97 (0.60-1.56) 0.89 
History of diabetes 1.39 (1.19-1.61) <0.01 1.21 (0.97-1.52) 0.10 0.98 (0.73-1.32) 0.91 
History of hypertension 1.31 (1.12-1.54) <0.01 1.41 (1.10-1.80) 0.01 0.98 (0.75-1.29) 0.89 
History of heart failure 1.59 (1.26-1.99) <0.01 1.67 (1.24-2.25) <0.01 1.38 (0.92-2.10) 0.12 
History of coronary artery disease 1.48 (1.25-1.76) <0.01 2.23 91.77-2.81) <0.01 0.96 (0.68-1.34) 0.80 
History of peripheral vascular disease 2.17 (1.77-2.65) <0.01 2.11 (1.60-2.78) <0.01 1.75 (1.21-2.53) <0.01 
History of stroke or transient ischaemic attack 1.46 (1.20-1.78) <0.01 1.14 (0.85-1.52) 0.37 1.53 (1.10-2.15) 0.01 
Preoperative eGFR (ml/min/1.73m2)       
<30 10.75 (8.69-13.29) <0.01 3.98 (2.96-5.36) <0.01 2.95 (2.01-4.31) <0.01 
30-44 2.51 (2.02-3.19) <0.01 1.69 (1.22-2.34) <0.01 1.58 (1.07-2.36) 0.02 
45-60 1.68 (1.39-2.03) <0.01 1.40 (1.04-1.87) 0.02 0.94 (0.63-1.40) 0.77 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.18 (0.97-1.45) 0.10 1.17 (0.83-1.49) 0.46 1.93 (1.40-2.65) <0.01 
Neurosurgery 1.14 (0.87-1.51) 0.34 0.58 (0.35-0.98) 0.04 1.82 (1.71-2.82) 0.01 
Urgent or emergency surgery 1.82 (1.54-2.15) <0.01 2.14 (1.70-2.69) <0.01 3.11 (2.41-4.02) <0.01 
Major surgery 1.66 (1.42-1.93) <0.01 2.19 (1.71-2.80) <0.01 1.51 (1.13-2.02) 0.01 
Preoperative heart rate (beats per minute)       
<60 0.92 (0.75-1.14) 0.46 0.89 (0.64-1.23) 0.48 0.50 (0.29-0.88) 0.02 
60-64 0.86 (0.69-1.06) 0.15 0.72 (0.51-1.01) 0.06 0.71 (0.45-1.13) 0.15 
65-68 0.88 (0.71-1.09) 0.26 0.99 (0.72-1.36) 0.96 0.61 (0.37-1.02) 0.06 
69-71 1.01 (0.82-1.26) 0.91 1.21 (0.89-1.64) 0.23 1.07 (0.71-1.63) 0.74 
72-74 0.71 (0.55-0.91) 0.01 0.74 (0.50-1.09) 0.13 0.70 (0.42-1.17) 0.18 
75-79 0.88 (0.73-1.07) 0.21 1.04 (0.79-1.37) 0.79 1.12 (0.79-1.58) 0.53 
80-82 1.01 (0.83-1.24) 0.90 0.97 (0.72-1.32) 0.85 1.11 (0.76-1.62) 0.58 
83-87 1.36 (1.11-1.66) <0.01 1.12 (0.82-1.54) 0.47 1.06 (0.70-1.61) 0.78 
88-96 1.11 (0.93-1.32) 0.23 0.92 (0.70-1.21) 0.92 1.46 (1.08-1.97) 0.01 
>96 1.48 (1.23-1.77) <0.01 1.71 (1.34-2.18) <0.01 3.16 (2.45-4.07) <0.01 





Table 3.3. Univariable (unadjusted) logistic regression models for preoperative heart rate deciles. Dependent variables are myocardial injury, 
myocardial infarction, and mortality within 30 days of surgery. Each heart rate decile was compared to the un-weighted average heart rate for the whole sample.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Heart rate deciles odds ratio p-value odds ratio p-value odds ratio p-value 
<60 0.92 (0.76-1.11) 0.40 0.85 (0.62-1.17) 0.31 0.52 (0.32-0.87) 0.01 
60-64 0.85 (0.70-1.02) 0.08 0.74 (0.54-1.02) 0.07 0.69 (0.45-1.06) 0.09 
65-68 0.86 (0.71-1.04) 0.11 0.91 (0.67-1.23) 0.54 0.62 (0.39-0.98) 0.04 
69-71 0.94 (0.77-1.14) 0.51 1.09 (0.81-1.45) 0.57 0.92 (0.62-1.38) 0.70 
72-74 0.71 (0.57-0.89) <0.01 0.70 (0.48-1.01) 0.05 0.65 (0.40-1.06) 0.09 
75-79 0.88 (0.75-1.05) 0.15 0.97 (0.75-1.26) 0.82 1.04 (0.74-1.44) 0.83 
80-82 0.98 (0.82-1.17) 0.80 1.01 (0.76-1.34) 0.95 1.12 (0.79-1.59) 0.52 
83-87 1.21 (1.01-1.45) 0.04 1.07 (0.79-1.45) 0.66 1.00 (0.67-1.49) 0.99 
88-96 1.19 (1.02-1.40) 0.03 1.03 (0.79-1.33) 0.85 1.63 (1.23-2.15) <0.01 
>96 1.80 (1.54-2.10) <0.01 2.14 (1.72-2.67) <0.01 3.92 (3.11-4.94) <0.01 















Table 3.4. Preoperative heart rate threshold of 104 beats per minute. Multivariable logistic regression models for myocardial injury, myocardial infarction, 
and mortality, all within 30-days of non-cardiac surgery. Preoperative heart rate was stratified according to a threshold of 104 beats per minute.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.07 (0.89-1.29) 0.47 1.15 (0.87-1.54) 0.32 1.60 (1.14-2.24) <0.01 
>75 2.05 (1.72-2.45) <0.01 1.88 (1.44-2.47) <0.01 2.37 (1.70-3.29) <0.01 
Male sex 1.38 (1.20-1.58) <0.01 1.02 (0.83-1.26) 0.83 1.21 (0.95-1.55) 0.12 
History of atrial fibrillation 1.53 (1.18-2.00) <0.01 1.30 (0.91-1.86) 0.16 0.97 (0.60-1.57) 0.91 
History of diabetes 1.40 (1.20-1.63) <0.01 1.22 (0.98-1.53) 0.08 1.01 (0.75-1.35) 0.97 
History of hypertension 1.32 (1.13-1.55) <0.01 1.40 (1.09-1.78) <0.01 0.99 (0.75-1.31) 0.95 
History of heart failure 1.60 (1.27-2.00) <0.01 1.69 (1.26-2.28) <0.01 1.40 (0.92-2.11) 0.11 
History of coronary artery disease 1.45 (1.23-1.72) <0.01 2.19 (1.74-2.76) <0.01 0.87 (0.63-1.22) 0.43 
History of peripheral vascular disease 2.15 (1.75-2.63) <0.01 2.11 (1.60-2.78) <0.01 1.77 (1.23-2.55) <0.01 
History of stroke or transient ischaemic attack 1.45 (1.20-1.77) <0.01 1.14 (0.85-1.51) 0.39 1.53 (1.10-2.14) 0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 10.69 (8.66-
13.21) 
<0.01 3.96 (2.94-5.32) <0.01 2.97 (2.03-4.35) <0.01 
30-45 2.50 (2.01-3.10) <0.01 1.70 (1.23-2.34) <0.01 1.57 (1.06-2.34) 0.03 
45-60 1.68 (1.39-2.03) <0.01 1.40 (1.05-1.88) 0.02 0.94 (0.63-1.39) 0.74 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.21 (0.99-1.47) 0.07 1.13 (0.85-1.51) 0.40 2.04 (1.49-2.80) <0.01 
Neurosurgery 1.14 (0.86-1.50) 0.36 0.58 (0.35-0.98) 0.04 1.75 (1.13-2.70) 0.01 
Urgent or emergency surgery 1.88 (1.59-2.21) <0.01 2.22 (1.77-2.79) <0.01 3.50 (2.72-4.50) <0.01 
Major surgery 1.67 (1.43-1.95) <0.01 2.19 (1.71-2.80) <0.01 1.56 (1.17-2.08) <0.01 
Heart rate >104 bpm 1.38 (1.21-1.57) <0.01 1.35 (1.14-1.61) <0.01 1.89 (1.60-2.24) <0.01 
 







Table 3.5. Preoperative heart rate threshold of 70 beats per minute. Multivariable logistic regression models for myocardial injury, myocardial infarction, 
and mortality, all within 30-days of non-cardiac surgery. Preoperative heart rate was stratified according to a threshold of 70 beats per minute.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.07 (0.89-1.28) 0.49 1.15 (0.86-1.53) 0.35 1.58 (1.13-2.20) <0.01 
>75 2.03 (1.70-2.42) <0.01 1.85 (1.41-2.42) <0.01 2.27 (1.63-3.15) <0.01 
Male sex 1.38 (1.20-1.59) <0.01 1.03 (0.84-1.26) 0.81 1.26 (0.98-1.61) 0.07 
History of atrial fibrillation 1.61 (1.24-2.09) <0.01 1.37 (0.96-1.95) 0.09 1.08 (0.67-1.74) 0.74 
History of diabetes 1.39 (1.20-1.62) <0.01 1.22 (0.98-1.53) 0.08 0.99 (0.74-1.33) 0.96 
History of hypertension 1.31 (1.12-1.53) <0.01 1.38 (1.08-1.77) 0.01 0.97 (0.74-1.28) 0.84 
History of heart failure 1.58 (1.26-1.99) <0.01 1.67 (1.24-2.25) <0.01 1.37 (0.91-2.07) 0.14 
History of coronary artery disease 1.47 (1.24-1.74) <0.01 2.20 (1.74-2.77) <0.01 0.94 (0.67-1.31) 0.70 
History of peripheral vascular disease 2.15 (1.76-2.63) <0.01 2.11 (1.60-2.79) <0.01 1.78 (1.24-2.57) <0.01 
History of stroke or transient ischaemic attack 1.47 (1.21-1.78) <0.01 1.14 (0.85-1.52) 0.38 1.55 (1.11-2.16) 0.01 
Preoperative eGFR (ml/min) 
      <30 10.83 (8.77-
13.39) 
<0.01 4.06 (3.02-5.46) <0.01 3.17 (2.17-4.62) <0.01 
30-45 2.54 (2.05-3.15) <0.01 1.75 (1.27-2.41) <0.01 1.72 (1.16-2.54) <0.01 
45-60 1.69 (1.40-2.05) <0.01 1.41 (1.05-1.89) 0.02 0.97 (0.65-1.44) 0.87 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.20 (0.98-1.46) 0.08 1.13 (0.84-1.51) 0.42 1.95 (1.42-2.67) <0.01 
Neurosurgery 1.14 (0.86-1.50) 0.36 0.58 (0.34-0.98) 0.04 1.79 (1.16-2.76) <0.01 
Urgent or emergency surgery 1.91 (1.62-2.25) <0.01 2.30 (1.83-2.89) <0.01 3.53 (2.75-4.54) <0.01 
Major surgery 1.66 (1.43-1.94) <0.01 2.19 (1.71-2.81) <0.01 1.55 (1.16-2.07) <0.01 
Heart rate >70 bpm 1.09 (1.01-1.17) 0.02 1.06 (0.95-1.18) 0.29 1.52 (1.30-1.77) <0.01 
 






3.3.3 Sensitivity analyses 
My principal findings remained similar when I repeated the regression analyses 
using a single decile (60-64 bpm) as the reference category (table 3.6), except 
that heart rates in the lowest decile were no longer associated with 
postoperative mortality (OR 0.71 [0.33-1.54]; p=0.39), heart rates 72-74bpm 
were no longer associated with myocardial injury (OR 0.83 [0.58-1.17]; p=0.28) 
and heart rates 69-71bpm were associated with myocardial infarction (OR 1.68 
[1.03-2.73]; p=0.04). To examine the potential confounding effect of 
preoperative tachyarrhythmia, I repeated the regression analyses excluding 
cases with current atrial fibrillation, the most common perioperative 
arrhythmia.340 When I excluded cases with current atrial fibrillation or 
emergency surgery, the results were very similar to the main results (tables 3.7-
3.12). The association between the highest decile of heart rate and each of the 
three outcome measures was not affected by the exclusion of patients who 
received a beta-blocker and/or a rate limiting calcium channel blocker within 24 
hours before surgery (table 3.13). The odds ratios for MINS, MI, and 30 day 
mortality were 1.52 (1.24-1.85; p<0.01), 1.83 (1.38-24.1; p<0.01), and 2.90 
(2.19-3.84; p<0.01), respectively. However, heart rates <60 bpm were no longer 






Table 3.6. Sensitivity analysis using heart rate 60-64bpm as the reference category. Multivariable model. Dependent variables were myocardial injury, 
myocardial infarction and mortality within 30 days of surgery. Each heart rate decile was compared to the second decile of heart rate (60-64bpm).  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.08 (0.90-1.30) 0.43 1.16 (0.87-1.55) 0.30 1.64 (1.17-2.30) <0.01 
>75 2.08 (1.74-2.48) <0.01 1.90 (1.45-2.49) <0.01 2.41 (1.73-3.35) <0.01 
Male sex 1.40 (1.22-1.61) <0.01 1.04 (0.85-1.28) 0.70 1.27 (0.99-1.63) 0.06 
History of atrial fibrillation 1.53 (1.18-2.00) <0.01 1.29 (0.90-1.85) 0.17 0.97 (0.60-1.56) 0.89 
History of diabetes 1.39 (1.19-1.61) <0.01 1.21 (0.97-1.52) 0.10 0.98 (0.73-1.32) 0.91 
History of hypertension 1.31 (1.12-1.54) <0.01 1.41 (1.10-1.80) 0.01 0.98 (0.75-1.29) 0.89 
History of heart failure 1.59 (1.26-1.99) <0.01 1.67 (1.24-2.25) <0.01 1.38 (0.92-2.10) 0.12 
History of coronary artery disease 1.48 (1.25-1.76) <0.01 2.23 (1.77-2.81) <0.01 0.96 (0.68-1.34) 0.80 
History of peripheral vascular disease 2.17 (1.77-2.65) <0.01 2.11 (1.60-2.78) <0.01 1.75 (1.21-2.53) <0.01 
History of stroke or transient ischaemic attack 1.46 (1.20-1.78) <0.01 1.14 (0.85-1.52) 0.37 1.53 (1.10-2.15) 0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 10.75 (8.69-13.29) <0.01 3.98 (2.96-5.36) <0.01 2.95 (2.01-4.31) <0.01 
30-45 2.51 (2.02-3.12) <0.01 1.69 (1.22-2.34) <0.01 1.58 (1.07-2.36) 0.02 
45-60 1.68 (1.39-2.03) <0.01 1.40 (1.04-1.87) 0.02 0.94 (0.63-1.40) 0.77 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.18 (0.97-1.45) 0.10 1.12 (0.83-1.49) 0.46 1.93 (1.40-2.65) <0.01 
Neurosurgery 1.14 (0.87-1.51) 0.34 0.58 (0.35-0.98) 0.04 1.82 (1.17-2.82) <0.01 
Urgent or emergency surgery 1.82 (1.54-2.15) <0.01 2.14 (1.70-2.69) <0.01 3.11 (2.41-4.02) <0.01 
Major surgery 1.66 (1.42-1.93) <0.01 2.19 (1.71-2.80) <0.01 1.51 (1.13-2.02) <0.01 
Preoperative heart rate (beats per minute) 
      <60 1.08 (0.79-1.48) 0.63 1.23 (0.74-2.05) 0.42 0.71 (0.33-1.54) 0.39 
60-64 (reference) - - - - - - 
65-68 1.03 (0.75-1.42) 0.84 1.38 (0.84-2.26) 0.20 0.86 (0.41-1.81) 0.69 
69-71 1.18 (0.86-1.63) 0.30 1.68 (1.03-2.73) 0.04 1.51 (0.78-2.93) 0.22 
72-74 0.83 (0.58-1.17) 0.28 1.03 (0.59-1.80) 0.91 0.99 (0.47-2.08) 0.98 
75-79 1.03 (0.77-1.39) 0.83 1.45 (0.91-2.30) 0.12 1.58 (0.85-2.91) 0.15 
80-82 1.19 (0.87-1.61) 0.28 1.35 (0.83-2.21) 0.23 1.57 (0.83-2.95) 0.17 
83-87 1.59 (1.17-2.16) <0.01 1.57 (0.95-2.58) 0.08 1.49 (0.77-2.91) 0.24 
88-96 1.30 (0.98-1.73) 0.07 1.28 (0.80-2.05) 0.30 2.06 (1.15-3.68) 0.02 
>96 1.73 (1.29-2.31) <0.01 2.38 (1.52-3.71) <0.01 2.24 (2.55-7.75) <0.01 





Table 3.7. Sensitivity analysis excluding atrial fibrillation cases. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 
days of surgery. Each heart rate decile was compared to the un-weighted average heart rate for the whole sample.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.08 (0.90-1.31) 0.42 1.20 (0.90-1.61) 0.22 1.71 (1.21-2.40) <0.01 
>75 2.08 (1.74-2.50) <0.01 1.93 (1.45-2.55) <0.01 2.44 (1.74-3.43) <0.01 
Male sex 1.38 (1.20-1.60) <0.01 0.99 (0.80-1.24) 0.95 1.26 (0.98-1.64) 0.08 
History of diabetes 1.44 (1.23-1.69) <0.01 1.26 (0.99-1.59) 0.06 0.99 (0.73-1.35) 0.95 
History of hypertension 1.27 (1.08-1.50) <0.01 1.37 (1.06-1.78) 0.02 0.91 (0.69-1.22) 0.54 
History of heart failure 1.70 (1.32-2.19) <0.01 1.74 (1.25-2.42) <0.01 1.24 (0.76-2.00) 0.39 
History of coronary artery disease 1.61 (1.35-1.92) <0.01 2.47 (1.93-3.16) <0.01 1.00 (0.70-1.44) 0.99 
History of peripheral vascular disease 2.09 (1.68-2.59) <0.01 2.02 (1.50-2.73) <0.01 1.68 (1.13-2.51) 0.01 
History of stroke or transient ischaemic attack 1.48 (1.20-1.83) <0.01 1.01 (0.73-1.40) 0.94 1.55 (1.08-2.23) 0.02 
Preoperative eGFR (ml/min/1.73m2) 
      <30 10.40 (8.33-12.98) <0.01 3.91 (2.84-5.38) <0.01 2.31 (2.22-4.91) <0.01 
30-45 2.49 (1.98-3.13) <0.01 1.71 (1.21-2.42) <0.01 1.53 (0.99-2.37) 0.05 
45-60 1.70 (1.39-2.07) <0.01 1.49 (1.10-2.02) 0.01 1.01 (0.67-1.52) 0.96 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.20 (0.97-1.48) 0.10 1.24 (0.92-1.69) 0.16 2.12 (1.53-2.95) <0.01 
Neurosurgery 1.19 (0.90-1.58) 0.22 0.59 (0.35-1.02) 0.06 1.92 (1.23-2.98) <0.01 
Urgent or emergency surgery 1.94 (1.64-2.30) <0.01 2.23 (1.75-2.84) <0.01 3.21 (2.46-4.19) <0.01 
Major surgery 1.62 (1.38-1.91) <0.01 2.15 (1.65-2.79) <0.01 1.51 (1.12-2.05) 0.01 
Preoperative heart rate (beats per minute) 
      <60 0.90 (0.71-1.11) 0.30 0.87 (0.61-1.23) 0.43 0.53 (0.30-0.93) 0.03 
60-64 0.82 (0.66-1.03) 0.09 0.69 (0.48-0.99) 0.05 0.71 (0.44-1.15) 0.16 
65-68 0.90 (0.72-1.12) 0.33 1.05 (0.76-1.45) 0.77 0.60 (0.35-1.02) 0.06 
69-71 1.01 (0.81-1.27) 0.92 1.14 (0.82-1.58) 0.44 1.03 (0.67-1.59) 0.89 
72-74 0.73 (0.56-0.94) 0.01 0.79 (0.54-1.17) 0.24 0.73 (0.44-1.23) 0.24 
75-79 0.89 (0.73-1.08) 0.24 1.05 (0.79-1.40) 0.72 1.17 (0.82-1.66) 0.40 
80-82 0.95 (0.77-1.18) 0.64 0.88 (0.62-1.23) 0.45 1.04 (0.70-1.56) 0.85 
83-87 1.39 (1.13-1.71) <0.01 1.13 (0.81-1.58) 0.46 1.09 (0.71-1.67) 0.70 
88-96 1.12 (0.94-1.35) 0.22 0.90 (0.67-1.21) 0.48 1.41 (1.03-1.93) 0.03 
>96 1.57 (1.30-1.90) <0.01 1.87 (1.45-2.42) <0.01 3.18 (2.44-4.15) <0.01 





Table 3.8. Sensitivity analysis excluding emergency cases. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days 
of surgery. Each heart rate decile was compared to the un-weighted average heart rate for the whole sample.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.09 (0.89-1.33) 0.39 1.20 (0.87-1.66) 0.26 1.71 (1.16-2.52) 0.01 
>75 2.10 (1.73-2.56) <0.01 2.26 (1.67-3.07) <0.01 2.58 (1.74-3.83) <0.01 
Male sex 1.42 (1.21-1.65) <0.01 1.07 (0.85-1.35) 0.58 1.34 (0.99-1.80) 0.06 
History of atrial fibrillation 1.88 (1.42-2.48) <0.01 1.48 (1.00-2.21) 0.05 1.13 (0.65-1.97) 0.66 
History of diabetes 1.33 (1.12-1.58) <0.01 1.15 (0.88-1.49) 0.30 0.85 (0.59-1.23) 0.40 
History of hypertension 1.24 (1.04-1.48) 0.02 1.26 (0.95-1.67) 0.10 1.03 (0.74-1.43) 0.87 
History of heart failure 1.46 (1.14-1.89) <0.01 1.44 (1.01-2.04) 0.04 1.13 (0.67-1.91) 0.65 
History of coronary artery disease 1.56 (1.30-1.88) <0.01 2.41 (1.85-3.13) <0.01 1.11 (0.75-1.64) 0.61 
History of peripheral vascular disease 2.03 (1.62-2.55) <0.01 2.12 (1.55-2.90) <0.01 1.45 (0.91-2.29) 0.12 
History of stroke or transient ischaemic attack 1.50 (1.21-1.87) <0.01 1.14 (0.82-1.59) 0.42 1.88 (1.28-2.77) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 11.80 (9.32-14.93) <0.01 4.07 (2.87-5.77) <0.01 2.22 (1.33-3.71) <0.01 
30-45 2.71 (2.13-3.44) <0.01 1.73 (1.20-2.51) <0.01 1.54 (0.95-2.49) 0.08 
45-60 1.65 (1.33-2.04) <0.01 1.38 (1.00-1.93) 0.05 0.78 (0.47-1.27) 0.32 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.24 (1.00-1.54) 0.05 1.09 (0.79-1.52) 0.59 2.19 (1.52-3.14) <0.01 
Neurosurgery 1.13 (0.84-1.52) 0.41 0.57 (0.33-1.00) 0.05 1.98 (1.22-3.21) 0.01 
Urgent or emergency surgery 1.94 (1.40-2.68) <0.01 2.28 (1.49-3.51) <0.01 3.47 (2.26-5.32) <0.01 
Major surgery 1.68 (1.42-1.99) <0.01 2.44 (1.84-3.24) <0.01 1.23 (0.89-1.71) 0.21 
Preoperative heart rate (beats per minute) 
      <60 0.88 (0.70-1.10) 0.25 0.79 (0.55-1.14) 0.21 0.39 (0.19-0.77) 0.01 
60-64 0.83 (0.67-1.04) 0.11 0.70 (0.48-1.02) 0.07 0.77 (0.47-1.28) 0.31 
65-68 0.87 (0.69-1.09) 0.22 0.95 (0.67-1.35) 0.78 0.62 (0.34-1.11) 0.11 
69-71 1.08 (0.86-1.36) 0.51 1.37 (1.00-1.89( 0.05 1.15 (0.72-1.84) 0.55 
72-74 0.73 (0.56-0.95) 0.02 0.81 (0.53-1.22) 0.31 0.60 (0.32-1.15) 0.13 
75-79 0.84 (0.68-1.04) 0.10 0.96 (0.70-1.32) 0.81 1.26 (0.85-1.87) 0.26 
80-82 1.04 (0.83-1.29) 0.76 1.04 (0.74-1.47) 0.82 1.42 (0.93-2.15) 0.10 
83-87 1.33 (1.06-1.66) 0.01 0.99 (0.68-1.46) 0.98 0.83 (0.47-1.45) 0.51 
88-96 1.15 (0.95-1.40) 0.16 1.00 (0.73-1.38) 0.98 1.58 (1.10-2.27) 0.01 
>96 1.52 (1.24-1.87) <0.01 1.71 (1.27-2.30) <0.01 3.38 (2.47-4.62) <0.01 





Table 3.9. Sensitivity analysis excluding atrial fibrillation cases. Multivariable logistic regression models for myocardial injury, myocardial infarction and 
mortality, all within 30-days of non-cardiac surgery. Preoperative heart rate was stratified according to a threshold of 70 beats per minute.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.07 (0.89-1.30) 0.48 1.18 (0.88-1.59) 0.26 1.65 (1.17-2.32) <0.01 
>75 2.03 (1.69-2.43) <0.01 1.87 (1.41-2.48) <0.01 2.29 (1.63-3.22) <0.01 
Male sex 1.37 (1.18-1.58) <0.01 0.98 (0.79-1.22) 0.87 1.26 (0.98-1.63) 0.08 
History of diabetes 1.45 (1.24-1.70) <0.01 1.28 (1.01-1.62) 0.05 1.01 (0.74-1.36) 0.98 
History of hypertension 1.27 (1.08-1.50) <0.01 1.36 (1.05-1.76) 0.02 0.91 (0.69-1.22) 0.54 
History of heart failure 1.70 (1.32-2.19) <0.01 1.73 (1.25-2.41) <0.01 1.24 (0.77-2.00) 0.38 
History of coronary artery disease 1.59 (1.33-1.90) <0.01 2.42 (1.90-3.09) <0.01 0.97 (0.68-1.39) 0.89 
History of peripheral vascular disease 2.07 (1.67-2.56) <0.01 2.02 (1.49-2.72) <0.01 1.70 (1.14-2.52) <0.01 
History of stroke or transient ischaemic attack 1.48 (1.20-1.83) <0.01 1.01 (0.73-1.39) 0.96 1.56 (1.09-2.24) 0.02 
Preoperative eGFR (ml/min/1.73m2) 
      <30 10.57 (8.48-13.17) <0.01 4.03 (2.94-5.54) <0.01 3.63 (2.45-5.37) <0.01 
30-45 2.50 (1.99-3.14) <0.01 1.76 (1.25-2.49) <0.01 1.64 (1.06-2.52) 0.03 
45-60 1.72 (1.40-2.09) <0.01 1.50 (1.11-2.04) <0.01 1.04 (0.69-1.56) 0.86 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.22 (0.98-1.50) 0.07 1.27 (0.94-1.72) 0.12 2.17 (1.57-3.01) <0.01 
Neurosurgery 1.19 (0.90-1.58) 0.22 0.60 (0.35-1.02) 0.06 1.90 (1.23-2.95) <0.01 
Urgent or emergency surgery 2.05 (1.73-2.42) <0.01 2.41 (1.90-3.06) <0.01 3.62 (2.79-4.69) <0.01 
Major surgery 1.63 (1.39-1.92) <0.01 2.17 (1.67-2.82) <0.01 1.56 (1.15-2.12) <0.01 
Heart rate threshold (beats per minute) 
      >70 1.11 (1.03-1.19) <0.01 1.08 (0.96-1.21) 0.21 1.53 (1.30-1.80) <0.01 
 







Table 3.10. Sensitivity analysis excluding atrial fibrillation cases. Multivariable logistic regression models for myocardial injury, myocardial infarction and 
mortality, all within 30-days of non-cardiac surgery. Preoperative heart rate was stratified according to a threshold of 104 beats per minute.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.08 (0.89-1.30) 0.45 1.20 (0.89-1.60) 0.24 1.67 (1.19-2.35) <0.01 
>75 2.06 (1.72-2.47) <0.01 1.91 (1.45-2.54) <0.01 2.41 (1.72-3.39) <0.01 
Male sex 1.35 (1.17-1.56) <0.01 0.98 (0.79-1.21) 0.82 1.21 (0.93-1.56) 0.15 
History of diabetes 1.46 (1.24-1.71) <0.01 1.27 (1.01-1.61) 0.05 1.02 (0.75-1.38) 0.92 
History of hypertension 1.28 (1.09-1.51) <0.01 1.37 (1.05-1.77) 0.02 0.93 (0.70-1.23) 0.60 
History of heart failure 1.71 (1.33-2.20) <0.01 1.75 (1.26-2.44) <0.01 1.25 (0.77-2.02) 0.36 
History of coronary artery disease 1.56 (1.31-1.86) <0.01 2.40 (1.88-3.06) <0.01 0.90 (0.63-1.29) 0.56 
History of peripheral vascular disease 1.08 (1.68-2.57) <0.01 2.02 (1.50-2.73) <0.01 1.70 (1.14-2.52) <0.01 
History of stroke or transient ischaemic attack 1.47 (1.20-1.82) <0.01 1.01 (0.73-1.40) 0.95 1.56 (1.09-2.23) 0.02 
Preoperative eGFR (ml/min/1.73m2) 
      <30 10.39 (8.33-12.95) <0.01 3.91 (2.84-5.37) <0.01 3.38 (2.27-5.03) <0.01 
30-45 2.47 (1.96-3.11) <0.01 1.72 (1.22-2.43) <0.01 1.50 (0.98-2.32) 0.07 
45-60 1.69 (1.39-2.07) <0.01 1.47 (1.10-2.01) 0.01 1.00 (0.67-1.51) 0.99 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.22 (0.99-1.51) 0.07 1.26 (0.93-1.71) 0.13 2.22 (1.60-3.08) <0.01 
Neurosurgery 1.19 (0.90-1.57) 0.23 0.60 (0.35-1.03) 0.06 1.94 (1.19-2.85) <0.01 
Urgent or emergency surgery 2.02 (1.70-2.39) <0.01 2.33 (1.83-2.96) <0.01 3.58 (2.76-4.66) <0.01 
Major surgery 1.64 (1.39-1.93) <0.01 2.16 (1.66-2.80) <0.01 1.57 (1.16-2.13) <0.01 
Heart rate threshold (beats per minute) 
      >104 1.42 (1.24-1.63) <0.01 1.39 (1.15-1.68) <0.01 1.92 (1.61-2.30) <0.01 
 







Table 3.11. Sensitivity analysis excluding emergency cases. Multivariable logistic regression models for myocardial injury, myocardial infarction and 
mortality, all within 30-days of non-cardiac surgery. Preoperative heart rate was stratified according to a threshold of 70 beats per minute.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.08 (0.88-1.32) 0.46 1.19 (0.86-1.64) 0.29 1.66 (1.13-2.44) 0.01 
>75 2.04 (1.68-2.48) <0.01 2.20 (1.62-2.98) <0.01 2.45 (1.66-3.63) <0.01 
Male sex 1.40 (1.20-1.63) <0.01 1.05 (0.83-1.32) 0.72 1.31 (0.98-1.77) 0.07 
History of atrial fibrillation 1.97 (1.49-2.60) <0.01 1.56 (1.05-2.33) 0.03 1.26 (0.72-2.18) 0.42 
History of diabetes 1.34 (1.13-1.59) <0.01 1.17 (0.90-1.52) 0.23 0.87 (0.61-1.25) 0.45 
History of hypertension 1.24 (1.04-1.48) 0.02 1.24 (0.94-1.64) 0.13 1.03 (0.74-1.43) 0.86 
History of heart failure 1.45 (1.13-1.86) <0.01 1.43 (1.01-2.03) 0.04 1.08 (0.64-1.83) 0.77 
History of coronary artery disease 1.54 (1.28-1.85) <0.01 2.36 (1.82-3.06) <0.01 1.10 (0.75-1.63) 0.62 
History of peripheral vascular disease 2.02 (1.61-2.53) <0.01 2.12 (1.55-2.90) <0.01 1.47 (0.93-2.34) 0.10 
History of stroke or transient ischaemic attack 1.51 (1.22-1.88) <0.01 1.16 (0.84-1.62) 0.36 1.91 (1.30-2.80) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 11.86 (9.38-15.01) <0.01 4.13 (2.92-5.86) <0.01 2.29 (1.37-3.82) <0.01 
30-45 2.72 (2.14-3.46) <0.01 1.74 (1.20-2.52) <0.01 1.60 (0.99-2.59) 0.05 
45-60 1.66 (1.34-2.06) <0.01 1.38 (0.99-1.93) 0.05 0.80 (0.49-1.31) 0.38 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.26 (1.02-1.57) 0.04 1.11 (0.80-1.54) 0.53 2.21 (1.54-3.18) <0.01 
Neurosurgery 1.13 (0.84-1.51) 0.43 0.56 (0.32-0.99) 0.04 1.93 (1.19-3.12) <0.01 
Urgent surgery 2.11 (1.53-2.92) <0.01 2.58 (1.70-3.93) <0.01 4.19 (2.76-6.35) <0.01 
Major surgery 1.69 (1.43-2.00) <0.01 2.46 (1.85-3.26) <0.01 1.26 (0.91-1.74) 0.17 
Heart rate threshold (beats per minute) 
      >70 1.09 (1.01-1.18) 0.02 1.06 (0.94-1.20) 0.33 1.57 (1.32-1.88) <0.01 
 






Table 3.12. Sensitivity analysis excluding emergency cases. Multivariable logistic regression models for myocardial injury, myocardial infarction and 
mortality, all within 30-days of non-cardiac surgery. Preoperative heart rate was stratified according to a threshold of 104 beats per minute.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.08 (0.89-1.32) 0.45 1.19 (0.87-1.64) 0.28 1.65 (1.12-2.43) 0.01 
>75 2.06 (1.70-2.50) <0.01 2.23 (1.65-3.03) <0.01 2.47 (1.67-3.66) <0.01 
Male sex 1.39 (1.19-1.62) <0.01 1.04 (0.82-1.31) 0.75 1.24 (0.92-1.67) 0.15 
History of atrial fibrillation 1.86 (1.40-2.47) <0.01 1.48 (0.99-2.20) 0.06 1.16 (0.67-2.03) 0.60 
History of diabetes 1.35 (1.14-1.60) <0.01 1.18 (0.91-1.53) 0.21 0.90 (0.62-1.29) 0.55 
History of hypertension 1.25 (1.05-1.49) 0.01 1.24 (0.94-1.64) 0.13 1.03 (0.74-1.43) 0.86 
History of heart failure 1.48 (1.15-1.90) <0.01 1.47 (1.04-2.08) 0.03 1.13 (0.67-1.90) 0.66 
History of coronary artery disease 1.53 (1.27-1.84) <0.01 2.36 (1.82-3.06) <0.01 1.02 (0.69-1.50) 0.94 
History of peripheral vascular disease 2.01 (1.61-2.52) <0.01 2.12 (1.55-2.89) <0.01 1.46 (0.92-2.32) 0.10 
History of stroke or transient ischaemic attack 1.50 (1.21-1.86) <0.01 1.15 (0.83-1.59) 0.41 1.84 (1/25-2.71) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 11.78 (9.31-14.90) <0.01 4.07 (2.87-5.77) <0.01 2.23 (1.33-3.74) <0.01 
30-45 2.69 (2.12-3.42) <0.01 1.70 (1.17-2.47) <0.01 1.51 (0.93-2.45) 0.10 
45-60 1.65 (1.33-2.04) <0.01 1.38 (0.99-1.91) 0.06 0.77 (0.47-1.26) 0.30 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.27 (1.02-1.57) 0.03 1.11 (0.80-1.54) 0.53 2.32 (1.62-3.33) <0.01 
Neurosurgery 1.13 (0.84-1.51) 0.42 0.57 (0.33-1.00) 0.05 1.83 (1.13-2.96) 0.01 
Urgent surgery 2.01 (1.45-2.78) <0.01 2.33 (1.52-3.58) <0.01 3.95 (2.58-6.04) <0.01 
Major surgery 1.70 (1.44-2.02) <0.01 2.46 (1.85-3.26) <0.01 1.29 (0.93-1.78) 0.13 
Heart rate threshold (beats per minute) 
      ≤104 0.68 (0.59-0.79) <0.01 0.69 (0.56-0.85) <0.01 0.53 (0.43-0.66) <0.01 
>104 1.46 (1.26-1.70) <0.01 1.44 (1.17-1.78) <0.01 1.88 (1.52-2.33) <0.01 
 





Table 3.13. Sensitivity analysis excluding beta-blockers and rate limiting calcium channel blockers. Multivariable logistic regression models for 
myocardial injury, myocardial infarction and mortality, all within 30-days of non-cardiac surgery.  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years) 
      45-64 (reference) - - - - - - 
65-75 1.01 (0.88-1.36) 0.41 1.08 (0.76-1.53) 0.67 1.70 (1.18-2.44) <0.01 
>75 2.28 (1.86-2.81) <0.01 1.88 (1.35-2.60) <0.01 2.34 (1.63-3.35) <0.01 
Male sex 1.27 (1.07-1.49) <0.01 0.80 (0.62-1.03) <0.01 1.20 (0.91-1.57) 0.20 
History of AF 1.75 (1.22-2.51) <0.01 1.29 (0.78-2.13) 0.33 0.82 (0.42-1.58) 0.55 
History of diabetes 1.31 (1.08-1.58) <0.01 1.29 (0.97-1.72) 0.08 0.99 (0.71-1.38) 0.94 
History of hypertension 1.19 (0.99-1.42) 0.06 1.20 (0.90-1.59) 0.21 0.99 (0.74-1.33) 0.94 
History of heart failure 1.76 (1.30-2.38) <0.01 2.09 (1.42-3.08) <0.01 1.23 (0.72-2.09) 0.45 
History of coronary artery disease 1.56 (1.24-1.97) <0.01 2.37 (1.74-3.23) <0.01 1.02 (0.67-1.54) 0.94 
History of peripheral vascular disease 1.85 (1.42-2.40) <0.01 2.01(1.40-2.90) <0.01 1.86 (1.22-2.82) <0.01 
History of stroke or transient ischaemic attack 1.52 (1.19-1.94) <0.01 1.15 (0.79-1.68) 0.47 1.67 (1.14-2.44) 0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 12.83 (9.90-16.61) <0.01 3.95 (2.70-5.80) <0.01 3.34 (2.16-5.15) <0.01 
30-45 2.90 (2.24-3.77) <0.01 1.94 (1.30-2.90) <0.01 1.85 (1.19-2.89) <0.01 
45-60 1.72 (1.36-2.16) <0.01 1.56 (1.09-2.24) 0.01 1.04 (0.67-1.60) 0.87 
>60 (reference) - - - - - - 
History of chronic obstructive pulmonary disease 1.36 (1.07-1.71) 0.01 1.53 (1.09-2.15) 0.01 2.24 (1.59-3.16) <0.01 
Neurosurgery 1.23 (0.89-1.69) 0.21 0.65 (0.34-1.21) 0.17 1.99 (1.25-3.17) <0.01 
Urgent or emergency surgery 1.81 (1.49-2.18) <0.01 2.35 (1.80-3.08) <0.01 3.32 (2.51-4.38) <0.01 
Major surgery 1.74 (1.45-2.09) <0.01 2.27 (1.68-3.09) <0.01 1.63 (1.18-2.25) <0.01 
Preoperative heart rate (beats per minute) 
      <60 0.92 (0.70-1.21) 0.56 0.81 (0.50-1.32) 0.40 0.61 (0.33-1.12) 0.11 
60-64 0.92 (0.71-1.19) 0.51 0.68 (0.42-1.10) 0.11 0.61 (0.34-1.10) 0.10 
65-68 0.98 (0.76-1.26) 0.85 1.21 (0.81-1.80) 0.35 0.73 (0.42-1.28) 0.27 
69-71 1.00 (0.78-1.26) 0.99 1.08 (0.72-1.60) 0.72 1.07 (0.67-1.70) 0.78 
72-74 0.65 (0.48-0.87) <0.01 0.60 (0.35-1.02) 0.06 0.73 (0.42-1.28) 0.27 
75-79 0.87 (0.70-1.09) 0.23 1.08 (0.78-1.50) 0.64 1.09 (0.75-1.60) 0.65 
80-82 0.97 (0.76-1.23) 0.78 0.92 (0.63-1.36) 0.68 1.03 (0.67-1.57) 0.91 
83-87 1.37 (1.09-1.72) <0.01 1.26 (0.88-1.82) 0.21 0.97 (0.61-1.54) 0.89 
88-96 1.08 (0.88-1.31) 0.48 1.01 (0.74-1.40) 0.94 1.52 (1.10-2.09) 0.01 
>96 1.52 (1.24-1.85) <0.01 1.83 (1.38-2.41) <0.01 2.90 (2.19-3.84) <0.01 




3.3.4 Fractional polynomial analysis 
The results of the multivariable fractional polynomial regression analysis 
confirms the linear association between heart rate and the risk of myocardial 
injury. A function plot of partial predictor + residual against increasing heart rate 
for the best fitting model is shown in figure 3.3, illustrating that as heart rate 
increases, the risk of myocardial injury increases in a linear fashion. 
	
 
Figure 3.3. Function plot of the multivariable fractional polynomial logistic 
regression model. The x-axis shows preoperative heart rate and the y-axis is the partial 
predictor + residual. The grey region indicates the 95% confidence interval. The partial predictor 
is the heart rate component of the regression equation plus the intercept. The residual is the 
residual variation between the regression line and the observed data. The function plot shows 
how a given term in a regression model varies across the data range. Here, heart rate varies in 
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3.4  Discussion 
The principal finding of this analysis is that elevated preoperative heart rate is 
associated with increased odds of MINS, MI, and death within 30 days of 
surgery. When I examined the entire range of heart rates, the highest decile 
(>96 bpm) was consistently associated with greater odds of each of these 
outcomes, while heart rate >87bpm was also associated with mortality. Heart 
rates in the first decile (<60 bpm) were associated with lower odds of mortality, 
but not MINS or MI. I found similar, but weaker, associations with pre-defined 
heart rate thresholds of >70 bpm and >104 bpm, which were identified from the 
existing general medical and perioperative literature. The absence of 
association between heart rates below the tenth decile and outcomes implies 
that the signal seen with the binary thresholds is predominantly due to higher 
event rates in patients with heart rates >96 bpm.  
 
My results contrast with those of population-based studies in which incremental 
increases in resting heart rate are associated with higher long-term rates of 
cardiovascular events across the whole heart rate spectrum.156, 331-333 While I 
observed a linear relationship between preoperative heart rate and myocardial 
injury, analysis of heart rate deciles suggests that this is due to associations at 
the extremes of the heart rate (i.e. very high or very low) and not across the 
entire data range. If a biologically plausible relationship exists between heart 
rate and clinical outcomes, it may have different profiles in patients undergoing 
surgery compared to the general population. This might be due to different 
underlying physiological mechanisms of harm, or due to the effect of 
perioperative factors superimposed on to a common pathophysiology. 
Consequently, my data suggests that previous perioperative studies using 
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arbitrary pre-defined heart rate thresholds may not accurately represent the 
relationship between heart rate and clinical outcomes, whilst the findings of 
population-based studies may not be generalisable to the perioperative period. 
My results raise the question of whether heart rate reduction is a potential 
therapeutic target to reduce the risk of perioperative cardiovascular events. 
However, a previous large randomised controlled trial found mortality and 
stroke risk was increased by beta-blocker therapy.166 In my study, 2,727 
(17.0%) patients received a beta-blocker or negatively chronotropic calcium 
channel blocker within 24 hours before surgery. After excluding these cases 
from the analysis, the independent association between heart rates >96 bpm 
and the outcomes remained. However, the potentially protective association 
between heart rates <60 bpm and mortality was no longer statistically 
significant, suggesting that the observed association may be confounded by 
rate-controlling medication (i.e. due to beta-blocker or calcium channel 
antagonists). Alternatively, this might suggest that rate-limiting medication was 
merely a marker of underlying heart disease. In either case, these data should 
be interpreted with caution since they are observational in nature and 
participants were not randomly assigned to heart rate control. Given this 
uncertainty, it is unclear whether therapeutic control of perioperative heart rate 
would influence clinical outcome. 
 
The observed associations between elevated preoperative heart rate and 
postoperative outcomes are consistent with several plausible biological 
mechanisms by which tachycardia could promote cardiac complications.97, 160 
The majority of perioperative myocardial infarctions are thought to arise not 
from the rupture of atheromatous coronary plaque, as in the general population, 
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but as the result of protracted myocardial ischaemia.96 The imbalance between 
myocardial oxygen supply and demand, and subsequent myocardial ischaemia, 
is proposed to be caused by multiple factors, including anaemia, hypotension 
and hypoxia.96 In this model, anaemia and hypoxia could contribute to oxygen 
supply-demand imbalance by reducing the supply of oxygen to respiring tissue, 
for example due to impaired oxygen carrying capacity in anaemia or 
hypoxaemia as a result of respiratory insufficiency, which is not uncommon in 
the perioperative period. Hypotension can reduce coronary perfusion pressure, 
which could impair oxygen delivery to the myocardium.75 However, the most 
prominent candidate mechanism of oxygen supply-demand imbalance is 
tachycardia, which could promote supply-demand imbalance by increasing 
oxygen consumption (demand) relative to a fixed supply, or at very high heart 
rates, reduced supply due to poor ventricular filling and impaired coronary 
perfusion.75, 96, 97 This is supported by evidence from a study in anaesthetised 
dogs with fixed coronary stenoses where tachycardia-induced myocardial 
ischaemia for four hours caused sub-endocardial necrosis.160  
 
Alternatively, elevated heart rate may simply be a marker of another, as yet 
unidentified, pathological process that causes myocardial injury. Tachycardia 
has multiple potential causes in the perioperative period, including: 
postoperative pain,344 hypotension,345, 346 autonomic nervous system 
dysfunction85, systemic inflammation277, 334, 347, 348  and reduction in heart rate 
limiting medications, some which could also cause myocardial injury.96, 239 An 
association between heart rate before surgery and perioperative myocardial 
injury suggests that elevated heart rate may represent a distinct preoperative 
physiological state, pathology or chronic condition. For example, both heart 
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failure and autonomic nervous system dysfunction can cause tachycardia, 
either through sympathetic stimulation or parasympathetic inhibition in the case 
of autonomic dysfunction, or in response to impaired left ventricular stroke 
volume or impaired cardiac output in the case of heart failure.85, 158 Both are 
associated with morbidity after surgery.178, 349, 350 In this analysis, I was able to 
adjust for pre-existing symptomatic heart failure. However, there may be 
residual confounding by patients with undiagnosed or sub-clinical heart failure, 
and the prevalence of autonomic dysfunction in this cohort is unknown. In 
addition, whether or not sub-clincal heart failure or autonomic dysfunction are 
associated with perioperative myocardial injury has not been tested. Further 
research is needed to determine the underlying mechanism of perioperative 
myocardial injury and whether the association between heart rate and 
myocardial injury is causative in nature. 
	
This analysis has several limitations. The influences of pre-medication and 
anxiety on heart rate are well established.351-353 In an attempt to standardise the 
heart rate measurement, preoperative heart rate was recorded before and as 
close to the induction of anaesthesia as possible. The potential confounding 
influence of atrial fibrillation, the commonest population-based tachyarrhythmia, 
was assessed both through the adjustment of the multivariable models and a 
sensitivity analysis.354, 355 340 Atrial fibrillation was present in only 6% of patients 
in the top decile and the removal of these cases had little impact on my 
findings. Nor did exclusion of patients taking beta-blockers or rate limiting 
calcium channel blockers, or patients undergoing emergency surgery. The 
strengths of my analyses derive from the multi-centre study design and large 
patient sample. The sample reflects a wide spectrum of non-cardiac surgery 
	
	106 
taking place in hospitals in a number of countries, making the results relevant to 
the majority of surgical patients.  The routine measurement of TnT allowed me 
to identify sub-clinical myocardial injury in addition to subjective clinical 
outcomes. I planned the statistical analysis before taking custody of the data 
and used multivariable models to correct for confounding factors. However, like 
all observational studies, my results may be susceptible to un-measured 
confounding. For example, the highest heart rate decile may include cases 
where the myocardial injury occurred before surgery, something we were 
unable to account for in our analysis.114, 356, 357 Nor was the presence of a 
pacemaker recorded, although it is likely that these patients comprised only a 




Elevated preoperative heart rate was associated with MINS, MI and mortality 
within 30 days after surgery. This was primarily due to significantly higher event 
rates in patients amongst the highest decile of heart rate. However, it is unclear 
whether this represents a causative association or unmeasured confounding. 
Further research is needed to understand the relationship between heart rate 
and postoperative myocardial injury, and to clarify whether or not heart rate 





Chapter four  
Preoperative pulse pressure 
 
Preoperative pulse pressure and myocardial injury after non-
cardiac surgery. A secondary analysis of data from a 
prospective international cohort study of myocardial injury 
after non-cardiac surgery. 
 
This chapter has been published in the British Journal of Anaesthesia (2017) 




The risk of perioperative cardiovascular complications associated with elevated 
arterial blood pressure before surgery is unclear.189, 195, 201 Internationally, the 
prevalence of poorly controlled blood pressure in patients with hypertension is 
high, while a significant proportion of the general population have undiagnosed 
hypertension.358 In England, ~7.8 million people are hypertensive (14% of the 
population), while a further ~5.6 million people are thought to have undiagnosed 
hypertension (10% of the population).359  Thus, it is not uncommon for patients 
to present with high blood pressure on the day of surgery, and procedures are 
frequently cancelled at short notice as a result. 188, 190, 360 This scenario, familiar 
to both anaesthetists and surgeons, reflects widespread uncertainty about 
whether or not isolated elevated blood pressure readings increase the risk of 
perioperative cardiovascular complications.190 Recent clinical guidelines 
suggest that surgery can be undertaken safely if the preoperative blood 
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pressure is below 160/110 mmHg.188, 191 However, this guidance, which varies 
internationally,192 is derived from a very limited evidence base constructed from 
small studies that use subjective clinical outcome measures, rather than 
objective biochemical markers of harm (e.g. troponin) and mortality.201, 202  
 
In the general population, elevated pulse pressure - the difference between 
systolic and diastolic blood pressure – is associated with the subsequent 
development of myocardial infarction and congestive cardiac failure, 
independently of high systolic and diastolic blood pressures, and controlled 
hypertension (including ‘white coat’ hypertension).147, 148, 212, 213 Pulse pressure 
reflects a composite of left ventricular stroke volume, cardiac contractility and 
arterial wall compliance, key factors that influence perioperative cardiovascular 
performance.279, 281 Pulse pressure before surgery may therefore refine risk 
assessment for perioperative cardiovascular complications in patients 
undergoing non-cardiac surgery. However, preoperative pulse pressure has not 
been widely investigated. 
 
I hypothesised that elevated pulse pressure was associated with an increased 
risk of myocardial injury within 30 days of non-cardiac surgery, independently of 
preoperative systolic arterial pressure.  
 
4.2  Methods 
I undertook a secondary analysis of the Vascular Events in Non-cardiac 
Surgery Patients Cohort Evaluation (VISION) study data set. VISION was a 
prospective international observational cohort study, which I have described in 
detail in chapter two (methods) and has been previously published.16, 95, 273, 275 
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Participants were aged 45 years or older and underwent non-cardiac surgery 
using general or regional anaesthesia, and with an expected overnight hospital 
stay. Researchers collected a detailed and standardised dataset from patients 
and their medical records, before and during the 30 days after surgery. A past 
history of hypertension was defined by a previous physician diagnosis. Clinical 
staff measured arterial blood pressure in millimetres of mercury (mmHg) as part 
of routine patient care according to local practice. Specific details of the 
equipment used to measure blood pressure are not available, although in most 
cases this will have been using the oscillometric, non-invasive technique. 
 
4.2.1 Exposures of interest 
Preoperative arterial blood pressure was defined as the systolic and diastolic 
arterial pressure measurements before and closest to the induction of 
anaesthesia. Preoperative arterial pulse pressure was defined as the arithmetic 
difference between preoperative systolic and diastolic arterial pressures.  
 
4.2.2 Outcome measure 
The primary outcome measure was myocardial injury after non-cardiac surgery 
(MINS), defined as any serum Troponin T (TnT) measurement ≥0.03ng/mL 
using a Roche 4th generation assay judged due to an ischaemic aetiology, 
within 30 days of surgery. This definition is used by the ESA-ESICM taskforce 
for perioperative clinical outcomes and was previously defined in the VISION 
study cohort.16, 95, 113 I describe the TnT assay, blood sampling and adjudication 
of raised serum TnT concentrations, which have been published previously, in 




4.2.3 Statistical analysis 
I planned the statistical analysis before taking custody of the data. I used SPSS 
version 22 (IBM, New York, USA) and STATA version 14 (StataCorp LP, Texas, 
USA) to analyse the data. The sample was ordered according to integer values 
of preoperative pulse pressure and divided into five approximately equal groups 
(quintiles) using cut-points closest to each 20th percentile. Participants with 
missing data were excluded by list-wise deletion. Baseline characteristics of the 
cohort were stratified by pulse pressure quintiles. Binary data were expressed 
as percentages, normally distributed continuous data as mean with standard 
deviation (SD) and non-normally distributed continuous data as median with 
interquartile range (IQR).  
 
I used multivariable logistic regression analysis to test for association between 
pulse pressure and MINS. Pulse pressure quintiles were considered as an 
ordered categorical variable. To avoid isolating any single pulse pressure 
quintile as the reference group, deviation contrasts were used to compare each 
pulse pressure category to the un-weighted average effect across the whole 
sample.338, 339 The models were corrected for potential confounding variables 
that were associated with myocardial injury or cardiac complications in previous 
perioperative studies: coronary artery disease, atrial fibrillation, heart failure, 
peripheral vascular disease, diabetes, age (45-64, 65-75, >75 years), previous 
stroke or transient ischaemic attack, chronic obstructive pulmonary disease, 
estimated glomerular filtration rate (eGFR), neurosurgery, urgent/emergency 
surgery and major surgery.16, 20, 21, 95 eGFR was considered a categorical 
variable and divided into four groups (<30, 30-44, 45-60, >60 ml/min), to be 
consistent with previous research in the field.16 The selection of covariates was 
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based on prior evidence of association with the dependent variable or similar 
clinical outcomes, rather than using univariable analysis or p-value based 
approaches.361, 362 Covariates were treated as categorical variables. Odds ratios 
were converted to risk ratios using Grant’s equation.363  
	
4.2.4 Post-hoc analyses 
To determine whether or not the relationship between elevated pulse pressure 
and myocardial injury was independent of systolic blood pressure I undertook a 
post-hoc analysis. The primary analysis was repeated including systolic blood 
pressure as a covariate in the multivariable model. Firstly, the sample was 
ranked by systolic blood pressure and divided into five approximately equal 
quintiles of preoperative systolic blood pressure, which were included in the 
statistical model using a deviation contrast. Secondly, the primary analysis was 
repeated including preoperative systolic blood pressure as a continuous 
variable in the multivariable model. Thirdly, the sample was stratified according 
to arterial pulse pressure >62mmHg (derived from the results of the primary 
analysis) and elevated systolic blood pressure of >160mmHg according to 
recent consensus guidelines.188 To aid the comparison between systolic blood 
pressure and pulse pressure, I conducted a post-hoc analysis to identify a 
systolic blood pressure threshold associated with pulse pressure >62 mmHg. 
The sample was divided into ten approximately equal groups according to 
preoperative systolic blood pressure and the planned multivariable logistic 
regression analysis was repeated using systolic blood pressure deciles as the 





4.2.5 Sensitivity analyses 
Since hypertension is associated with cardiac complications and long-term 
mortality in the general population, I repeated the primary analysis using 
myocardial infarction (MI) and all-cause mortality within 30-days of surgery as 
additional outcome measures.141 MI was defined by clinical criteria according to 
the third universal definition, comprising troponin elevation in the presence of 
clinical symptoms or dynamic electrocardiographic/echocardiographic changes 
suggestive of myocardial ischaemia.113 Surgical procedures performed as an 
emergency carry a higher risk of morbidity and mortality.10, 16 To account for 
potential confounding by urgency of surgery, I repeated the analysis excluding 
cases of emergency surgery. In the primary analysis, isolating an arbitrary 
group of multi-level categorical variables as the reference category in the 
logistic regression models was avoided, in order to reduce bias. However, to 
make my analysis comparable to other research using reference specific 
groups, the primary analysis was repeated using an indicator contrast with 
pulse pressure ≤45 mmHg as the reference group.314 Patients with heart failure 
are at high risk of perioperative cardiovascular complications and heart failure 
can influence blood pressure and, by extension, pulse pressure. To determine 
whether or not the observed association was confounded by heart failure, the 
analysis was repeated including only patients with a pre-existing diagnosis of 
heart failure.349, 350 To investigate the possibility of a non-linear relationship 
between pulse pressure and myocardial injury, I conducted a post-hoc analysis 







4.3  Results 
16,079 patients were recruited into the study between 6th August 2007 and 11th 
January 2011. After excluding participants that were missing data for 
preoperative pulse pressure or myocardial injury, 15,057 remained (figure 4.1 
and table 4.1). The mean age of participants was 65 (+/-11.8) years, 7,289 
(48.4%) were male and the majority (85.9%) underwent elective surgery. The 
frequency of co-morbidities progressively increased across pulse pressure 
quintiles one to five (<45 mmHg, 46-53 mmHg, 54-62 mmHg, 63-75 mmHg and 
>75 mmHg; table 4.1). Advanced age, diabetes mellitus, pre-existing 
hypertension, previous stroke or TIA, peripheral vascular disease, and eGFR 
<30 ml/min/1.73m2 were significantly more common in pulse pressure quintiles 




Figure 4.1 STROBE diagram showing the number of patients included and 
excluded from the primary analysis.343 
13,933 cases with complete set of 
dependent and independent variables 
were included in multivariable analysis 
16,079 patients recruited into study 
16,023 cases with preoperative arterial 
pressure recorded 
Excluded 56 cases without preoperative arterial 
pressure  




966 cases with missing outcome data were excluded 




Table 4.1. Baseline patient characteristics. Data stratified by preoperative pulse pressure quintiles, presented as frequencies with percentages (%) or means 
with standard deviations (SD). Data rounded to nearest whole number. Preoperative pulse pressure in mmHg. Estimated glomerular filtration rate (eGFR). 
 
Preoperative pulse pressure (mmHg) Whole cohort ≤45 46-53 54-62 63-75 >75 
Number of cases (n) 15057 3448 2657 2949 2980 3023 
Mean age (SD) 65 (11.8) 60 (10.7) 62 (11.0) 65 (11.4) 68 (11.3) 72 (10.9) 
Sex  
     Male (%) 7289 (48.4) 1799 (52.2) 1363 (51.3) 1426 (48.4) 1421 (47.7) 1280 (42.3)
Mean preoperative pulse pressure (SD) 60.5 (19.0) 38.3 (5.8) 49.7 (2.1) 58.2 (2.5) 68.7 (3.6) 89.5 (12.4) 
Comorbid disorder (%)  
     Atrial fibrillation 499 (3.3) 107 (3.1) 73 (2.7) 102 (3.5) 103 (3.5) 114 (3.8)
Diabetes 2934 (19.5) 447 (13.0) 418 (15.7) 595 (20.2) 634 (21.3) 840 (27.8) 
Hypertension 7670 (50.9) 1252 (36.3) 1160 (43.7) 1494 (50.7) 1713 (57.5) 2051 (67.8) 
Congestive cardiac failure 697 (4.6) 119 (3.5) 110 (4.1) 119 (4.0) 163 (5.5) 186 (6.2) 
Coronary artery disease 1820 (12.1) 332 (9.6) 270 (10.2) 339 (11.5) 383 (12.9) 496 (16.4) 
Peripheral vascular disease 799 (5.3) 119 (3.5) 111 (4.2) 130 (4.4) 169 (5.7) 270 (8.9) 
Previous stroke or transient ischaemic attack 1067 (7.1) 129 (3.7) 122 (4.6) 198 (6.7) 257 (8.6) 361 (11.9) 
Chronic obstructive pulmonary disease 1268 (8.4) 254 (7.4) 196 (7.4) 234 (7.9) 297 (10.0) 287 (9.5) 
Active cancer 1917 (12.7) 451 (13.1) 364 (13.7) 379 (12.9) 385 (12.9) 338 (11.2) 
Preoperative eGFR, ml/min/1.73m2 (%)  
     <30 514 (3.7) 88 (2.9) 61 (2.5) 73 (2.7) 116 (4.1) 176 (6.1)
30-44 751 (5.4) 114 (3.7) 91 (3.7) 126 (4.6) 156 (5.6) 264 (9.1) 
45-60 1490 (10.7) 230 (7.5) 207 (8.5) 266 (9.8) 341 (12.2) 446 (15.4) 
>60 11185 (80.2) 2648 (86.0) 2085 (85.3) 2261 (82.9) 2184 (78.1) 2007 (69.4) 
Surgical procedure category (%)  
     Elective 12935 (85.9) 2981 (86.5) 2313 (87.1) 2544 (86.3) 2556 (85.8) 2541 (84.1)
Urgent 430 (2.9) 86 (2.5) 80 (3.0) 96 (3.3) 77 (2.6) 91 (3.0) 
Emergency 1692 (11.2) 381 (11.0) 264 (9.9) 309 (10.5) 347 (11.6) 391 (12.9) 
Major surgery (%) 9096 (60.4) 1959 (56.8) 1540 (58.0) 1727 (58.6) 1910 (64.1) 1960 (64.8) 
Outcome measures (%)  
     Myocardial injury 1191 (7.9) 198 (5.7) 141 (5.3) 201 (6.8) 279 (9.4) 372 (12.3)
 
 





Table 4.2. Multivariable logistic regression models for preoperative pulse pressure >62 mmHg. Dependent variable is pulse pressure >62 mmHg. 
Results given as odds ratios with 95% confidence intervals. 
 
  Pulse pressure > 62 mmHg 
Covariates odds ratio p-value 
Age (years)   
45-64 (reference) - - 
65-75 2.26 (2.07-2.45) <0.01 
>75 3.59 (3.26-3.96) <0.01 
Male sex 0.82 (0.76-0.88) <0.01 
History of atrial fibrillation 0.62 (0.51-0.75) <0.01 
History of diabetes 1.31 (1.20-1.43) <0.01 
History of hypertension 1.44 (1.34-1.56) <0.01 
History of heart failure 0.89 (0.76-1.05) 0.18 
History of coronary artery disease 0.90 (0.81-1.01) 0.07 
History of peripheral vascular disease 1.26 (1.08-1.47) <0.01 
History of stroke or transient ischaemic attack 1.45 (1.26-1.65) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  <30 1.39 (1.16-1.67) <0.01 
30-44 1.05 (0.90-1.23) 0.50 
45-60 1.08 (0.97-1.22) 0.17 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.01 (0.89-1.14) 0.94 
Neurosurgery 1.23 (1.06-1.42) 0.01 
Urgent or emergency surgery 1.08 (0.98-1.20) 0.13 
Major surgery 1.06 (0.98-1.14) 0.14 






4.3.1  Primary analysis 
Participants who were missing predefined covariates were excluded from the 
multivariable logistic regression analyses (figure 4.1). Myocardial injury was 
more frequent among participants in the two highest pulse pressure quintiles 
(>62 mmHg) compared to other quintiles. Preoperative pulse pressure >62 
mmHg was associated with myocardial injury amongst patients in quintile 4 (63-
75 mmHg, RR 1.14 [1.01-1.28]; p=0.03), and quintile 5 (>75 mmHg, RR 1.15 
[1.03-1.29]; p=0.02) independent of confounding factors (table 4.3 and figure 
4.2). Pulse pressure of 46-53 mmHg was associated with reduced incidence of 
myocardial injury (RR 0.83 [0.72-0.96]; p=0.02). 
 
 
Figure 4.2. Forest plot showing the relative odds of myocardial injury for each 
quintile of preoperative pulse pressure. The x-axis shows odds ratios for myocardial 




Table 4.3. Multivariable logistic regression models for preoperative pulse pressure. Dependent variable is myocardial injury within 30 days of surgery. 
Preoperative pulse pressure was divided into quintiles and treated as a categorical variable. Results given as odds ratios with 95% confidence intervals. Estimated 
glomerular filtration rate (eGFR). 
 
  Myocardial Injury 
Covariates odds ratio p-value 
Age (years)   
45-64 (reference) - - 
65-75 1.02 (0.84-1.22) 0.87 
>75 1.88 (1.57-2.25) <0.01 
Male sex 1.39 (1.21-1.59) <0.01 
History of atrial fibrillation 1.67 (1.28-2.17) <0.01 
History of diabetes 1.38 (1.18-1.60) <0.01 
History of hypertension 1.28 (1.09-1.50) <0.01 
History of heart failure 1.59 (1.27-2.00) <0.01 
History of coronary artery disease 1.45 (1.22-1.71) <0.01 
History of peripheral vascular disease 2.13 (1.74-2.61) <0.01 
History of stroke or transient ischaemic attack 1.43 (1.18-1.74) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  <30 10.78 (8.73-13.32) <0.01 
30-44 2.55 (2.06-3.17) <0.01 
45-60 1.67 (1.38-2.03) <0.01 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.21 (0.99-1.48) 0.06 
Neurosurgery 1.10 (0.84-1.45) 0.48 
Urgent or emergency surgery 1.97 (1.67-2.32) <0.01 
Major Surgery 1.68 (1.44-1.96) <0.01 
Pulse pressure quintiles (mmHg) 
  ≤45 0.91 (0.78-1.05) 0.20 
46-53 0.82 (0.70-0.96) 0.02 
54-62 1.00 (0.87-1.15) 0.96 
63-75 1.15 (1.01-1.31) 0.03 
>75 1.16 (1.03-1.32) 0.02 







4.3.2  Post-hoc analyses 
When I repeated the primary multivariable analysis adjusted for preoperative 
systolic blood pressure divided into quintiles and considered as an ordered 
categorical variable, pulse pressure 63-75 mmHg and >75 mmHg remained 
associated with myocardial injury (RRs 1.20 [1.05-1.37]; p<0.01 and 1.25 [1.06-
1.48]; p<0.01 respectively). However, preoperative systolic blood pressure was 
not associated with myocardial injury (table 4.4 and figure 4.3). When the 
primary multivariable analysis was repeated adjusting for preoperative systolic 
blood pressure as a continuous variable, elevated pulse pressure remained 
associated with myocardial injury, but systolic blood pressure was not 
associated with myocardial injury (table 5.5). When I stratified the cohort by 
pulse pressure >62 mmHg and systolic blood pressure >160 mmHg, pulse 
pressure >62 mmHg was independently associated with myocardial injury, 
irrespective of systolic blood pressure (table 4.6). Multivariable logistic 
regression analysis showed that systolic blood pressures >139 mmHg were 







Table 4.4. Multivariable logistic regression model to predict myocardial injury 
after non-cardiac surgery. Dependent variable is myocardial injury within 30 days of 
surgery. Preoperative pulse pressure was divided into quintiles and treated as a categorical 
variable. Preoperative systolic blood pressure was divided into quintiles and included as a 
covariate. Results given as odds ratios with 95% confidence intervals. Estimated glomerular 
filtration rate (eGFR). 
	
  
MYOCARDIAL INJURY Covariates odds ratio p-value 
Age (years)   
45-64 (reference) - - 
65-75 1.01 (0.84-1.22) 0.93 
>75 1.86 (1.55-2.23) <0.01 
Male sex 1.40 (1.22-1.60) <0.01 
History of atrial fibrillation 1.67 (1.29-2.17) <0.01 
History of diabetes 1.37 (1.18-1.60) <0.01 
History of hypertension 1.29 (1.10-1.51) <0.01 
History of heart failure 1.58 (1.25-1.98) <0.01 
History of coronary artery disease 1.44 (1.21-1.70) <0.01 
History of peripheral vascular disease 2.13 (1.74-2.60) <0.01 
History of stroke or transient ischaemic attack 1.44 (1.18-1.75) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  <30 10.70 (8.66-13.22) <0.01 
30-44 2.56 (2.06-3.17) <0.01 
45-60 1.67 (1.38-2.03) <0.01 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.20 (0.98-1.47) 0.08 
Neurosurgery 1.11 (0.84-1.46) 0.47 
Urgent or emergency surgery 1.97 (1.67-2.32) <0.01 
Major surgery 1.68 (1.44-1.97) <0.01 
Systolic blood pressure quintiles (mmHg)   
<120 1.07 (0.91-1.24) 0.43 
120-131 1.19 (0.97-1.44) 0.09 
132-143 0.95 (0.83-1.10) 0.52 
144-159 0.93 (0.80-1.07) 0.29 
≥160 0.90 (0.75-1.07) 0.24 
Pulse pressure quintiles (mmHg) 
  ≤45 0.81 (0.67-0.98) 0.03 
46-53 0.78 (0.66-0.93) <0.01 
54-62 1.01 (0.87-1.17) 0.91 
63-75 1.22 (1.06-1.41) <0.01 
>75 1.28 (1.07-1.54) <0.01 





Figure 4.3. Forest plot showing the relative odds of myocardial injury for each 
quintile of preoperative pulse pressure, adjusted for quintiles of preoperative 
systolic pressure. The x-axis shows odds ratios for myocardial injury within 30 days of 






Table 4.5. Sensitivity analysis including systolic blood pressure as a continuous variable. Dependent variable is myocardial injury within 30 days of 
surgery. Results presented as odds ratios with 95% confidence intervals. 
 
  Myocardial injury 
Covariates odds ratio p-value 
Age (years)   
45-64 (reference) - - 
65-75 1.01 (0.84-1.22) 0.92 
>75 1.87 (1.56-2.24) <0.01 
Male sex 1.39 (1.21-1.60) <0.01 
History of atrial fibrillation 1.67 (1.28-2.17) <0.01 
History of diabetes 1.37 (1.18-1.60) <0.01 
History of hypertension 1.39 (1.10-1.51) <0.01 
History of heart failure 1.59 (1.26-1.99) <0.01 
History of coronary artery disease 1.44 (1.22-1.70) <0.01 
History of peripheral vascular disease 2.13 (1.74-2.61) <0.01 
History of stroke or transient ischaemic attack 1.44 (1.18-1.75) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  <30 10.74 (8.69-13.27) <0.01 
30-44 2.55 (2.06-3.17) <0.01 
45-60 1.67 (1.38-2.02) <0.01 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.20 (0.98-1.47) 0.07 
Neurosurgery 1.11 (0.84-1.46) 0.46 
Urgent or emergency surgery 1.97 (1.68-2.32) <0.01 
Major surgery 1.68 (1.44-1.96) <0.01 
Systolic blood pressure (mmHg) 0.99 (0.99-1.00) 0.19 
Pulse pressure quintiles (mmHg) 
  ≤45 0.85 (0.70-1.01) 0.07 
46-53 0.79 (0.67-0.94) <0.01 
54-62 0.99 (0.86-1.15) 0.94 
63-75 1.18 (1.03-1.35) 0.02 
>75 1.27 (1.06-1.52) <0.01 






Table 4.6. Multivariable logistic regression models for preoperative pulse pressure and hypertension status. The dependent variable is 
myocardial injury within 30 days of surgery. The sample was divided into four groups according to preoperative pulse pressure (PP) and preoperative systolic blood 
pressure (SBP): (1) systolic blood pressure ≤160mmHg and preoperative pulse pressure ≤62mmHg, (2) systolic blood pressure >160mmHg and preoperative pulse 
pressure ≤62mmHg, (3) systolic blood pressure ≤160mmHg and preoperative pulse pressure >62mmHg and (4) systolic blood pressure >160mmHg and 
preoperative pulse pressure >62mmHg. The reference category was systolic blood pressure ≤160mmHg and preoperative pulse pressure ≤62mmHg. Results given 
as odds ratios with 95% confidence intervals. eGFR = estimated glomerular filtration rate. 
 
  Myocardial Injury 
Covariates odds ratio p-value 
Age (years)   
45-64 (reference) - - 
65-75 1.02 (0.85-1.23) 0.82 
>75 1.90 (1.59-2.27) <0.01 
Male sex 1.38 (1.20-1.59) <0.01 
History of atrial fibrillation 1.67 (1.29-2.17) <0.01 
History of diabetes 1.38 (1.19-1.61) <0.01 
History of hypertension 1.29 (1.10-1.51) <0.01 
History of heart failure 1.58 (1.26-1.99) <0.01 
History of coronary artery disease 1.45 (1.22-1.71) <0.01 
History of peripheral vascular disease 2.14 (1.75-2.62) <0.01 
History of stroke or transient ischaemic attack 1.44 (1.19-1.76) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  <30 10.75 (8.70-13.28) <0.01 
30-44 2.55 (2.06-3.16) <0.01 
45-60 1.67 (1.39-2.03) <0.01 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.21 (0.99-1.48) 0.06 
Neurosurgery 1.11 (0.85-1.47) 0.45 
Urgent or emergency surgery 1.98 (1.68-2.32) <0.01 
Major surgery 1.68 (1.44-1.96) <0.01 
Pulse pressure and hypertension status 
  SBP ≤160mmHg, PP≤62mmHg (reference) - - 
SBP >160mmHg, PP≤62mmHg 0.66 (0.29-1.48) 0.31 
SBP ≤160mmHg, PP>62mmHg 1.27 (1.08-1.49) <0.01 
SBP >160mmHg, PP>62mmHg 1.23 (1.03-1.46) 0.02 




Table 4.7. Multivariable logistic regression model to predict pulse pressure >62 
mmHg. Dependent variable is pulse pressure >62 mmHg. Number of cases with pulse 
pressure >62mmHg and the total for each covariate. Results are reported as odds ratios with 








  Pulse pressure > 62 mmHg 
Covariates Number of cases/total odds ratio p-value 
Age (years)    
45-64 (reference) 1950/7467 - - 
65-75 1955/4133 2.11 (1.87-2.38) <0.01 
>75 2098/1359 3.43 (2.99-3.94) <0.01 
Male sex 2701/7289 0.64 (0.58-0.71) <0.01 
History of atrial fibrillation 217/499 0.72 (0.55-0.95) 0.02 
History of diabetes 1474/2934 1.28 (1.13-1.45) <0.01 
History of hypertension 3764/7670 0.96 (0.86-1.07) 0.42 
History of heart failure 349/697 1.21 (0.95-1.53) 0.13 
History of coronary artery disease 879/1820 1.21 (1.03-1.42) 0.18 
History of peripheral vascular disease 439/799 1.24 (0.99-1.51) 0.06 
History of stroke or transient ischaemic attack 618/1067 1.12 (0.92-1.36) 0.26 
Preoperative eGFR (ml/min/1.73m2)  
  <30 292/514 1.74 (1.31-2.31) <0.01 
30-44 420/751 0.97 (0.78-1.22) 0.79 
45-60 787/1490 1.10 (0.94-1.30) 0.24 
>60 (reference) 4191/11185 - - 
History of chronic obstructive pulmonary disease 584/1268 1.52 (1.27-1.81) <0.01 
Neurosurgery 395/975 1.00 (0.81-1.24) 1.00 
Urgent or emergency surgery 906/2122 0.93 (0.80-1.08) 0.33 
Major surgery 3870/9096 1.19 (1.07-1.32) <0.01 
Systolic blood pressure groups (mmHg)    
≤110 101/1693 0.14 (0.12-0.18) <0.01 
111-119 9/1548 0.01 (0.01-0.06) <0.01 
120-125 31/1266 0.05 (0.04-0.07) <0.01 
126-131 220/1584 0.33 (0.28-0.39) <0.01 
132-138 378/1522 0.67 (0.58-0.78) <0.01 
139-143 555/1486 1.26 (1.10-1.45) 0.01 
144-150 988/1692 3.08 (2.69-3.53) <0.01 
151-159 966/1314 6.22 (5.33-7.26) <0.01 
160-171 1306/1477 16.83 (14.05-20.17) <0.01 
	
	124 
4.3.3  Sensitivity analyses 
When I excluded cases where surgery was performed as an emergency (table 
4.8), pulse pressure >75 mmHg remained associated with myocardial injury 
(RR 1.20 [1.06-1.36]; p<0.01). However, the association between pulse 
pressure 63-75 mmHg and myocardial injury was not significant (RR 1.14 [1.00-
1.29]; p=0.058). When I repeated the analysis using an indicator contrast (i.e. 
comparison with a reference group rather than cohort average) with pulse 
pressure ≤45 mmHg as the reference group the results were similar (table 4.9). 
When I repeated the analysis for only participants with a pre-existing diagnosis 
of heart failure, I observed no association between pulse pressure and 
myocardial injury (table 4.10). When I repeated the main analysis for the 
additional outcome measures myocardial infarction and mortality, I excluded 
participants with missing independent and dependent variables: 452/15,975 
(2.8%) participants sustained myocardial infarction and 313/16,005 (2.0%) died. 
Pulse pressure of >75 mmHg was associated with myocardial infarction (RR 














Table 4.8. Sensitivity analysis excluding emergency cases. Multivariable logistic regression models for preoperative pulse pressure. Dependent variable is 
myocardial injury within 30 days of surgery. Preoperative pulse pressure was divided into quintiles and treated as a categorical variable. Results given as odds ratios 
with 95% confidence intervals. 
 
  Myocardial Injury 
Covariates odds ratio p-value 
Age (years)   45-64 (reference) - - 
65-75 1.02 (0.28-1.24) 0.88 
>75 1.86 (1.53-2.27) <0.01 
Male sex 1.40 (1.21-1.64) <0.01 
History of atrial fibrillation 2.07 (1.56-2.74) <0.01 
History of diabetes 1.31 (1.11-1.56) <0.01 
History of hypertension 1.20 (1.01-1.44) 0.04 
History of heart failure 1.46 (1.14-1.88) <0.01 
History of coronary artery disease 1.52 (1.26-1.82) <0.01 
History of peripheral vascular disease 2.00 (1.60-2.51) <0.01 
History of stroke or transient ischaemic attack 1.47 (1.88-1.83) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  <30 11.69 (9.24-14.80) <0.01 
30-44 2.72 (2.15-3.47) <0.01 
45-60 1.64 (1.32-2.03) <0.01 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.28 (1.03-1.59) 0.03 
Neurosurgery 1.08 (0.81-1.45) 0.60 
Urgent or emergency surgery 2.21 (1.60-3.04) <0.01 
Major surgery 1.70 (1.44-2.02) <0.01 
Pulse pressure quintiles (mmHg) 
  ≤45 0.86 (0.73-1.01) 0.07 
46-53 0.81 (0.68-0.97) 0.02 
54-62 1.03 (0.88-1.20) 0.71 
63-75 1.15 (1.00-1.32) 0.06 
>75 1.22 (1.07-1.40) <0.01 






Table 4.9. Sensitivity analysis using indicator contrast with pulse pressure less than 45 mmHg as the reference category. Multivariable logistic 
regression models for preoperative pulse pressure. Dependent variable is myocardial injury within 30 days of surgery. Results presented as odds ratios with 95% 
confidence intervals. 
 
  Myocardial injury 
Covariates odds ratio p-value 
Age (years)   
45-64 (reference) - - 
65-75 1.02 (0.84-1.22) 0.87 
>75 1.88 (1.57-2.25) <0.01 
Male sex 1.39 (1.21-1.59) <0.01 
History of atrial fibrillation 1.67 (1.28-2.17) <0.01 
History of diabetes 1.38 (1.18-1.60) <0.01 
History of hypertension 1.28 (1.09-1.50) <0.01 
History of heart failure 1.59 (1.27-2.00) <0.01 
History of coronary artery disease 1.45 (1.22-1.71) <0.01 
History of peripheral vascular disease 2.13 (1.74-2.61) <0.01 
History of stroke or transient ischaemic attack 1.43 (1.18-1.74) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  <30 10.78 (8.73-13.32) <0.01 
30-44 2.55 (2.06-3.17) <0.01 
45-60 1.67 (1.38-2.03) <0.01 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.21 (0.99-1.48) 0.06 
Neurosurgery 1.10 (0.84-1.45) 0.48 
Urgent or emergency surgery 1.97 (1.67-2.32) <0.01 
Major surgery 1.68 (1.44-1.96) <0.01 
Pulse pressure quintiles (mmHg) 
  ≤45 - - 
46-53 0.90 (0.70-1.16) 0.43 
54-62 1.11 (0.88-1.39) 0.39 
63-75 1.27 (1.02-1.58) 0.03 
>75 1.28 (1.04-1.59) 0.02 






Table 4.10. Sensitivity analysis including only participants with a pre-existing diagnosis of heart failure. Multivariable logistic regression models 
for preoperative pulse pressure. Dependent variable is myocardial injury within 30 days of surgery. Results presented as odds ratios with 95% confidence intervals. 
 
  Myocardial injury 
Covariates odds ratio p-value 
Age (years)   
45-64 (reference) - - 
65-75 0.35 (0.18-0.68) <0.01 
>75 1.03 (0.59-1.79) 0.92 
Male sex 1.74 (1.14-2.67) 0.01 
History of atrial fibrillation 1.10 (0.68-1.80) 0.69 
History of diabetes 1.04 (0.66-1.62) 0.87 
History of hypertension 1.01 (0.57-1.81) 0.96 
History of coronary artery disease 1.21 (0.80-1.85) 0.37 
History of peripheral vascular disease 3.50 (2.05-6.00) <0.01 
History of stroke or transient ischaemic attack 1.71 (1.03-2.82) 0.04 
Preoperative eGFR (ml/min/1.73m2) 
  <30 7.53 (4.39-12.92) <0.01 
30-44 2.19 (1.24-3.85) <0.01 
45-60 1.09 (0.58-2.06) 0.79 
>60 (reference) - - 
History of chronic obstructive pulmonary disease 1.00 (0.61-1.62) 0.99 
Neurosurgery 0.74 (0.28-1.95) 0.55 
Urgent or emergency surgery 2.22 (1.33-3.69) <0.01 
Major surgery 1.39 (0.88-2.19) 0.16 
Pulse pressure quintiles (mmHg) 
  ≤45 0.97 (0.62-1.51) 0.88 
46-53 0.97 (0.61-1.55) 0.91 
54-62 0.94 (0.60-1.45) 0.76 
63-75 1.08 (0.74-1.59) 0.69 
>75 1.05 (0.73-1.52) 0.79 






Table 4.11. Sensitivity analysis including all cases for dependent variables myocardial infarction and mortality within 30 days of surgery. 
Multivariable logistic regression models for preoperative pulse pressure. Preoperative pulse pressure was divided into quintiles and treated as a categorical variable. 
Results given as odds ratios with 95% confidence intervals. 
 
  Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value 
Age (years)     
45-64 (reference) - - - - 
65-75 1.08 (0.81-1.44) 0.59 1.65 (1.17-2.32) <0.01 
>75 1.69 (1.28-2.22) <0.01 2.45 (1.74-3.45) <0.01 
Male sex 1.04 (0.84-1.28) 0.73 1.17 (0.92-1.50) 0.21 
History of atrial fibrillation 1.42 (0.99-2.04) 0.05 1.12 (0.70-1.81) 0.63 
History of diabetes 1.20 (0.96-1.50) 0.12 1.04 (0.78-1.39) 0.79 
History of hypertension 1.34 (1.05-1.72) 0.02 0.99 (0.75-1.30) 0.92 
History of heart failure 1.68 (1.25-2.27) <0.01 1.33 (0.88-2.01) 0.18 
History of coronary artery disease 2.18 (1.73-2.75) <0.01 0.85 (0.61-1.18) 0.33 
History of peripheral vascular disease 2.08 (1.58-2.75) <0.01 1.80 (1.25-2.59) <0.01 
History of stroke or transient ischaemic attack 1.11 (0.83-1.48) 0.48 1.59 (1.14-2.22) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
  
  
<30 4.00 (2.98-5.38) <0.01 3.25 (2.23-4.75) <0.01 
30-44 1.74 (1.26-2.41) <0.01 1.71 (1.15-2.53) <0.01 
45-60 1.39 (1.04-1.87) 0.03 0.94 (0.63-1.40) 0.77 
>60 (reference) - - - - 
History of chronic obstructive pulmonary disease 1.15 (0.86-1.53) 0.36 2.02 (1.47-2.77) <0.01 
Neurosurgery 0.56 (0.34-0.95) 0.03 1.67 (1.08-2.57) 0.02 
Urgent or emergency surgery 2.35 (1.88-2.94) <0.01 3.93 (3.06-5.03) <0.01 
Major Surgery 2.22 (1.74-2.85) <0.01 1.61 (1.20-2.14) <0.01 
Pulse pressure quintiles (mmHg) 
  
  
≤45 0.86 (0.68-1.09) 0.21 1.26 (0.99-1.60) 0.06 
46-53 0.88 (0.69-1.12) 0.30 1.18 (0.91-1.52) 0.22 
54-62 0.95 (0.77-1.18) 0.66 0.82 (0.63-1.07) 0.14 
63-75 1.09 (0.90-1.32) 0.39 0.98 (0.78-1.24) 0.89 
>75 1.27 (1.07-1.52) <0.01 0.84 (0.67-1.06) 0.14 







4.3.3  Fractional polynomial analysis 
Multivariable fractional polynomial regression analysis confirmed that the 
relationship between increasing pulse pressure and the probability of 
myocardial injury was linear in nature (figure 4.4). 
	
	
Figure 4.4. Function plot of the one-term multivariable fractional polynomial 
logistic regression model. The x-axis shows preoperative pulse pressure in mmHg and the 
y-axis is the partial predictor + residual. The grey region indicates the 95% confidence interval. 
The partial predictor is the pulse pressure component of the regression equation plus the 
intercept. The residual is the residual variation between the regression line and the observed 
data. The function plot shows how a given term in a regression model varies across the data 
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5.4  Discussion 
The principal finding of this analysis of ~14,000 patients is that elevated 
preoperative pulse pressure (>62 mmHg) occurred in two out of every five 
patients and is associated with myocardial injury, defined as TnT ≥0.03ng/mL 
judged due to an ischaemic aetiology within 30 days after non-cardiac surgery. 
This association persists after adjusting for preoperative systolic blood 
pressure. Patients with elevated preoperative systolic blood pressure (>160 
mmHg) were only at increased risk of myocardial injury if the preoperative pulse 
pressure was >62 mmHg.  
 
A preoperative diagnosis of arterial hypertension has been reported to have a 
small but significant influence on cardiovascular morbidity following non-cardiac 
surgery,200, 365, 366 However, previous studies were heterogeneous and did not 
use a robust, independently prognostic biomarker for myocardial injury 
(troponin) as the primary endpoint or undertake prospective data collection in a 
large selection of patients. Consequently, the impact of high blood pressure 
immediately before surgery has remained unclear.367-369 My data suggest that, 
in the preoperative setting, pulse pressure is a better predictor of the 
development of myocardial injury, compared to systolic blood pressure. Whilst 
the degree of association between elevated pulse pressure and myocardial 
injury was modest, due to the high volume of surgical treatment (~8 million in 
the UK per year), this could still have a clinically significant impact on patient 
outcomes.19 At the population level, small increases in risk from multiple 
independent factors are widely considered to be central to the development of 
non-communicable disease. This thesis centres around identifying simple 
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exposures that could be used to predict, or modified to prevent or treat, 
perioperative disease. 
 
This analysis identifies a relationship between preoperative pulse pressure and 
perioperative myocardial injury, an association that is independent of age and 
systolic blood pressure. Several large, international non-operative registry 
studies have reported that elevated pulse pressure confers increased risk of 
multiple adverse cardiovascular events independent of systolic blood 
pressure.147, 148, 212, 213 Pulse pressure widens with age as a result of increasing 
systolic and falling diastolic blood pressures. In the Framingham study, 
increasing age was associated with a shift from diastolic to systolic blood 
pressure, and then to pulse pressure, as the predominant predictor of 
cardiovascular disease.143 The prospective cardiovascular Münster (PROCAM) 
study reported that normotensive older men with higher pulse pressure were at 
increased risk of cardiac events, similar to the increased risk of myocardial 
injury in elderly men I found in this analysis.147 
 
The underlying pathophysiological mechanisms that link pulse pressure to 
myocardial injury may be explained by four different, but potentially interlinked, 
mechanisms. Firstly, elevated systolic blood pressure can cause left ventricular 
hypertrophy and increase end-systolic myocardial stress,	which are 
independently associated with cardiovascular mortality.216, 217 Secondly, lower 
diastolic blood pressure relative to left ventricular end-diastolic pressure 
reduces coronary perfusion pressure and oxygen supply to the myocardium,218 
which may promote myocardial ischaemia.147, 217 Thirdly, elevated pulse 
pressure is associated with smaller aortic lumen areas, and larger end-diastolic 
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left ventricular volumes suggesting that patients with high pulse pressures may 
have aorto-ventricular decoupling, characterised by a larger cardiac output than 
can be accommodated by the gauge of the aorta.214, 370 It is plausible that aorto-
ventricular decoupling could be exacerbated by fluid shifts or inotropic agents 
commonly seen in the perioperative period, which may lead to ventricular 
overload and impaired cardiac output, despite preserved systolic function. This 
could explain the increased risk of morbidity in patients with elevated pulse 
pressure, since impaired cardiac output in the perioperative period is associated 
with increased organ dysfunction and poorer clinical outcomes.279, 281 Fourthly, 
arterial blood pressure is regulated by baroreceptors, which detect arterial wall 
stretch on a beat-by-beat basis.75 Elevated pulse pressure is associated with 
increased aortic wall stiffness,214 and impaired baroreflex sensitivity (a 
biomarker of parasympathetic dysfunction) in elderly men and women,215 
healthy middle-aged volunteers,371 and patients with diabetes mellitus.372 
Impaired baroreflex sensitivity is a principal cause of labile hypertension373 and 
is associated with cardiovascular morbidity after major surgery.178 Therefore the 
observed association between elevated pulse pressure and myocardial injury 
could be explained by parasympathetic dysfunction. 
 
My analysis has several strengths. This is one of the largest prospective cohort 
studies to investigate the influence of blood pressure immediately prior to 
surgery on clinical outcomes after non-cardiac surgery.374 The sample included 
patients undergoing a variety of non-cardiac surgical procedures at multiple 
international centres, so my results are relevant to the majority of patients 
having non-cardiac surgery. The large sample size allowed adjustment for a 
large number of confounding variables, including systolic blood pressure. 
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However, there may be residual, un-measured confounding. The primary 
outcome measure, myocardial injury, is an objective biochemical endpoint that 
lacks the subjectivity associated with clinical outcome measures used in 
previous studies.198, 202  
 
My analysis also has several weaknesses. Preoperative arterial blood pressure 
was measured by local clinical staff at each participating hospital before the 
induction of anaesthesia. The oscillometric technique was used in the majority 
of cases, but the specific measurement apparatus, timing and location of 
measurement varied between centres and the exact details are not known. 
Since this was intended to be a pragmatic analysis, I do not believe this 
adversely affected the results or interpretation. However, non-invasive blood 
pressure measurement is less reliable that intra-arterial measurement.375 It is 
possible that pre-medication could influence preoperative arterial blood 
pressure, although the practice of premedication is uncommon in participating 
centres (particularly since recent evidence shows that preoperative sedation 
fails to improve outcomes).376 Omission of usual anti-hypertensive therapy 
before surgery, for example angiotensin converting enzyme inhibitors, may 
have contributed to high blood pressure readings in patients with established 
hypertension. However, I did not have access to these data and so was unable 
to perform sensitivity analyses to address this question. The association 
between elevated pulse pressure and myocardial injury appeared independent 
of urgency of surgery, which is a potential confounding variable, due to 
expected lower preoperative blood pressures as a result of sepsis or blood loss. 
The data used in this analysis was derived from the first VISION study cohort 
and so preoperative troponin measurements were not available.16, 115 Therefore 
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the incidence of preoperative myocardial injury is unknown, although I would 
only expect this to occur in a small proportion of cases.377 The analysis was 
repeated using myocardial infarction and mortality as outcome measures, to aid 
comparisons within the perioperative literature. However, myocardial infarction 
is a clinically derived outcome and is subject to bias. I attempted to limit this by 
using standard definitions and excluding this from the main analysis.  
 
The association between pulse pressure and myocardial injury was lost when 
the analysis was restricted only to participants with a confirmed diagnosis of 
heart failure. This is counterintuitive since lower pulse pressure is independently 
associated with mortality in patients with reduced ejection fraction heart failure, 
so I had expected to observe a negative association between increasing pulse 
pressure and risk of myocardial injury.72 The results are more consistent with 
the more variable relationship between pulse pressure and clinical outcomes in 
patients with preserved ejection fraction heart failure.72, 378 Therefore, the data 
may reflect un-measured heterogeneity within the cohort of patients with 
diagnosed heart failure in this data set. However, in the absence of routine 
preoperative echocardiography in the VISION cohort, it is not possible to 
comment on whether there were differences in the relationship between pulse 
pressure and myocardial injury in patients with preserved or reduced ejection 
fraction heart failure. I am also unable to determine whether undiagnosed aortic 
regurgitation was a potential confounding factor, although this is unlikely given 
that the population prevalence of aortic regurgitation is less than 2%.379 The 
relationships between pulse pressure, preserved/reduced ejection fraction heart 
failure and postoperative outcomes, including long-term survival, requires 





The results of this analysis help to address a daily clinical dilemma for 
anaesthetists and surgeons, by establishing that preoperative pulse pressure 
can refine the interpretation of elevated blood pressure on the day of surgery. 
These data suggest that patients with elevated pulse pressure are at higher risk 
of myocardial injury and, where limited time is available to reduce blood 
pressure (e.g. cancer surgery), may benefit from closer perioperative 
monitoring. In particular, surveillance for myocardial injury may be warranted in 
this higher-risk group.95 Conversely, the results should reassure clinicians that 
in this cohort, patients with high preoperative systolic blood pressure but normal 
pulse pressure were not at increased risk of myocardial injury. These data 
suggest that a reappraisal of guidelines for managing elevated blood pressure 
on the day of surgery may be warranted, particularly since abnormal pulse 
pressure could be a modifiable risk factor. Further research is needed to 
determine the underlying pathophysiological mechanism responsible for the 




Chapter five  
Intraoperative heart rate and blood pressure 
 
A secondary analysis of data from a prospective international 
multi-centre cohort study of myocardial injury after non-cardiac 
surgery 
 
This chapter is in press with Anesthesia and Analgesia (2017). 
 
	
5.1  Introduction 
The aetiology of perioperative myocardial injury is unclear. In a large and 
generalisable cohort of patients undergoing non-cardiac surgery I have 
previously identified that both elevated preoperative heart rate (chapter 3) and 
elevated preoperative pulse pressure (chapter 4) are associated with increased 
risk of perioperative myocardial injury. These data suggest that abnormal 
preoperative heart rate and arterial pressure may contribute to the causal 
pathway for perioperative myocardial injury.96, 97 Yet it is unclear whether this is 
also true for heart rate and blood pressure during surgery. 
 
In opposition the traditional plaque rupture and thrombosis model of myocardial 
infarction, the prevailing paradigm of perioperative myocardial injury is 
myocardial oxygen supply-demand imbalance during surgery (a period of 
increased physiological stress), leading to ischaemia, cellular necrosis and 
troponin release into the circulation.96 However, other plausible mechanisms of 
troponin release have been proposed, including: inflammation leading to 
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increased cell membrane permeability; increased cardiac myocyte turnover; 
and extracellular transport of troponin via membrane vesicles.98, 380 Changes in 
intraoperative heart rate and blood pressure, either separately or in 
combination, have been implicated as potential triggers for oxygen supply-
demand imbalance and perioperative cardiovascular complications.96, 169, 203, 381-
383 However, previous research has largely focused on intraoperative 
hypotension, with little consideration of intraoperative heart rate or 
hypertension.203, 381, 384 The majority of previous studies were retrospective in 
design and/or used subjective clinically-defined outcome measures and not 
objective biochemical outcome measures.171, 173, 203, 385, 386 Attempts to control 
elevated heart rate with beta-blockers have consistently demonstrated a 
reduction in the risk of myocardial infarction, but at the expense of increased 
risk of mortality and stroke, likely due to hypotension.166, 261 However, despite 
this, the clinical impact of interaction between intraoperative heart rate and 
blood pressure remains largely unexplored.173 Similarly, the influence of the 
duration of abnormal heart rate or blood pressure on the development of 
myocardial injury is uncertain and under-investigated.173, 384, 387, 388  
 
In this chapter I tested whether high or low intraoperative heart rate or systolic 
blood pressure, in isolation or combination, were associated with myocardial 
injury or mortality within 30 days of non-cardiac surgery in the VISION study 
cohort. In addition, I tested whether the duration of high or low heart 
rate/systolic blood pressure was associated with myocardial injury within 30 





5.2  Methods 
This was a secondary analysis of a prospective international observational 
cohort study, the Vascular Events in Non-cardiac Surgery Cohort Evaluation 
(VISION) study.16 I have described the study in detail in chapter 2 (methods) 
and the study methods have been published previously.16, 95, 273, 275 I planned 
the analysis prospectively before I was given access to the data. Participants 
were aged ≥45 years, undergoing non-cardiac surgery using general or regional 
anaesthesia, and with a planned postoperative hospital stay of at least one 
night. Clinical staff measured heart rate and blood pressure before and during 
surgery as part of routine medical care according to local practice. Blood 
pressure was measured using the oscillometric non-invasive technique. 
 
5.2.1 Exposures of interest 
The exposures of interest were elevated or reduced heart rate or blood 
pressure during surgery, pre-defined by consensus of the VISION study 
investigators before the study started. Elevated heart rate was defined as any 
single measurement >100 beats per minute during surgery. Reduced heart rate 
was defined as any single measurement <55 beats per minute during surgery. 
Elevated systolic blood pressure was defined as any single measurement >160 
mmHg during surgery. Reduced systolic blood pressure was defined as any 
single measurement <100 mmHg during surgery. Heart rate and blood pressure 
data were collected by researchers who reviewed the anaesthetics charts and 
patient records. The duration of heart rate and systolic blood pressure above or 






5.2.2 Outcome measures 
The primary outcome measure was myocardial injury after non-cardiac surgery 
(MINS), according to the VISION study definition: serum Troponin T (TnT) 
≥0.03ng/mL (4th generation assay) within 30 days after surgery, adjudicated as 
due to an ischemic pathology, which excludes non-ischaemic causes of 
transient troponin elevation.95, 113 I have described the blood sampling regime, 
the TnT assay and the adjudication process in chapter 2 (methods) and this has 
also been published previously.16, 95, 273, 275  
 
The secondary outcome measure was all-cause mortality within 30 days after 
surgery. The tertiary outcome was myocardial infarction within 30 days of 
surgery, defined according to the third universal definition (serum troponin 
elevation in the presence of at least one of: ischemic symptoms; the 
development of new or presumed new Q waves, ST segment or T wave 
changes, or left bundle branch block on the electrocardiogram; or the finding of 
a new or presumed new regional wall motion abnormality on 
echocardiography).94  
 
5.2.3 Statistical analysis 
I analysed the data using SPSS (IBM, New York, USA). Cases that were 
missing a record of highest or lowest intraoperative heart rate or systolic blood 
pressure, or outcome data, were excluded from respective analyses by list-wise 
deletion. I sorted and dichotomised the sample according to predefined 
thresholds for highest intraoperative heart rate (>100 bpm), lowest 
intraoperative heart rate (<55 bpm), highest intraoperative systolic blood 
pressure (>160 mmHg) and lowest intraoperative systolic blood pressure (<100 
	
	140 
mmHg). I considered these as categorical variables.  I presented demographic 
data stratified according to these groups.  Continuous data that followed a 
normal distribution were presented as mean (standard deviation), continuous 
data that did not follow a normal distribution were presented as median 
(interquartile range), and binary categorical data as frequencies with 
percentages.  
 
I used multivariable logistic regression analysis to test for associations between 
independent variables (exposures) and myocardial injury. The reference groups 
were: heart rate ≤100 bpm for highest heart rate, heart rate ≥55 bpm for lowest 
heart rate, systolic blood pressure ≤160 mmHg for highest systolic pressure and 
systolic blood pressure ≥100 mmHg for lowest systolic pressure.  Each 
multivariable model was adjusted for potentially confounding factors known to 
be associated with myocardial injury, cardiovascular complications or mortality 
in other perioperative research: age (45-64, 65-75, >75 years), current atrial 
fibrillation, diabetes, hypertension, heart failure, coronary artery disease, 
peripheral vascular disease, previous stroke or transient ischaemic attack, 
estimated glomerular filtration rate (eGFR <30, 30-44, 45-60, >60 ml/min), 
chronic obstructive pulmonary disease, neurosurgery, major surgery and 
urgent/emergency surgery were considered as categorical variables in the 
multivariable models.16, 20, 21, 389 These analyses were repeated for the 
secondary and tertiary outcomes. The results of logistic regression analyses 
were presented as odds ratios (OR) with 95% confidence intervals.  
 
There is some evidence that association between low blood pressure during 
surgery and clinical outcomes may vary according to the duration of the 
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hypotensive episode in a non-linear fashion.384, 390 Therefore, I wanted to test 
whether the duration of high or low systolic blood pressure or heart rate was 
associated with myocardial injury. I stratified duration of intraoperative heart rate 
>100 bpm / <55 bpm or systolic blood pressure >160 mmHg / <100 mmHg into 
quartiles and repeated the primary multivariable logistic regression analysis for 
quartiles of duration as the exposure of interest and myocardial injury as the 
outcome. The reference categories were patients with ‘normal’ heart rate or 
systolic blood pressure, for example in the analysis of duration of heart rate > 
100 bpm, the reference group was patients with heart rate ≤ 100 bpm. To 
examine the relative influence of heart rate and systolic blood pressure on 
myocardial injury, I categorised the cohort according to combinations 
highest/lowest heart rate and highest/lowest systolic blood pressure. I repeated 
primary statistical analysis using these categorical variables. 
 
5.2.4 Power calculation 
For the primary (myocardial injury) analysis the available sample size was 
15,019. Given a type I error rate of 5% and a background incidence of MINS of 
7.9%, I have >99% power to detect a 1.8% absolute difference in the incidence 
of myocardial injury for participants with intraoperative heart rate >100 bpm. 
The minimum sample size required to detect an absolute difference of 1.8% in 
the incidence of myocardial injury, assuming a type I error rate of 5% and power 
of 99% is 4,967 participants. For the secondary and tertiary outcomes, 
assuming a type I error rate of 5% and a total sample of 15,019, I have 99% 
power to detect an absolute difference of 2.1% (2.0% vs 4.1%) in the incidence 
of mortality for participants with intraoperative heart rate >100bpm and 99% 
power to detect an absolute difference of 0.9% (2.8% vs 3.7%) in the incidence 
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of myocardial infarction. The minimum sample sizes required to detect these 
differences would be 1,639 participants for mortality and 8,082 participants for 
myocardial infarction.  
 
5.2.5 Sensitivity analyses 
Emergency surgery is associated with increased risk of adverse postoperative 
outcomes; patients undergoing emergency surgery may be more likely to be 
tachycardic or hypotensive. Therefore, to determine the influence of emergency 
surgery, I excluded all emergency cases and repeated the primary analyses. 
Similarly, patients with atrial fibrillation are at higher risk of postoperative 
cardiovascular complications and may have higher heart rates. Therefore, to 
determine the influence of atrial fibrillation, I repeated the primary heart rate 
analyses after excluding all cases with a previous history of atrial fibrillation. 
Heart rate limiting medications have previously been shown to reduced the risk 
of myocardial infarction after surgery.166 Therefore, I excluded patients that 
received a beta-blocker and/or a calcium channel blocker within 24 hours 
before surgery and repeated the primary analysis of heart rate. In the primary 
analysis I categorised heart rate and systolic blood pressure as either high or 
low and compared this to a pre-defined normal range. However, this did not 
take account of patients who had both a high and low heart rate or systolic 
blood pressure during surgery. Therefore, I undertook a post hoc sensitivity 
analysis where I categorised heart rate as: 55-100 bpm / minimum heart rate < 
55 bpm / maximum heart rate > 100 bpm / minimum heart rate < 55bpm and 
maximum heart rate > 100 bpm; and systolic blood pressure as: 100 – 160 
mmHg / minimum systolic pressure < 100 mmHg / maximum systolic pressure > 
160 mmHg / minimum systolic pressure < 100 mmHg and maximum systolic 
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pressure > 160 mmHg. I repeated the primary analysis to test for association 




To confirm whether the relationships between duration of highest/lowest heart 
rate or systolic blood pressure and myocardial injury was linear or non-linear, I 
undertook additional analyses using fractional polynomial regression using 
STATA version 14 (StataCorp, USA). This technique is described in detail in 







5.3  Results 
16,079 patients were recruited to the VISION study from twelve hospitals in 
eight countries.16 1,197/15,109 patients (7.9%) sustained MINS, 454/16,031 
patients (2.8%) sustained MI and 315/16,061 patients (2.0%) died, within 30 
days of surgery. Baseline characteristics are presented in table 5.1. Cases 
included in multivariable analyses are shown in figure 5.1. 
 
5.3.1 Intraoperative heart rate 
Highest intraoperative heart rate >100 bpm was associated with increased odds 
of MINS (OR 1.27 [1.07 – 1.50]; p <0.01), myocardial infarction (OR 1.34 [1.05 
– 1.70]; p=0.02) and mortality (OR 2.65 [2.06 – 3.41]; p <0.01). Lowest 
intraoperative heart rate <55 bpm was associated with reduced odds of MINS 
(OR 0.70 [0.59 – 0.82]; p <0.01), myocardial infarction (OR 0.75 [0.58 - 0.97]; 
p=0.03) and mortality (OR 0.58 [0.41 – 0.81]; p <0.01) (tables 5.2-5.4 and figure 
3.2). Duration of intraoperative heart rate >100 bpm for longer than 30 minutes 
was associated with MINS (OR 2.22 [1.71 – 2.88]; p <0.01) compared to 
participants with intraoperative heart rate ≤100 bpm (figure 5.3 and table 5.5). 
Heart rate <55 bpm for any duration was associated with reduced odds of MINS 
and there was a trend towards reduced likelihood of MINS as duration of heart 



































Table 5.1. Baseline patient characteristics. Descriptive data stratified by binary thresholds for highest and lowest intraoperative heart rate (HR) and systolic 
blood pressure (SBP), presented as frequencies with percentages (%) or means with standard deviations (SD). Age rounded to nearest whole number. Heart rate in 
beats per minute (bpm) and systolic blood pressure in mmHg. Highest intraoperative heart rate >100 bpm (HR >100); lowest intraoperative heart rate <55 bpm (HR 
<55); Highest systolic blood pressure >160 mmHg (SBP >160); lowest systolic blood pressure <100 mmHg (SBP <100); estimated glomerular filtration rate (eGFR). 
Missing cases shown in figure 5.1. 
	
Intraoperative HR or SBP groups Whole 
cohort 
HR >100 HR <55 SBP >160 SBP <100 
Number of cases (n) 16079 2936 4256 4754 9891 
Mean age (SD) 65 (11.9) 64 (12.3) 65 (11.3) 68 (11.6) 64 (11.6) 
Sex 
     Male (%) 7763 (48.3) 1448 (49.3) 2118
(49.8) 
2197 (46.2) 4702 (47.5) 
Female (%) 8316 (51.7) 1488 (50.7) 2138 
(50.2) 
2557 (53.8) 5189 (52.5) 
Comorbid disorder (%) 
     Atrial fibrillation 545 (3.4) 142 (4.8) 106 (2.5) 171 (3.6) 281 (2.8) 
Diabetes 3153 (19.6) 626 (21.3) 744 (17.5) 1163 (24.5) 1785 (18.0) 
Hypertension 8171 (50.8) 1304 (44.4) 2226 
(52.3) 
2844 (59.8) 4754 (48.1) 
Heart failure 761 (4.7) 121 (4.1) 184 (4.3) 256 (5.4) 405 (4.1) 
Coronary artery disease 1947 (12.1) 247 (8.4) 608 (14.3) 674 (14.2) 1054 (10.7) 
Peripheral vascular disease 858 (5.3) 127 (4.3) 238 (5.6) 316 (6.6) 421 (4.3) 
Previous stroke or transient ischaemic attack 1167 (7.3) 279 (9.5) 317 (7.5) 533 (11.2) 643 (6.5) 
Chronic obstructive pulmonary disease (COPD) 1337 (8.3) 205 (7.0) 269 (6.3) 396 (8.3) 797 (8.1) 
Preoperative eGFR, ml/min/1.73m2 (%) 
     <30  564 (3.5) 131 (4.7) 104 (2.6) 195 (4.3) 311 (3.4) 
30-45  831 (5.2) 171 (6.1) 224 (5.7) 336 (7.4) 459 (5.0) 
45-60  1579 (9.8) 241 (8.6) 457 (11.5) 592 (13.0) 904 (9.9) 
>60  11938 (74.2) 2254 (80.6) 3179 
(80.2) 
3416 (75.3) 7483 (81.7) 
Surgical procedure category (%) 
     Elective 13765 (85.6) 2312 (78.7) 3881
(91.2) 
4020 (84.6) 8512 (86.1) 
Urgent 485 (3.0) 162 (5.5) 83 (2.0) 170 (3.6) 317 (3.2) 
Emergency 1828 (11.4) 462 (15.7) 292 (6.9) 564 (11.9) 1062 (10.7) 
Major surgery (%) 9600 (59.7) 1774 (60.4) 2477 
(58.2) 
2956 (62.2) 6075 (61.4) 
Outcome measures (%) 
     Myocardial injury 1197 (7.4) 257 (9.7) 233 (5.8) 436 (10.0) 711 (7.7) 
Myocardial infarction 454 (2.8) 109 (3.7) 88 (2.1) 185 (2.8) 276 (2.8) 




Table 5.2. Summary multivariable logistic regression models for highest and lowest intraoperative heart rate and systolic blood pressure. 
Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days after surgery. Highest intraoperative heart rate was dichotomised 
according to a threshold of >100 beats per minute (bpm) with heart rate ≤100 bpm as the reference category. Lowest intraoperative heart rate was dichotomised 
according to the threshold of <55 bpm with heart rate ≥55 bpm as the reference category. Highest intraoperative systolic blood pressure was dichotomised according 
to a threshold of >160 mmHg with systolic blood pressure ≤160 mmHg as the reference category. Lowest intraoperative systolic blood pressure was dichotomised 
according to the threshold of <100 mmHg with systolic blood pressure ≥100 mmHg as the reference category. Results of adjusted analyses are presented with 
unadjusted analyses for comparison. Full multi-variable models are presented in tables 5.3, 5.4, 5.7 and 5.8.  
	
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Highest intraoperative heart rate >100 bpm 
      Unadjusted 1.31 (1.14-1.52) <0.01 1.42 (1.15-1.78) <0.01 2.79 (2.21-3.51) <0.01 
Adjusted 1.27 (1.07-1.50) <0.01 1.34 (1.05-1.70) 0.02 2.65 (2.06-3.41) <0.01 
       Lowest intraoperative heart rate <55 bpm 
      Unadjusted 0.66 (0.57-0.76) <0.01 0.66 (0.52-0.84) <0.01 0.51 (0.37-0.69) <0.01 
Adjusted 0.70 (0.59-0.82) <0.01 0.75 (0.58-0.97) 0.03 0.58 (0.41-0.81) <0.01 
       
Highest intraoperative systolic blood pressure >160 mmHg       
Unadjusted 1.48 (1.30-1.67) <0.01 1.67 (1.38-2.03) <0.01 0.96 (0.75-1.23) 0.75 
Adjusted 1.16 (1.01-1.34) 0.04 1.34 (1.09-1.64) 0.01 0.76 (0.58-0.99) 0.04 
       
Lowest intraoperative systolic blood pressure <100mmHg       
Unadjusted 0.94 (0.83-1.06) 0.28 0.97 (0.80-1.17) 0.72 1.49 (1.16-1.91) <0.01 
Adjusted 1.21 (1.05-1.39) 0.01 1.21 (0.98-1.49) 0.07 1.81 (1.39-2.37) <0.01 





Table 5.3. Multivariable logistic regression models for maximum intraoperative heart rate. Dependent variables are myocardial injury, myocardial 
infarction and mortality within 30 days of surgery. Intraoperative heart rate was dichotomised according to a threshold of >100 beat per minute (bpm). Heart rate 
≤100 bpm was the reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years)       
45-64 (reference) - - - - - - 
65-75 1.09 (0.91-1.31) 0.39 1.17 (0.88-1.55) 0.29 1.61 (1.15-2.25) <0.01 
>75 2.06 (1.72-2.45) <0.01 1.87 (1.43-2.45) <0.01 2.35 (1.69-3.27) <0.01 
Male sex 1.37 (1.20-1.57) <0.01 1.02 (0.83-1.26) 0.83 1.18 (0.92-1.51) 0.19 
History of atrial fibrillation 1.58 (1.22-2.06) <0.01 1.33 (0.93-1.90) 0.12 1.00 (0.62-1.62) 0.99 
History of diabetes 1.40 (1.20-1.63) <0.01 1.22 (0.98-1.53) 0.08 1.02 (0.77-1.37) 0.88 
History of hypertension 1.31 (1.12-1.54) <0.01 1.39 (1.08-1.77) 0.01 0.99 (0.75-1.30) 0.92 
History of heart failure 1.60 (1.27-2.00) <0.01 1.70 (1.27-2.30) <0.01 1.45 (0.97-2.19) 0.07 
History of coronary artery disease 1.45 (1.23-1.72) <0.01 2.21 (1.76-2.78) <0.01 0.96 (0.69-1.34) 0.81 
History of peripheral vascular disease 2.17 (1.77-2.65) <0.01 2.13 (1.62-2.81) <0.01 1.84 (1.27-2.65) <0.01 
History of stroke or transient ischaemic attack 1.43 (1.18-1.74) <0.01 1.11 (0.83-1.48) 0.47 1.40 (1.00-1.96) 0.05 
History of chronic obstructive pulmonary disease 1.22 (1.00-1.50) 0.05 1.15 (0.86-1.53) 0.35 2.09 (1.52-2.86) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 10.76 (8.72-13.29) <0.01 4.01 (2.98-5.38) <0.01 3.03 (2.07-4.42) <0.01 
30-44 2.50 (2.02-3.10) <0.01 1.72 (1.25-2.37) <0.01 1.65 (1.11-2.44) 0.01 
45-60 1.68 (1.39-2.04) <0.01 1.42 (1.06-1.90) 0.02 0.99 (0.67-1.47) 0.97 
>60 (reference) - - - - - - 
Neurosurgery 1.12 (0.85-1.48) 0.42 0.57 (0.34-0.97) 0.04 1.70 (1.10-2.63) 0.02 
Urgent or emergency surgery 1.93 (1.64-2.27) <0.01 2.29 (1.83-2.87) <0.01 3.46 (2.69-4.44) <0.01 
Major surgery 1.66 (1.42-1.94) <0.01 2.21 (1.72-2.83) <0.01 1.57 (1.18-2.10) <0.01 
Maximum intraoperative heart rate (bpm) 
      >100 1.27 (1.07-1.50) <0.01 1.34 (1.05-1.70) 0.02 2.65 (2.06-3.41) <0.01 







Table 5.4. Multivariable logistic regression models for minimum intraoperative heart rate. Dependent variables are myocardial injury, myocardial 
infarction and mortality within 30 days of surgery. Intraoperative heart rate was dichotomised according to a threshold of <55 beats per minute (bpm). Heart rate ≥55 
bpm was the reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years)       
45-64 (reference) - - - - - - 
65-75 1.09 (0.91-1.31) 0.35 1.17 (0.88-1.55) 0.29 1.54 (1.10-2.15) 0.01 
>75 2.05 (1.72-2.44) <0.01 1.86 (1.42-2.43) <0.01 2.22 (1.60-3.09) <0.01 
Male sex 1.39 (1.21-1.59) <0.01 1.03 (0.84-1.27) 0.75 1.22 (0.96-1.56) 0.11 
History of atrial fibrillation 1.59 (1.23-2.07) <0.01 1.35 (0.95-1.93) 0.10 1.11 (0.69-1.78) 0.66 
History of diabetes 1.39 (1.20-1.62) <0.01 1.22 (0.98-1.53) 0.08 1.03 (0.77-1.38) 0.83 
History of hypertension 1.31 (1.12-1.53) <0.01 1.38 (1.08-1.76) 0.01 0.96 (0.73-1.26) 0.75 
History of heart failure 1.58 (1.25-1.98) <0.01 1.68 (1.24-2.26) <0.01 1.37 (0.91-2.06) 0.13 
History of coronary artery disease 1.46 (1.23-1.73) <0.01 2.20 (1.75-2.77) <0.01 0.90 (0.65-1.26) 0.55 
History of peripheral vascular disease 2.17 (1.77-2.65) <0.01 2.11 (1.60-2.79) <0.01 1.79 (1.24-2.57) <0.01 
History of stroke or transient ischaemic attack 1.46 (1.20-1.77) <0.01 1.13 (0.85-1.51) 0.41 1.52 (1.09-2.12) 0.01 
History of chronic obstructive pulmonary disease 1.19 (0.97-1.45) 0.10 1.12 (0.84-1.50) 0.44 1.98 (1.45-2.70) <0.01 
Preoperative eGFR (ml/min/1.73m2) 
      <30 10.71 (8.67-13.23) <0.01 4.01 (2.98-5.39) <0.01 3.15 (2.16-4.59) <0.01 
30-44 2.54 (2.05-3.15) <0.01 1.74 (1.26-2.40) <0.01 1.71 (1.16-2.53) <0.01 
45-60 1.69 (1.40-2.05) <0.01 1.43 (1.07-1.91) 0.02 0.98 (0.66-1.45) 0.91 
>60 (reference) - - - - - - 
Neurosurgery 1.17 (0.88-1.54) 0.28 0.59 (0.35-0.99) 0.05 1.72 (1.11-2.66) 0.02 
Urgent or emergency surgery 1.89 (1.61-2.22) <0.01 2.30 (1.83-2.88) <0.01 3.71 (2.89-4.75) <0.01 
Major surgery 1.66 (1.42-1.93) <0.01 2.20 (1.71-2.81) <0.01 1.60 (1.20-2.14) <0.01 
Minimum intraoperative heart rate (bpm) 
      <55 0.70 (0.59-0.82) <0.01 0.75 (0.58-0.97) 0.03 0.58 (0.41-0.81) <0.01 







Table 5.5 Full adjusted logistic regression model for duration of intraoperative 
heart rate >100 beats per minute. Multivariable logistic regression analysis. Dependent 
variable is myocardial injury within 30 days of surgery. Duration of heart rate >100 beats per 
minute (bpm) was stratified into quartiles. The reference group was participants with heart rate ≤ 
100 beats per minute. Estimated glomerular filtration rate (eGFR).  
 
Covariates odds ratio p-value 
Age (years) 
  45-64 (reference) - - 
65-75 1.10 (0.91-1.32) 0.33 
>75 2.09 (1.75-2.49) <0.01 
Male sex 1.37 (1.19-1.57) <0.01 
Comorbid disease 
  Atrial fibrillation 1.54 (1.19-2.01) <0.01 
Diabetes 1.39 (1.19-1.62) <0.01 
Hypertension 1.32 (1.12-1.54) <0.01 
Heart failure 1.59 (1.27-2.00) <0.01 
Coronary artery disease 1.45 (1.23-1.72) <0.01 
Peripheral vascular disease 2.16 (1.76-2.54) <0.01 
Previous stroke or transient ischaemic attack 1.43 (1.18-1.74) <0.01 
Chronic obstructive pulmonary disease 1.22 (1.00-1.49) 0.05 
eGFR (ml/min/1.73m2) 
  <30 10.47 (8.47-12.94) <0.01 
30-45 2.45 (1.97-3.03) <0.01 
45-60 1.68 (1.38-2.03) <0.01 
>60 (reference) - - 
Neurosurgery 1.13 (0.86-1.49) 0.38 
Urgent or emergency surgery 1.89 (1.60-2.23) <0.01 
Major surgery 1.63 (1.40-1.91) <0.01 
Duration of heart rate >100 bpm 
  <5 minutes 0.92 (0.67-1.25) 0.58 
5 - 10 mintues 0.93 (0.62-1.38) 0.71 
11 - 30 minutes 1.07 (0.79-1.46) 0.66 
>30 minutes 2.22 (1.71-2.88) <0.01 





Table 5.6. Full adjusted logistic regression model for duration of intraoperative 
heart rate <55 beats per minute. Multivariable logistic regression analysis. Dependent 
variable is myocardial injury within 30 days of surgery.  Duration of heart rate <55 beats per 
minute (bpm) was stratified into quartiles. The reference group was participants with heart rate ≥ 
55 beats per minute. Estimated glomerular filtration rate (eGFR).  
 
Covariates odds ratio p-value 
Age 
  45-64 ref ref 
65-75 1.09 (0.91-1.31) 0.35 
>75 2.05 (1.72-2.44) <0.01 
Male sex 1.39 (1.21-1.59) <0.01 
Comorbid disease 
  Existing atrial fibrillation 1.59 (1.23-2.07) <0.01 
Diabetes 1.39 (1.20-1.62) <0.01 
Hypertension 1.31 (1.12-1.54) <0.01 
Heart failure 1.57 (1.25-1.98) <0.01 
Coronary artery disease 1.46 (1.24-1.73) <0.01 
Peripheral vascular disease 2.17 (1.77-2.66) <0.01 
Previous stroke or transient ischaemic attack 1.46 (1.20-1.77) <0.01 
Chronic obstructive pulmonary disease 1.18 (0.97-1.45) 0.10 
eGFR (ml/min/1.73m2) 
  <30 10.70 (8.66-13.22) <0.01 
30-45 2.54 (2.05-3.15) <0.01 
45-60 1.70 (1.40-2.05) <0.01 
>60 ref ref 
Neurosurgery 1.17 (0.89-2.05) 0.26 
Urgent or emergency surgery 1.89 (1.61-2.23) <0.01 
Major surgery 1.66 (1.42-1.94) <0.01 
Duration of heart rate <55 bpm 
  <14 minutes 0.72 (0.53-0.98) 0.04 
14 - 30 minutes 0.75 (0.57-1.00) 0.05 
31 - 65 minutes 0.69 (0.51-0.95) 0.02 
> 65 minutes 0.64 (0.47-0.86) <0.01 





Figure 5.2. Forest plot summarizing multivariable logistic regression models for highest and lowest intraoperative heart rate (HR) and 
systolic blood pressure (SBP). Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days after surgery. Highest 
intraoperative heart rate was dichotomised according to a threshold of >100 beats per minute (bpm) with heart rate ≤100 bpm as the reference category. Lowest 
intraoperative heart rate was dichotomised according to the threshold of <55 bpm with heart rate ≥55 bpm as the reference category. Highest intraoperative systolic 
blood pressure was dichotomised according to a threshold of >160 mmHg with systolic blood pressure ≤160 mmHg as the reference category. Lowest intraoperative 
systolic blood pressure was dichotomised according to the threshold of <100 mmHg with systolic blood pressure ≥100 mmHg as the reference category. The x-axis 







Figure 5.3. Forest plot summarizing multivariable logistic regression models for 
the duration of high/low intraoperative heart rate (HR) and systolic blood 
pressure (SBP). The dependent variable was myocardial injury within 30 days after surgery. 
There were four separate regression models for duration of: intraoperative heart rate >100 
beats per minute (bpm), intraoperative heart rate <55 bpm intraoperative systolic blood 
pressure >160 mmHg and intraoperative systolic blood pressure <100 mmHg. For each model, 
duration was stratified into four approximately equal quartiles. The reference categories were 
patients with ‘normal’ heart rate or systolic blood pressure, for example in the analysis of 
duration of heart rate > 100 bpm, the reference group was patients with heart rate ≤ 100 bpm. 
The x-axis shows odds ratios and the error bars show 95% confidence intervals. The full 
multivariable regression models are presented in tables 5.5, 5.6, 5.9 and 5.10. 
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5.3.2 Intraoperative systolic blood pressure 
Highest intraoperative systolic blood pressure >160mmHg was associated with 
increased odds of MINS (OR 1.16 [1.01 – 1.34]; p=0.04) and myocardial 
infarction (OR 1.34 [1.09 – 1.64]; p=0.01) and reduced odds of mortality (OR 
0.76 [0.58 – 0.99]; p=0.04). Lowest intraoperative systolic blood pressure 
<100mmHg was associated with increased odds of MINS (OR 1.21 [1.05 – 
1.39]; p=0.01) and mortality (OR 1.81 [1.39 – 2.37]; p <0.01), but was not 
associated with myocardial infarction (OR 1.21 [0.98-1.49]; p=0.07) (table 5.2, 
5.7 and 5.8, and figure 5.2). Duration of systolic blood pressure >160 mmHg 
was not associated with MINS (figure 5.3 and table 5.9). In comparison, 
duration of systolic blood pressure <100 mmHg for <15 minutes or >61 minutes 
was associated with MINS (OR 1.26 [1.04-1.54]; p=0.02 and OR 1.33 [1.08-










Table 5.7. Full adjusted logistic regression model for highest intraoperative systolic blood pressure. Multivariable logistic regression analysis. 
Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative systolic blood pressure was dichotomised 
according to a threshold of >160 mmHg. Systolic blood pressure ≤160 mmHg was the reference category. Estimated glomerular filtration rate (eGFR).  
 
 Myocardial Injury Myocardial Infarction Mortality 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Age (years)       
45-64 (reference) - - - - - - 
65-75 1.07 (0.89-1.29) 0.46 1.14 (0.85-1.52) 0.39 1.59 (1.14-2.22) <0.01 
>75 2.06 (1.72-2.47) <0.01 1.82 (1.39-2.39) <0.01 2.29 (1.64-3.19) <0.01 
Male sex 1.35 (1.18-1.56) <0.01 1.01 (0.82-1.24) 0.96 1.16 (0.91-1.49) 0.23 
History of atrial fibrillation 1.68 (1.29-2.19) <0.01 1.44 (1.01-2.06) 0.05 1.10 (0.68-1.78) 0.71 
History of diabetes 1.38 (1.18-1.61) <0.01 1.23 (0.98-1.54) 0.08 1.03 (0.77-1.39) 0.83 
History of hypertension 1.30 (1.11-1.53) <0.01 1.36 (1.06-1.74) 0.02 0.97 (0.73-1.27) 0.81 
History of heart failure 1.55 (1.23-1.96) <0.01 1.65 (1.22-2.24) <0.01 1.33 (0.88-2.02) 0.18 
History of coronary artery disease 1.44 (1.22-1.71) <0.01 2.12 (1.68-2.68) <0.01 0.88 (0.63-1.23) 0.46 
History of peripheral vascular disease 2.25 (1.83-2.76) <0.01 2.22 (1.68-2.92) <0.01 1.86 (1.29-2.68) <0.01 
History of stroke or transient ischaemic attack 1.46 (1.20-1.78) <0.01 1.14 (0.86-1.52) 0.37 1.60 (1.14-2.24) <0.01 
History of chronic obstructive pulmonary disease 1.22 (0.99-1.49) 0.06 1.19 (0.89-1.59) 0.25 1.93 (1.41-2.66) <0.01 
Preoperative eGFR (ml/min/1.73m2)       
<30 10.76 (8.69-13.32) <0.01 4.01 (2.97-5.41) <0.01 3.25 (2.23-4.75) <0.01 
30-44 2.51 (2.02-3.12) <0.01 1.75 (1.27-2.42) <0.01 1.70 (1.14-2.53) <0.01 
45-60 1.63 (1.34-1.97) <0.01 1.39 (1.03-1.86) 0.03 0.92 (0.62-1.38) 0.70 
>60 (reference) - - - - - - 
Neurosurgery 1.13 (0.86-1.50) 0.38 0.59 (0.35-0.99) 0.05 1.67 (1.08-2.59) 0.02 
Urgent or emergency surgery 1.99 (1.69-2.34) <0.01 2.35 (1.88-2.95) <0.01 3.95 (3.08-5.07) <0.01 
Major surgery 1.67 (1.43-1.95) <0.01 2.16 (1.69-2.77) <0.01 1.66 (1.24-2.22) <0.01 
Maximum intraoperative systolic blood pressure (mmHg)       
>160 1.16 (1.01-1.34) 0.04 1.34 (1.09-1.64) 0.01 0.76 (0.58-0.99) 0.04 






Table 5.8. Full adjusted logistic regression model for lowest intraoperative systolic blood pressure. Multivariable logistic regression analysis. 
Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative systolic blood pressure was dichotomised 
according to a threshold of <100 mmHg. Systolic blood pressure ≥100 mmHg was the reference category. Estimated glomerular filtration rate (eGFR). 
 
		 Myocardial	Injury	 Myocardial	Infarction	 Mortality	
Covariates	 odds	ratio	 p-value	 odds	ratio	 p-value	 odds	ratio	 p-value	
Age	(years)	 	 	 	 	 	 	
45-64	(reference)	 -	 -	 -	 -	 -	 -	
65-75	 1.09	(0.91-1.32)	 0.36	 1.16	(0.87-1.55)	 0.32	 1.62	(1.16-2.26)	 0.01	
>75	 2.13	(1.78-2.55)	 <0.01	 1.91	(1.45-2.50)	 <0.01	 2.39	(1.71-3.33)	 <0.01	
Male	sex	 1.35	(1.17-1.55)	 <0.01	 1.00	(0.81-1.23)	 0.99	 1.19	(0.93-1.52)	 0.17	
History	of	atrial	fibrillation	 1.68	(1.29-2.19)	 <0.01	 1.41	(0.98-2.02)	 0.06	 1.19	(0.74-1.91)	 0.48	
History	of	diabetes	 1.40	(1.20-1.63)	 <0.01	 1.23	(0.98-1.55)	 0.07	 1.04	(0.78-1.40)	 0.78	
History	of	hypertension	 1.32	(1.12-1.55)	 <0.01	 1.40	(1.09-1.80)	 0.01	 0.97	(0.73-1.27)	 0.97	
History	of	heart	failure	 1.56	(1.24-1.97)	 <0.01	 1.65	(1.22-2.23)	 <0.01	 1.38	(0.91-2.09)	 0.13	
History	of	coronary	artery	disease	 1.45	(1.22-1.72)	 <0.01	 2.13	(1.69-2.69)	 <0.01	 0.91	(0.66-1.27)	 0.59	
History	of	peripheral	vascular	disease	 2.29	(1.87-2.81)	 <0.01	 2.25	(1.70-2.97)	 <0.01	 1.91	(1.32-2.75)	 <0.01	
History	of	stroke	or	transient	ischaemic	attack	 1.48	(1.21-1.80)	 <0.01	 1.17	(0.88-1.56)	 0.29	 1.57	(1.12-2.20)	 0.01	
History	of	chronic	obstructive	pulmonary	disease	 1.20	(0.98-1.47)	 0.08	 1.15	(0.86-1.54)	 0.35	 1.92	(1.40-2.64)	 <0.01	
Preoperative	eGFR	(ml/min/1.73m2)	 	 	 	 	 	 	
<30	 10.82	(8.74-13.40)	 <0.01	 4.00	(2.96-5.39)	 <0.01	 3.26	(2.23-4.76)	 <0.01	
30-44	 2.52	(2.03-3.13)	 <0.01	 1.76	(1.28-2.43)	 <0.01	 1.73	(1.17-2.57)	 0.01	
45-60	 1.63	(1.34-1.98)	 <0.01	 1.39	(1.04-1.87)	 0.03	 0.91	(0.61-1.37)	 0.66	
>60	(reference)	 -	 -	 -	 -	 -	 -	
Neurosurgery	 1.13	(0.86-1.50)	 0.38	 0.60	(0.36-1.00)	 0.05	 1.58	(1.02-2.44)	 0.04	
Urgent	or	emergency	surgery	 1.99	(1.69-2.34)	 <0.01	 2.35	(1.88-2.95)	 <0.01	 3.89	(3.04-4.99)	 <0.01	
Major	surgery	 1.66	(1.42-1.94)	 <0.01	 2.15	(1.67-2.75)	 <0.01	 1.61	(1.20-2.16)	 <0.01	
Minimum	intraoperative	systolic	blood	pressure	(mmHg)	 	 	 	 	 	 	
<100	 1.21	(1.05-1.39)	 0.01	 1.21	(0.98-1.49)	 0.07	 1.81	(1.39-2.37)	 <0.01	





Table 5.9. Full adjusted logistic regression model for duration of intraoperative 
systolic blood pressure >160 mmHg. Multivariable logistic regression analysis. 
Dependent variable is myocardial injury within 30 days of surgery.  Duration of systolic blood 
pressure (SBP) >160 mmHg was stratified into quartiles. The reference group was participants 
with SBP ≤160 mmHg. Estimated glomerular filtration rate (eGFR).  
	
Covariates odds ratio p-value 
Age 
  45-64 ref ref 
65-75 1.07 (0.89-1.29) 0.47 
>75 2.00 (1.68-2.39) <0.01 
Male sex 1.38 (1.21-1.59) <0.01 
Comorbid disease 
  Existing atrial fibrillation 1.64 (1.26-2.13) <0.01 
Diabetes 1.40 (1.20-1.63) <0.01 
Hypertension 1.29 (1.10-1.51) <0.01 
Heart failure 1.59 (1.26-1.99) <0.01 
Coronary artery disease 1.43 (1.21-1.69) <0.01 
Peripheral vascular disease 2.15 (1.76-2.63) <0.01 
Previous stroke or transient ischaemic attack 1.44 (1.18-1.75) <0.01 
Chronic obstructive pulmonary disease 1.23 (1.01-1.50) 0.04 
eGFR (ml/min/1.73m2) 
  <30 10.87 (8.80-13.42) <0.01 
30-45 2.51 (2.02-3.11) <0.01 
45-60 1.67 (1.38-2.02) <0.01 
>60 ref ref 
Neurosurgery 1.11 (0.84-1.46) 0.48 
Urgent or emergency surgery 1.98 (1.69-2.33) <0.01 
Major surgery 1.67 (1.43-1.94) <0.01 
Duration of systolic blood pressure >160 mmHg 
  <6 minutes 1.20 (0.95-1.52) 0.13 
6 - 12 minutes 1.19 (0.92-1.53) 0.18 
13 - 25 minutes 1.11 (0.89-1.38) 0.38 
>25 minutes 1.16 (0.92-1.48) 0.21 




Table 5.10. Full adjusted logistic regression model for duration of intraoperative 
systolic blood pressure <100 mmHg. Multivariable logistic regression analysis. 
Dependent variable is myocardial injury within 30 days of surgery.  Duration of systolic blood 
pressure (SBP) <100 mmHg was stratified into quartiles. The reference group was participants 
with SBP ≥100 mmHg. Estimated glomerular filtration rate (eGFR).  
	
Covariates odds ratio p-value 
Age 
  45-64 ref ref 
65-75 1.10 (0.91-1.32) 0.34 
>75 2.09 (1.75-2.50) <0.01 
Male sex 1.38 (1.20-1.58) <0.01 
Comorbid disease 
  Existing atrial fibrillation 1.63 (1.25-2.12) <0.01 
Diabetes 1.41 (1.21-1.64) <0.01 
Hypertension 1.31 (1.12-1.53) <0.01 
Heart failure 1.58 (1.26-1.99) <0.01 
Coronary artery disease 1.44 (1.22-1.71) <0.01 
Peripheral vascular disease 2.18 (1.78-2.67) <0.01 
Previous stroke or transient ischaemic attack 1.47 (1.21-1.78) <0.01 
Chronic obstructive pulmonary disease 1.21 (0.99-1.u48) 0.06 
eGFR (ml/min/1.73m2) 
  <30 10.92 (8.84-13.49) <0.01 
30-45 2.52 (2.03-3.12) <0.01 
45-60 1.67 (1.38-2.03) <0.01 
>60 ref ref 
Neurosurgery 1.10 (0.83-1.45) 0.50 
Urgent or emergency surgery 1.99 (1.70-2.35) <0.01 
Major surgery 1.64 (1.41-1.91) <0.01 
Duration of systolic blood pressure <100 mmHg 
  <15 minutes 1.26 (1.04-1.54) 0.02 
15 - 30 minutes 1.10 (0.91-1.33) 0.33 
31 - 61 minutes 1.05 (0.84-1.30) 0.69 
>61 minutes 1.33 (1.08-1.64) <0.01 





5.3.3 Intraoperative heart rate and systolic blood pressure 
The association between heart rate (HR) and myocardial injury was modified by 
systolic blood pressure (SBP); shown in figure 5.4 and tables 5.11-5.14. The 
incidence of MINS in patients with hypotension (SBP <100 mmHg) and 
tachycardia (HR >100bpm) was 176/1906 (9.2%) and had higher odds of MINS 
(OR 1.42 [1.15-1.76]; p<0.01), compared to patients with hypotension in the 
absence of tachycardia (499/6632 [7.5%]; OR 1.20 [1.03-1.40]; p=0.02) or 
patients with tachycardia in the absence of hypotension (76/736 [10.3%]; OR 
1.26 [0.94-1.69]; p=0.13), where the reference group was patients without 
hypotension or tachycardia. Patients with hypertension (SBP >160 mmHg) 
without bradycardia (HR <55 bpm) were at increased risk of MINS (326/2802 
[11.6%]; OR 1.22 (1.04-1.43); p=0.02). However, bradycardia was associated 
with less risk of MINS, regardless of highest systolic blood pressure (figure 5.4). 








Figure 5.4. Forest plot summarising multivariable logistic regression models for 
combinations of highest/lowest intraoperative systolic blood pressure (SBP) and 
heart ate (HR). The dependent variable was myocardial injury within 30 days after surgery. 
The sample was categorised according to highest intraoperative systolic blood pressure (SBP) 
>160 mmHg, lowest intraoperative SBP <100 mmHg, highest intraoperative heart rate (HR) 
>100 beats per minute (bpm) and lowest intraoperative HR <55 bpm. For highest SBP and HR 
the reference group was SBP ≤160 & HR ≤100, for lowest SBP and highest HR the reference 
group was SBP ≥100 & HR ≤100, for highest SBP and lowest HR the reference group was SBP 
≤160 & HR ≥55 and for lowest SBP and lowest HR the reference group was SBP ≥100 & HR 
≥55. The x-axis shows odds ratios and the error bars show 95% confidence intervals. The 
results presented are summaries of adjusted analyses (as per the primary analysis). Full multi-




Table 5.11. Multivariable logistic regression model for combinations of high 
intraoperative systolic blood pressure and high heart rate. The dependent variable is 
myocardial injury within 30 days after surgery. The sample was categorised according to 
highest intraoperative systolic blood pressure (SBP) >160 mmHg, and highest intraoperative 
heart rate (HR) >100 beats per minute (bpm).  The reference group was SBP ≤160mmHg and 
heart rate ≤100 bpm. The analysis was corrected for potentially confounding factors; estimated 
glomerular filtration rate (eGFR). Results presented as odds ratios with 95% confidence 
intervals (95% CI) with lower and upper bounds shown. 
 
  Myocardial Injury 
    95% CI   
Covariates odds ratio Lower Upper p-value 
Age (years) 
    45-64 (reference) - - - - 
65-75 1.09 0.90 1.31 0.39 
>75 2.09 1.75 2.50 0.00 
Male sex 1.35 1.18 1.55 0.00 
Comorbid disease 
    Existing atrial fibrillation 1.65 1.27 2.15 0.00 
Diabetes 1.37 1.17 1.60 0.00 
Hypertension 1.31 1.12 1.54 0.00 
Heart failure 1.57 1.24 1.97 0.00 
Coronary artery disease 1.46 1.23 1.73 0.00 
Peripheral vascular disease 2.27 1.85 2.78 0.00 
Previous stroke or transient ischaemic attack 1.45 1.19 1.76 0.00 
Chronic obstructive pulmonary disease 1.22 1.00 1.50 0.05 
eGFR (ml/min/1.73m2) 
    <30 10.59 8.55 13.1
1 
0.00 
30-45 2.49 2.01 3.10 0.00 
45-60 1.63 1.34 1.98 0.00 
>60 (reference) - - - - 
Neurosurgery 1.14 0.86 1.51 0.36 
Urgent or emergency surgery 1.94 1.65 2.29 0.00 
Major surgery 1.66 1.42 1.95 0.00 
Maximum SBP and maximum HR 
    SBP ≤160 & HR ≤100 (reference) - - - - 
SBP >160 & HR ≤100 1.22 1.04 1.43 0.02 
SBP ≤160 & HR >100 1.40 1.11 1.75 0.00 
SBP >160 & HR >100 1.23 0.98 1.54 0.07 




Table 5.12. Multivariable logistic regression model for combinations of low 
intraoperative systolic blood pressure and high heart rate. The dependent variable is 
myocardial injury within 30 days after surgery. The sample was categorised according to lowest 
intraoperative systolic blood pressure (SBP) <100 mmHg, and highest intraoperative heart rate 
(HR) >100 beats per minute (bpm).  The reference group was SBP ≥100mmHg and heart rate 
≤100 bpm. The analysis was corrected for potentially confounding factors; estimated glomerular 
filtration rate (eGFR). Results presented as odds ratios with 95% confidence intervals (95% CI) 
with lower and upper bounds shown. 
 
  Myocardial Injury 
    95% CI   
Covariates odds ratio Lower Upper p-value 
Age (years) 
    45-64 (reference) - - - - 
65-75 1.10 0.92 1.33 0.30 
>75 2.16 1.80 2.58 0.00 
Male sex 1.35 1.17 1.55 0.00 
Comorbid disease 
    Existing atrial fibrillation 1.63 1.25 2.13 0.00 
Diabetes 1.38 1.19 1.61 0.00 
Hypertension 1.33 1.13 1.56 0.00 
Heart failure 1.57 1.24 1.97 0.00 
Coronary artery disease 1.47 1.24 1.74 0.00 
Peripheral vascular disease 2.30 1.88 2.83 0.00 
Previous stroke or transient ischaemic attack 1.47 1.21 1.79 0.00 
Chronic obstructive pulmonary disease 1.21 0.98 1.48 0.07 
eGFR (ml/min/1.73m2) 
    <30 10.70 8.64 13.25 0.00 
30-45 2.52 2.02 3.13 0.00 
45-60 1.64 1.35 1.99 0.00 
>60 (reference) - - - - 
Neurosurgery 1.14 0.86 1.51 0.37 
Urgent or emergency surgery 1.95 1.65 2.29 0.00 
Major surgery 1.65 1.41 1.93 0.00 
Maximum SBP and maximum HR 
    SBP ≥100 & HR ≤100 (reference) - - - - 
SBP <100 & HR ≤100 1.20 1.03 1.40 0.02 
SBP ≥100 & HR >100 1.26 0.94 1.69 0.13 
SBP <100 & HR >100 1.42 1.15 1.76 0.00 




Table 5.13. Multivariable logistic regression model for combinations of high 
intraoperative systolic blood pressure and low heart rate. The dependent variable is 
myocardial injury within 30 days after surgery. The sample was categorised according to 
highest intraoperative systolic blood pressure (SBP) >160 mmHg, and lowest intraoperative 
heart rate (HR) <55 bpm.  The reference group was SBP ≤160mmHg and heart rate ≥55 bpm. 
The analysis was corrected for potentially confounding factors; estimated glomerular filtration 
rate (eGFR). Results presented as odds ratios with 95% confidence intervals (95% CI) with 
lower and upper bounds shown. 
	
  Myocardial Injury 
    95% CI   
Covariates odds ratio Lower Upper p-value 
Age (years) 
    45-64 (reference) - - - - 
65-75 1.09 0.90 1.31 0.38 
>75 2.08 1.74 2.49 0.00 
Male sex 1.37 1.19 1.57 0.00 
Comorbid disease 
    Existing atrial fibrillation 1.65 1.27 2.15 0.00 
Diabetes 1.36 1.17 1.59 0.00 
Hypertension 1.31 1.12 1.54 0.00 
Heart failure 1.55 1.23 1.95 0.00 
Coronary artery disease 1.47 1.24 1.75 0.00 
Peripheral vascular disease 2.27 1.85 2.79 0.00 
Previous stroke or transient ischaemic attack 1.46 1.20 1.77 0.00 
Chronic obstructive pulmonary disease 1.18 0.96 1.45 0.11 
eGFR (ml/min/1.73m2) 
    <30 10.61 8.57 13.14 0.00 
30-45 2.52 2.03 3.13 0.00 
45-60 1.64 1.35 1.99 0.00 
>60 (reference) - - - - 
Neurosurgery 1.18 0.89 1.57 0.24 
Urgent or emergency surgery 1.88 1.59 2.22 0.00 
Major surgery 1.66 1.42 1.94 0.00 
Maximum SBP and maximum HR 
    SBP ≤160 & HR ≥55 (reference) - - - - 
SBP >160 & HR ≥55 1.22 1.04 1.43 0.02 
SBP ≤160 & HR <55 0.70 0.56 0.87 0.00 
SBP >160 & HR <55 0.78 0.61 0.99 0.05 




Table 5.14. Multivariable logistic regression model for combinations of low 
intraoperative systolic blood pressure and low heart rate. The dependent variable is 
myocardial injury within 30 days after surgery. The sample was categorised according to 
highest intraoperative systolic blood pressure (SBP) <100 mmHg, and lowest intraoperative 
heart rate (HR) <55 bpm.  The reference group was SBP ≥100mmHg and heart rate ≥55 bpm. 
The analysis was corrected for potentially confounding factors; estimated glomerular filtration 
rate (eGFR). Results presented as odds ratios with 95% confidence intervals (95% CI) with 
lower and upper bounds shown. 
 
  Myocardial Injury 
    95% CI   
Covariates odds ratio Lower Upper p-value 
Age (years) 
    45-64 (reference) - - - - 
65-75 1.11 0.92 1.34 0.26 
>75 2.17 1.82 2.60 0.00 
Male sex 1.36 1.18 1.56 0.00 
Comorbid disease 
    Existing atrial fibrillation 1.64 1.26 2.13 0.00 
Diabetes 1.38 1.18 1.61 0.00 
Hypertension 1.33 1.13 1.56 0.00 
Heart failure 1.55 1.23 1.95 0.00 
Coronary artery disease 1.49 1.25 1.77 0.00 
Peripheral vascular disease 2.32 1.89 2.85 0.00 
Previous stroke or transient ischaemic attack 1.49 1.23 1.82 0.00 
Chronic obstructive pulmonary disease 1.16 0.95 1.42 0.15 
eGFR (ml/min/1.73m2) 
    <30 10.65 8.60 13.20 0.00 
30-45 2.55 2.05 3.17 0.00 
45-60 1.65 1.36 2.00 0.00 
>60 (reference) - - - - 
Neurosurgery 1.19 0.90 1.58 0.22 
Urgent or emergency surgery 1.88 1.59 2.22 0.00 
Major surgery 1.64 1.40 1.92 0.00 
Maximum SBP and maximum HR 
    SBP ≥100 & HR ≥55 (reference) - - - - 
SBP <100 & HR ≥55 1.22 1.04 1.42 0.02 
SBP ≥100 & HR <55 0.60 0.44 0.81 0.00 
SBP <100 & HR <55 0.85 0.69 1.05 0.13 





5.3.4  Sensitivity analyses 
When I repeated the primary analyses excluding 1828 participants undergoing 
emergency surgery, the results were similar (tables 5.15-5.18). When the 
primary heart rate analysis was repeated excluding 2727 participants that 
received either a beta-blocker or rate-limiting calcium channel blocker within 24 
hours before surgery, the results were very similar (tables 5.19 and 5.20). 
However, the association between the lowest intraoperative heart rate <55 bpm 
and reduced mortality was no longer statistically significant (OR 0.71 [0.49 – 
1.03]; p=0.07). When the primary heart rate analysis was repeated excluding 
545 participants with pre-existing atrial fibrillation, the results were very similar 
(tables 5.21 and 5.22). However, the association between highest intraoperative 
heart rate >100 bpm and MI was only a trend (OR 1.29 [0.99 – 1.67]; p=0.06). A 
post-hoc analysis that categorised heart rate and SBP into two four-level 
categorical variables (table 5.23) generated similar results to the primary 
analysis (tables 5.24 and 5.25), except that the association between maximum 
SBP >160 mmHg and MINS was no longer statistically significant (OR 1.22 
[0.97-1.52]; p=0.08). The combination of minimum SBP <100 mmHg and 
maximum SBP >160 mmHg was associated with MINS (OR 1.42 [1.16-1.75]; 
p<0.01). However, the combination of minimum heart rate <55 bpm and 
maximum heart rate >100 bpm was not associated with MINS (OR 0.70 [0.44-
1.13]; p=0.15). To account for possible increased type I error associated with 
multiple comparisons in the analysis of duration of high or low HR/SBP, I 
undertook Bonferroni corrections. The results remained similar: longest 
durations of SBP <100 mmHg (>61 minutes), HR >100 bpm (>30 mins) and HR 
<55 bpm (>55 mins) remained associated with MINS. However, associations 




Table 5.15. Sensitivity analysis excluding participants undergoing emergency surgery. Multivariable logistic regression models for highest 
intraoperative heart rate. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative heart rate was 
dichotomised according to a threshold of >100 beat per minute (bpm). Heart rate ≤100 bpm was the reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.10 0.90 1.34 0.35 1.22 0.88 1.68 0.23 1.69 1.15 2.49 0.01 
>75 2.08 1.72 2.53 <0.01 2.24 1.65 3.04 <0.01 2.52 1.70 3.73 <0.01 
Male sex 1.38 1.19 1.61 <0.01 1.05 0.83 1.32 0.70 1.24 0.92 1.67 0.16 
Comorbid disease 
            History of atrial fibrillation 1.93 1.46 2.55 <0.01 1.51 1.02 2.25 0.04 1.16 0.67 2.03 0.60 
History of diabetes 1.34 1.13 1.59 <0.01 1.17 0.90 1.51 0.24 0.90 0.63 1.28 0.55 
History of hypertension 1.24 1.04 1.48 0.02 1.24 0.94 1.64 0.13 1.03 0.74 1.44 0.85 
History of heart failure 1.47 1.14 1.89 <0.01 1.47 1.04 2.08 0.03 1.14 0.68 1.91 0.63 
History of coronary artery disease 1.53 1.28 1.84 <0.01 2.38 1.84 3.09 <0.01 1.14 0.77 1.67 0.51 
History of peripheral vascular disease 2.04 1.63 2.55 <0.01 2.14 1.56 2.92 <0.01 1.49 0.94 2.38 0.09 
History of stroke or transient ischaemic attack 1.47 1.19 1.83 <0.01 1.13 0.81 1.57 0.48 1.68 1.14 2.49 0.01 
History of chronic obstructive pulmonary disease 1.28 1.03 1.59 0.03 1.12 0.81 1.56 0.48 2.33 1.63 3.35 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 11.84 9.37 14.98 <0.01 4.11 2.90 5.82 <0.01 2.26 1.35 3.80 <0.01 
30-44 2.68 2.11 3.41 <0.01 1.72 1.19 2.49 <0.01 1.56 0.96 2.52 0.07 
45-60 1.65 1.34 2.05 <0.01 1.41 1.01 1.95 0.04 0.83 0.51 1.35 0.46 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.11 0.82 1.48 0.51 0.56 0.32 0.97 0.04 1.77 1.09 2.87 0.02 
Urgent surgery 2.12 1.54 2.92 <0.01 2.58 1.70 3.90 <0.01 3.87 2.54 5.90 <0.01 
Major surgery 1.70 1.44 2.01 <0.01 2.48 1.87 3.29 <0.01 1.30 0.94 1.80 0.12 
Maximum intraoperative heart rate (bpm) 
            >100 1.38 1.14 1.66 <0.01 1.46 1.10 1.93 0.01 2.82 2.08 3.82 <0.01 






Table 5.16. Sensitivity analysis excluding participants undergoing emergency surgery. Multivariable logistic regression models for lowest 
intraoperative heart rate. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative heart rate was 
dichotomised according to a threshold of <55 beat per minute (bpm). Heart rate ≥55 bpm was the reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.10 0.90 1.34 0.35 1.21 0.88 1.67 0.23 1.61 1.10 2.37 0.02 
>75 2.06 1.70 2.51 <0.01 2.22 1.64 3.01 <0.01 2.38 1.61 3.51 <0.01 
Male sex 1.40 1.20 1.62 <0.01 1.06 0.84 1.33 0.65 1.27 0.95 1.71 0.11 
Comorbid disease 
            History of atrial fibrillation 1.95 1.48 2.58 <0.01 1.55 1.04 2.30 0.03 1.30 0.75 2.24 0.35 
History of diabetes 1.35 1.14 1.59 <0.01 1.17 0.91 1.52 0.23 0.92 0.64 1.31 0.64 
History of hypertension 1.24 1.04 1.47 0.02 1.23 0.93 1.63 0.15 1.01 0.73 1.40 0.96 
History of heart failure 1.44 1.12 1.85 0.01 1.44 1.02 2.04 0.04 1.08 0.64 1.80 0.78 
History of coronary artery disease 1.53 1.28 1.84 <0.01 2.35 1.81 3.04 <0.01 1.06 0.72 1.55 0.77 
History of peripheral vascular disease 2.04 1.63 2.55 <0.01 2.12 1.55 2.90 <0.01 1.48 0.94 2.34 0.09 
History of stroke or transient ischaemic attack 1.51 1.22 1.87 <0.01 1.16 0.83 1.61 0.38 1.87 1.27 2.75 <0.01 
History of chronic obstructive pulmonary 
disease 
1.24 0.99 1.54 0.06 1.10 0.80 1.53 0.56 2.25 1.57 3.22 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 11.73 9.27 14.84 <0.01 4.06 2.87 5.76 <0.01 2.26 1.35 3.78 <0.01 
30-44 2.74 2.16 3.48 <0.01 1.74 1.20 2.52 <0.01 1.63 1.01 2.63 0.05 
45-60 1.67 1.35 2.06 <0.01 1.41 1.01 1.95 0.04 0.82 0.51 1.33 0.42 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.15 0.85 1.54 0.37 0.57 0.33 1.00 0.05 1.78 1.10 2.88 0.02 
Urgent surgery 2.15 1.56 2.95 <0.01 2.72 1.81 4.09 <0.01 4.56 3.03 6.87 <0.01 
Major surgery 1.70 1.44 2.01 <0.01 2.47 1.86 3.28 <0.01 1.32 0.95 1.82 0.10 
Minimum intraoperative heart rate (bpm) 
            <55 0.70 0.59 0.83 <0.01 0.76 0.58 1.00 <0.05 0.57 0.39 0.83 <0.01 






Table 5.17. Sensitivity analysis excluding participants undergoing emergency surgery. Multivariable logistic regression models for highest 
intraoperative systolic blood pressure. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative 
systolic blood pressure (SBP) was dichotomised according to a threshold of >160 mmHg. SBP ≤160 mmHg was the reference category. Estimated glomerular 
filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.09 0.89 1.33 1.18 1.18 0.86 1.64 0.31 1.67 1.13 2.45 0.01 
>75 2.09 1.71 2.54 2.18 2.18 1.60 2.97 <0.01 2.45 1.65 3.62 <0.01 
Male sex 1.37 1.18 1.60 1.03 1.03 0.81 1.30 0.81 1.21 0.90 1.63 0.20 
Comorbid disease 
            History of atrial fibrillation 2.06 1.55 2.73 <0.01 1.64 1.10 2.44 0.02 1.28 0.73 2.24 0.39 
History of diabetes 1.32 1.11 1.57 <0.01 1.17 0.90 1.52 0.24 0.90 0.62 1.29 0.56 
History of hypertension 1.23 1.03 1.47 0.02 1.21 0.91 1.61 0.18 1.01 0.72 1.41 0.96 
History of heart failure 1.41 1.09 1.82 0.01 1.40 0.98 1.99 0.06 1.03 0.60 1.76 0.92 
History of coronary artery disease 1.50 1.25 1.81 <0.01 2.27 1.74 2.94 <0.01 1.03 0.70 1.52 0.88 
History of peripheral vascular disease 2.08 1.66 2.61 <0.01 2.20 1.61 3.01 <0.01 1.55 0.97 2.46 0.07 
History of stroke or transient ischaemic attack 1.51 1.22 1.88 <0.01 1.16 0.84 1.61 0.38 1.99 1.35 2.93 <0.01 
History of chronic obstructive pulmonary disease 1.28 1.03 1.59 0.03 1.17 0.84 1.62 0.35 2.20 1.53 3.18 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 11.86 9.35 15.05 <0.01 4.15 2.91 5.90 <0.01 2.39 1.43 4.01 <0.01 
30-44 2.68 2.11 3.41 <0.01 1.75 1.21 2.54 <0.01 1.58 0.97 2.58 0.06 
45-60 1.58 1.27 1.96 <0.01 1.35 0.96 1.88 0.08 0.74 0.45 1.23 0.25 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.12 0.83 1.51 0.46 0.58 0.33 1.02 0.06 1.74 1.07 2.81 0.03 
Urgent surgery 2.16 1.57 2.99 <0.01 2.55 1.67 3.88 <0.01 4.83 3.19 7.31 <0.01 
Major surgery 1.70 1.43 2.01 <0.01 2.40 1.81 3.19 <0.01 1.37 0.99 1.90 0.06 
Maximum intraoperative systolic blood pressure (mmHg) 
(bpm)             >160 1.22 1.05 1.43 0.01 1.40 1.11 1.77 0.01 0.78 0.57 1.08 0.13 






Table 5.18. Sensitivity analysis excluding participants undergoing emergency surgery. Multivariable logistic regression models for lowest 
intraoperative systolic blood pressure. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative 
systolic blood pressure (SBP) was dichotomised according to a threshold of <100 mmHg. SBP ≥100 mmHg was the reference category. Estimated glomerular 
filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.11 0.91 1.36 0.30 1.21 0.88 1.68 0.24 1.71 1.16 2.51 0.01 
>75 2.19 1.80 2.67 <0.01 2.33 1.71 3.17 <0.01 2.59 1.74 3.84 <0.01 
Male sex 1.37 1.17 1.59 <0.01 1.03 0.81 1.30 0.83 1.24 0.92 1.67 0.15 
Comorbid disease 
            History of atrial fibrillation 2.03 1.54 2.70 <0.01 1.59 1.07 2.37 0.02 1.37 0.79 2.37 0.27 
History of diabetes 1.34 1.13 1.59 <0.01 1.18 0.90 1.53 0.23 0.91 0.64 1.31 0.63 
History of hypertension 1.25 1.04 1.49 0.02 1.25 0.94 1.66 0.12 1.00 0.72 1.39 0.98 
History of heart failure 1.43 1.10 1.84 0.01 1.41 0.99 2.01 0.06 1.09 0.65 1.85 0.75 
History of coronary artery disease 1.52 1.26 1.82 <0.01 2.30 1.77 2.98 <0.01 1.08 0.73 1.58 0.71 
History of peripheral vascular disease 2.14 1.71 2.69 <0.01 2.28 1.66 3.12 <0.01 1.57 0.99 2.49 0.06 
History of stroke or transient ischaemic attack 1.55 1.25 1.93 <0.01 1.21 0.87 1.67 0.26 1.93 1.31 2.85 <0.01 
History of chronic obstructive pulmonary disease 1.27 1.02 1.58 0.03 1.13 0.82 1.57 0.46 2.21 1.54 3.18 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 12.02 9.47 15.25 <0.01 4.15 2.92 5.91 <0.01 2.47 1.47 4.14 <0.01 
30-44 2.69 2.11 3.42 <0.01 1.76 1.21 2.55 <0.01 1.61 1.00 2.60 0.05 
45-60 1.60 1.29 1.98 <0.01 1.36 0.98 1.90 0.07 0.74 0.45 1.23 0.24 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.12 0.83 1.51 0.46 0.59 0.34 1.03 0.07 1.70 1.05 2.75 0.03 
Urgent surgery 2.16 1.56 2.98 <0.01 2.52 1.65 3.85 <0.01 4.58 3.02 6.94 <0.01 
Major surgery 1.68 1.42 2.00 <0.01 2.38 1.79 3.17 <0.01 1.32 0.95 1.84 0.10 
Minimum intraoperative systolic blood pressure (mmHg) 
            <100 1.32 1.13 1.55 <0.01 1.43 1.12 1.82 <0.01 1.81 1.31 2.49 <0.01 






Table 5.19. Sensitivity analysis excluding participants receiving beta-blockers or rate-limiting calcium channel blockers within 24 hours 
before surgery. Multivariable logistic regression models for highest intraoperative heart rate. Dependent variables are myocardial injury, myocardial infarction and 
mortality within 30 days of surgery. Intraoperative heart rate was dichotomised according to a threshold of >100 beat per minute (bpm). Heart rate ≤100 bpm was the 
reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.12 0.90 1.39 0.32 1.09 0.77 1.54 0.64 1.68 1.17 2.41 0.01 
>75 2.27 1.85 2.79 <0.01 1.85 1.34 2.57 <0.01 2.28 1.59 3.27 <0.01 
Male sex 1.24 1.05 1.45 0.01 0.78 0.60 1.00 0.05 1.10 0.84 1.44 0.51 
Comorbid disease 
            History of atrial fibrillation 1.79 1.25 2.55 <0.01 1.28 0.77 2.12 0.34 0.81 0.42 1.57 0.54 
History of diabetes 1.31 1.09 1.58 0.01 1.30 0.98 1.72 0.07 1.01 0.73 1.40 0.96 
History of hypertension 1.20 1.01 1.44 0.04 1.20 0.91 1.59 0.21 1.02 0.76 1.37 0.91 
History of heart failure 1.75 1.30 2.36 <0.01 2.14 1.46 3.14 <0.01 1.32 0.79 2.22 0.30 
History of coronary artery disease 1.56 1.24 1.96 <0.01 2.40 1.77 3.27 <0.01 1.05 0.70 1.58 0.83 
History of peripheral vascular disease 1.86 1.44 2.42 <0.01 2.08 1.45 2.98 <0.01 1.99 1.31 3.01 <0.01 
History of stroke or transient ischaemic attack 1.49 1.17 1.90 <0.01 1.13 0.77 1.64 0.54 1.58 1.08 2.32 0.02 
History of chronic obstructive pulmonary disease 1.40 1.11 1.76 0.01 1.56 1.12 2.19 0.01 2.42 1.72 3.40 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 12.75 9.86 16.48 <0.01 4.00 2.73 5.85 <0.01 3.47 2.25 5.35 <0.01 
30-44 2.89 2.23 3.75 <0.01 1.97 1.32 2.94 <0.01 1.94 1.25 3.01 <0.01 
45-60 1.72 1.36 2.16 <0.01 1.60 1.13 2.29 0.01 1.11 0.72 1.70 0.64 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.20 0.87 1.65 0.27 0.63 0.34 1.18 0.15 1.90 1.20 3.02 0.01 
Urgent or emergency surgery 1.91 1.58 2.30 <0.01 2.53 1.95 3.30 <0.01 3.69 2.81 4.85 <0.01 
Major surgery 1.74 1.45 2.09 <0.01 2.33 1.72 3.16 <0.01 1.71 1.24 2.36 <0.01 
Maximum intraoperative heart rate (bpm) 
            >100 1.28 1.06 1.55 0.01 1.46 1.11 1.93 0.01 2.23 1.69 2.94 <0.01 






Table 5.20. Sensitivity analysis excluding participants receiving beta-blockers or rate-limiting calcium channel blockers within 24 hours 
before surgery. Multivariable logistic regression models for lowest intraoperative heart rate. Dependent variables are myocardial injury, myocardial infarction and 
mortality within 30 days of surgery. Intraoperative heart rate was dichotomised according to a threshold of <55 beat per minute (bpm). Heart rate ≥55 bpm was the 
reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.12 0.90 1.39 0.32 1.09 0.77 1.54 0.63 1.62 1.13 2.32 0.01 
>75 2.26 1.84 2.77 <0.01 1.83 1.32 2.54 <0.01 2.16 1.51 3.09 <0.01 
Male sex 1.25 1.07 1.47 0.01 0.79 0.61 1.02 0.07 1.12 0.85 1.46 0.42 
Comorbid disease 
            History of atrial fibrillation 1.83 1.28 2.62 <0.01 1.35 0.82 2.23 0.24 0.90 0.47 1.74 0.76 
History of diabetes 1.30 1.08 1.56 0.01 1.28 0.97 1.70 0.09 1.01 0.73 1.41 0.95 
History of hypertension 1.19 1.00 1.42 0.05 1.18 0.89 1.56 0.24 1.00 0.75 1.35 0.98 
History of heart failure 1.75 1.30 2.36 <0.01 2.10 1.43 3.09 <0.01 1.23 0.73 2.07 0.43 
History of coronary artery disease 1.56 1.24 1.97 <0.01 2.38 1.75 3.23 <0.01 1.00 0.66 1.50 0.99 
History of peripheral vascular disease 1.86 1.43 2.41 <0.01 2.05 1.43 2.94 <0.01 1.94 1.29 2.93 <0.01 
History of stroke or transient ischaemic attack 1.53 1.20 1.95 <0.01 1.15 0.79 1.68 0.46 1.71 1.17 2.50 0.01 
History of chronic obstructive pulmonary disease 1.36 1.08 1.71 0.01 1.51 1.08 2.12 0.02 2.34 1.68 3.28 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 12.67 9.80 16.39 <0.01 4.03 2.75 5.88 <0.01 3.72 2.42 5.71 <0.01 
30-44 2.92 2.26 3.79 <0.01 2.01 1.35 3.00 <0.01 2.05 1.33 3.18 <0.01 
45-60 1.72 1.37 2.17 <0.01 1.60 1.12 2.28 0.01 1.09 0.71 1.68 0.68 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.26 0.91 1.73 0.16 0.66 0.36 1.24 0.20 1.89 1.19 3.00 0.01 
Urgent or emergency surgery 1.88 1.56 2.27 <0.01 2.52 1.94 3.28 <0.01 3.96 3.02 5.20 <0.01 
Major surgery 1.73 1.45 2.08 <0.01 2.32 1.71 3.14 <0.01 1.75 1.27 2.42 <0.01 
Minimum intraoperative heart rate (bpm) 
            <55 0.67 0.54 0.82 <0.01 0.58 0.41 0.83 <0.01 0.71 0.49 1.03 0.07 





Table 5.21. Sensitivity analysis excluding participants with pre-existing atrial fibrillation. Multivariable logistic regression models for maximum 
intraoperative heart rate. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative heart rate was 
dichotomised according to a threshold of >100 beat per minute (bpm). Heart rate ≤100 bpm was the reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.09 0.91 1.32 0.35 1.20 0.90 1.61 0.22 1.67 1.19 2.36 <0.01 
>75 2.06 1.72 2.47 <0.01 1.89 1.43 2.50 <0.01 2.37 1.69 3.33 <0.01 
Male sex 1.35 1.17 1.56 <0.01 0.98 0.79 1.21 0.84 1.17 0.91 1.52 0.22 
Comorbid disease 
            History of diabetes 1.46 1.25 1.71 <0.01 1.28 1.01 1.62 0.04 1.04 0.77 1.41 0.81 
History of hypertension 1.28 1.08 1.50 <0.01 1.36 1.05 1.75 0.02 0.92 0.69 1.23 0.57 
History of heart failure 1.72 1.34 2.21 <0.01 1.77 1.28 2.46 <0.01 1.33 0.83 2.13 0.24 
History of coronary artery disease 1.57 1.31 1.87 <0.01 2.42 1.90 3.09 <0.01 1.01 0.71 1.44 0.96 
History of peripheral vascular disease 2.09 1.69 2.60 <0.01 2.03 1.51 2.74 <0.01 1.74 1.17 2.59 0.01 
History of stroke or transient ischaemic attack 1.45 1.18 1.79 <0.01 0.99 0.72 1.37 0.96 1.43 1.00 2.06 0.05 
History of chronic obstructive pulmonary disease 1.25 1.01 1.54 0.04 1.29 0.96 1.75 0.10 2.34 1.69 3.23 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 10.45 8.38 13.02 <0.01 3.96 2.88 5.45 <0.01 3.40 2.29 5.05 <0.01 
30-44 2.46 1.95 3.09 <0.01 1.74 1.23 2.45 <0.01 1.56 1.01 2.40 0.04 
45-60 1.70 1.39 2.07 <0.01 1.51 1.12 2.05 0.01 1.06 0.71 1.59 0.77 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.17 0.89 1.55 0.27 0.59 0.34 1.01 0.06 1.80 1.16 2.80 0.01 
Urgent or emergency surgery 2.07 1.75 2.45 <0.01 2.43 1.92 3.08 <0.01 3.57 2.75 4.63 <0.01 
Major surgery 1.63 1.39 1.91 <0.01 2.18 1.68 2.84 <0.01 1.59 1.17 2.15 <0.01 
Maximum intraoperative heart rate (bpm) 
            >100 1.31 1.10 1.56 <0.01 1.29 0.99 1.67 0.06 2.57 1.97 3.35 <0.01 







Table 5.22. Sensitivity analysis excluding participants with pre-existing atrial fibrillation. Multivariable logistic regression models for minimum 
intraoperative heart rate. Dependent variables are myocardial injury, myocardial infarction and mortality within 30 days of surgery. Intraoperative heart rate was 
dichotomised according to a threshold of <55 beat per minute (bpm). Heart rate ≥55 bpm was the reference category. Estimated glomerular filtration rate (eGFR).  
 
  Myocardial Injury Myocardial Infarction Mortality 
    95% CI     95% CI     95% CI   
Covariates odds ratio Lower Upper p-value odds ratio Lower Upper p-value odds ratio Lower Upper p-value 
Age 
            45-64 (reference) - - - - - - - - - - - - 
65-75 1.10 0.91 1.32 0.34 1.21 0.90 1.62 0.21 1.60 1.14 2.25 0.01 
>75 2.05 1.71 2.46 <0.01 1.88 1.42 2.49 <0.01 2.24 1.60 3.14 <0.01 
Male sex 1.36 1.18 1.57 <0.01 0.99 0.80 1.23 0.92 1.22 0.95 1.58 0.13 
Comorbid disease 
            History of diabetes 1.45 1.24 1.70 <0.01 1.27 1.01 1.61 0.05 1.06 0.78 1.43 0.73 
History of hypertension 1.27 1.08 1.50 <0.01 1.35 1.04 1.74 0.02 0.90 0.68 1.19 0.45 
History of heart failure 1.69 1.32 2.18 <0.01 1.75 1.26 2.42 <0.01 1.26 0.79 2.01 0.33 
History of coronary artery disease 1.58 1.32 1.88 <0.01 2.42 1.89 3.08 <0.01 0.94 0.66 1.33 0.72 
History of peripheral vascular disease 2.08 1.68 2.58 <0.01 2.01 1.49 2.72 <0.01 1.69 1.14 2.50 0.01 
History of stroke or transient ischaemic attack 1.47 1.19 1.82 <0.01 1.00 0.72 1.38 0.98 1.52 1.06 2.18 0.02 
History of chronic obstructive pulmonary disease 1.21 0.98 1.49 0.08 1.26 0.93 1.71 0.13 2.22 1.60 3.06 <0.01 
Preoperative eGFR (ml/min/1.73m2) 
            <30 10.42 8.36 12.99 <0.01 3.98 2.90 5.47 <0.01 3.61 2.44 5.34 <0.01 
30-44 2.49 1.98 3.13 <0.01 1.75 1.24 2.47 <0.01 1.62 1.05 2.49 0.03 
45-60 1.72 1.41 2.09 <0.01 1.52 1.12 2.06 0.01 1.06 0.71 1.58 0.79 
>60 (reference) - - - - - - - - - - - - 
Neurosurgery 1.22 0.92 1.62 0.16 0.61 0.35 1.04 0.07 1.80 1.16 2.80 0.01 
Urgent or emergency surgery 2.03 1.72 2.40 <0.01 2.42 1.91 3.06 <0.01 3.82 2.95 4.95 <0.01 
Major surgery 1.63 1.39 1.91 <0.01 2.17 1.67 2.82 <0.01 1.63 1.20 2.20 <0.01 
Minimum intraoperative heart rate (bpm) 
            <55 0.68 0.58 0.81 <0.01 0.75 0.58 0.98 0.04 0.63 0.45 0.88 0.01 






Table 5.23. Post-hoc analysis for four-level heart rate and systolic pressure variables. Baseline data stratified by heart rate (HR) in beats per minute 
and systolic blood pressure (SBP) in mmHg. Estimated glomerular filtration rate (eGFR). Myocardial injury after non-cardiac surgery (MINS). 
	
  Intraoperative heart rate (HR) Intraoperative systolic blood pressure (SBP) 
  HR 55-100 HR  <55 HR >100 HR >100 & <55 SBP 100-160 SBP  <100 SBP >160 SBP >160 & <100 
Number of cases (n) 8022 3202 2051 465 3491 6081 1711 2457 
Mean age (SD) 66.0 (11.8) 66.2 (11.2) 64.2 (12.4) 63.6 (11.4) 66.3 (11.7) 63.4 (11.4) 70.1 (11.7) 67.3 (11.3) 
Sex 
        Male (%) 3838 (47.8) 1603 (50.1) 1024 (49.9) 244 (52.5) 1835 (52.6) 2938 (48.3) 769 (44.9) 1167 (47.5) 
Female (%) 4184 (52.2) 1599 (49.9) 1027 (50.1) 221 (47.5) 1656 (47.4) 3143 (51.7) 942 (55.1) 1290 (52.5) 
Comorbid disorder (%) 
        Atrial fibrillation 267 (3.3) 87 (2.7) 109 (5.3) 12 (2.6) 155 (4.4) 173 (2.8) 66 (3.9) 81 (3.3) 
Diabetes 1627 (20.3) 584 (18.2) 477 (23.3) 74 (15.9) 716 (20.5) 1019 (16.8) 452 (26.4) 575 (23.4) 
Hypertension 4221 (52.6) 1772 (55.3) 960 (46.8) 185 (39.8) 1795 (51.4) 2817 (46.3) 1119 (65.4) 1407 (57.3) 
Heart failure 408 (5.1) 155 (4.8) 91 (4.4) 11 (2.4) 195 (5.6) 244 (4.0) 107 (6.3) 119 (4.8) 
Coronary artery disease 990 (12.3) 500 (15.6) 185 (9.0) 34 (7.3) 482 (13.8) 625 (10.3) 287 (16.8) 315 (12.8) 
Peripheral vascular disease 439 (5.5) 199 (6.2) 98 (4.8) 10 (2.2) 218 (6.2) 246 (4.0) 152 (8.9) 130 (5.3) 
Previous stroke or transient ischemic attack 522 (6.5) 238 (7.4) 213 (10.4) 34 (7.3) 234 (6.7) 304 (5.0) 211 (12.3) 258 (10.5) 
Chronic obstructive pulmonary disease  809 (10.1) 223 (7.0) 164 (8.0) 15 (3.2) 331 (9.5) 524 (8.6) 149 (8.7) 207 (8.4) 
Preoperative eGFR, ml/min/1.73m2 (%) 
        <30  304 (3.8) 87 (2.7) 105 (5.1) 8 (1.7) 130 (3.7) 199 (3.3) 95 (5.6) 80 (3.3) 
30-45  407 (5.1) 187 (5.8) 129 (6.3) 17 (3.7) 167 (4.8) 277 (4.6) 159 (9.3) 137 (5.6) 
45-60  852 (10.6) 390 (12.2) 183 (8.9) 35 (7.5) 372 (10.7) 533 (8.8) 239 (14.0) 316 (12.9) 
>60  6459 (80.5) 2538 (79.3) 1634 (79.7) 405 (87.1) 2822 (80.8) 5072 (83.4) 1218 (71.2) 1924 (78.3) 
Surgical procedure category (%) 
        Elective 6906 (86.1) 2964 (92.6) 1591 (77.6) 419 (90.1) 3022 (86.6) 5297 (87.1) 1449 (84.7) 2112 (86.0) 
Urgent 217 (2.7) 56 (1.7) 122 (5.9) 10 (2.2) 85 (2.4) 175 (2.9) 49 (2.9) 96 (3.9) 
Emergency 899 (11.2) 182 (5.7) 338 (16.5) 36 (7.7) 384 (11.0) 609 (10.0) 213 (12.4) 249 (10.1) 
Major surgery (%) 4950 (61.7) 1951 (60.9) 1289 (62.8) 258 (55.5) 1963 (56.2) 3825 (62.9) 1070 (62.5) 1590 (64.7) 




Table 5.24. Post-hoc analysis for heart rate as a four-level categorical variable. 
Multivariable logistic regression model. Dependent variable is myocardial injury after non-
cardiac surgery (MINS). Estimated glomerular filtration rate (eGFR).  
 
  Myocardial injury 
Covariates odds ratio p-value 
Age 
  45-64 (reference) - - 
65-75 1.11 (0.92-1.33) 0.30 
>75 2.14 (1.79-2.56) <0.01 
Male sex 1.35 (1.18-1.55) <0.01 
Comorbid disease 
  Existing atrial fibrillation 1.60 (1.23-2.08) <0.01 
Diabetes 1.37 (1.17-1.59) <0.01 
Hypertension 1.33 (1.13-1.56) <0.01 
Heart failure 1.56 (1.23-1.96) <0.01 
Coronary artery disease 1.49 (1.25-1.76) <0.01 
Peripheral vascular disease 2.29 (1.86-2.81) <0.01 
Previous stroke or transient ischaemic attack 1.46 (1.20-1.78) <0.01 
Chronic obstructive pulmonary disease 1.18 (0.96-1.44) 0.11 
eGFR (ml/min/1.73m2) 
  <30 10.47 (8.45-13.00) <0.01 
30-45 2.52 (2.02-3.13) <0.01 
45-60 1.65 (1.36-2.00) <0.01 
>60 (reference) - - 
Neurosurgery 1.19 (0.90-1.58) 0.22 
Urgent or emergency surgery 1.85 (1.56-2.18) <0.01 
Major surgery 1.66 (1.42-1.94) <0.01 
Intraoperative heart rate (bpm) 
  Maximum and minimum 55-100 (reference) - - 
Minimum <55 0.73 (0.61-0.88) <0.01 
Maximum >100 1.27 (1.06-1.52) 0.01 











Table 5.25. Post-hoc analysis for systolic blood pressure as a four-level 
categorical variable. Multivariable logistic regression model. Dependent variable is 
myocardial injury after non-cardiac surgery (MINS). Estimated glomerular filtration rate (eGFR).  
 
  Myocardial injury 
Covariates odds ratio p-value 
Age 
  45-64 (reference) - - 
65-75 1.09 (0.90-1.31) 0.38 
>75 2.11 (1.77-2.53) <0.01 
Male sex 1.36 (1.18-1.56) <0.01 
Comorbid disease 
  Existing atrial fibrillation 1.69 (1.30-2.20) <0.01 
Diabetes 1.38 (1.18-1.61) <0.01 
Hypertension 1.31 (1.11-1.53) <0.01 
Heart failure 1.56 (1.24-1.97) <0.01 
Coronary artery disease 1.45 (1.23-1.72) <0.01 
Peripheral vascular disease 2.28 (1.86-2.80) <0.01 
Previous stroke or transient ischaemic attack 1.47 (1.21-1.79) <0.01 
Chronic obstructive pulmonary disease 1.21 (0.99-1.48) 0.07 
eGFR (ml/min/1.73m2) 
  <30 10.80 (8.73-13.38) <0.01 
30-45 2.51 (2.02-3.12) <0.01 
45-60 1.62 (1.34-1.97) <0.01 
>60 (reference) - - 
Neurosurgery 1.12 (0.85-1.48) 0.42 
Urgent or emergency surgery 1.99 (1.69-2.34) <0.01 
Major surgery 1.65 (1.41-1.93) <0.01 
Intraoperative systolic blood pressure (mmHg) 
  Maximum and minimum 100 - 160 (reference) - - 
Minimum <100 1.24 (1.04-1.49) 0.02 
Maximum >160 1.22 (0.97-1.52) 0.08 





5.3.5 Fractional polynomial analysis 
Multivariable fractional polynomial analysis demonstrates that the duration of 
intraoperative heart rate >100 bpm was associated with myocardial injury in a 
non-linear fashion. The function plot (figure 5.5A) shows the duration of 
elevated heart rate component of the model (duration x regression coefficient) 
and the intercept, sometimes called the ‘partial predictor’, plus the residual (the 
residual variation between the observed data and the regression line), plotted 
against increasing heart rate.323, 324 The function plot is used to illustrate how a 
particular term in a given model varies over the data range. In this case, the 
function plot (figure 5.5A) shows that the duration of elevated heart rate term in 
the model varies in a curvilinear fashion, indicating that the relationship 
between duration of elevated heart rate and myocardial injury is non-linear.  
This analysis also showed that the durations of low heart rate, and high/low 






Figure 5.5. Function plots of fractional polynomial regression models for (A) 
Duration of intraoperative heart rate > 100 beats per minute (bpm),  (B) Duration 
of intraoperative heart rate < 55 bpm, (C) Duration of intraoperative systolic 
blood pressure < 100 mmHg and (D) Duration of intraoperative systolic blood 
pressure > 160 mmHg. The x-axes show time in minutes and the y-axes, the partial 
predictor + residual. The partial predictor is the duration component of the regression equation 
plus the intercept. The residual is the residual variation between the regression line and the 
observed data. The function plot shows how a given term in a regression model varies across 
the data range. Here, duration of intraoperative HR > 100 bpm (panel A) varies in a curvilinear 
fashion, while the remaining plots show linear relationships. 
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5.4  Discussion 
The principal finding of this analysis is that intraoperative tachycardia, 
hypotension and hypertension are independently associated with myocardial 
injury and mortality. Here, I demonstrate the effect of combinations of 
intraoperative heart rate and systolic blood pressure suggesting that the 
association between hypotension and myocardial injury is increased in the 
presence of tachycardia and reduced in the presence of bradycardia. Prolonged 
durations of tachycardia and hypotension were associated with increased risk of 
myocardial injury. Furthermore, intraoperative bradycardia was associated with 
reduced risk of myocardial injury and mortality. 
 
My results are consistent with studies demonstrating association between 
intraoperative hypotension and postoperative adverse events following non-
cardiac surgery.166, 171, 173, 203, 381, 391 However, unlike my study, these were small 
and mostly retrospective studies that did not use objective biomarkers as 
outcome measure. This is the first study to identify relationships between high 
intraoperative heart rate/systolic blood pressure and increased risk of 
perioperative myocardial injury, and low intraoperative heart rate and reduced 
risk of myocardial injury. While the observational nature of my data does allow 
me to infer causal relationships, it is reasonable to hypothesise that avoidance 
of either very high heart rate, or very high/low systolic blood pressures during 
surgery may be clinically beneficial. Data from clinical trials suggest that 
treatment with beta-blockers (which lower heart rate) can reduce the risk of 
myocardial infarction after non-cardiac surgery, but at the expense of larger 
increases in the risk of mortality and stroke.166, 258 However, it is difficult to 
disentangle the effect of heart rate from the effect of beta-blockers and the 
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degree of interaction between these variables. In this study, 2,727 (16.9%) 
patients received a beta-blocker or negatively chronotropic calcium channel 
blocker within 24 hours before surgery. I repeated the primary analysis after 
removing these cases and found that the associations between maximum 
intraoperative heart rate and the outcomes were unchanged. However, the 
negative association between minimum intraoperative heart rate < 55bpm and 
mortality was no longer statistically significant. In other words, the ‘protective’ 
association between low heart rate and reduced risk of mortality was lost in 
patients not receiving a beta-blocker or calcium channel antagonist. However, it 
is not possible to infer a causative relationship due to the observational nature 
of the data. This contrasts with the results of previous clinical trials where heart 
rate lowering medication was associated with increased mortality.166 Further 
research is needed to investigate potential mechanisms underlying this 
observation, in addition to trials of new heart rate control methods that avoid 
hypotension. 
 
These data suggest that very high or very low intraoperative heart rate and 
blood pressure may be key factors that, alone or in combination, contribute to 
the development of myocardial injury. The most widely accepted model 
suggests that most perioperative myocardial injury is caused by extended 
periods of myocardial ischaemia as a result of oxygen supply-demand 
imbalance in cardiac muscle.96 In this context, intraoperative hypotension or 
tachycardia may reduce myocardial perfusion pressure leading to reduced 
myocardial oxygen supply. Similarly, elevated systolic pressure, which 
increases end-systolic stress, may cause myocardial oxygen demand to exceed 
the available supply, resulting in relative hypoperfusion of the cardiac muscle 
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and myocardial injury.147 My results are consistent with a myocardial oxygen 
supply-demand imbalance hypothesis, given the increasing risk of myocardial 
injury as the duration of tachycardia or hypotension increased. This is 
supported by the results of animal studies, where tachycardia induces sub-
endocardial myocardial necrosis at a rate correlated with the duration of 
ischaemia.160 It is also possible that my observations are due to confounding by 
other factors. The analyses were adjusted for multiple perioperative variables 
that are known to be associated with cardiovascular morbidity and mortality 
after surgery. However, it was not possible to account for confounding by other 
unmeasured factors. Therefore, I cannot exclude the possibility that 
tachycardia/hypertension/hypotension are merely markers of other conditions or 
treatment interventions that may promote myocardial injury.277, 347, 348, 392, 393 In 
addition, this analysis was limited to intraoperative heart rate and blood 
pressure, although, other analyses suggest that abnormalities of preoperative 
heart rate and blood pressure are also associated with myocardial injury after 
surgery (chapters three and four). Further research is needed into the potential 
for preoperative identification of patients at risk of myocardial injury.17, 279 
 
A strength of this analysis is the large sample size derived from multiple centres 
in multiple countries, giving robust external validity and making the results 
generalisable to the vast majority of patients undergoing non-cardiac surgery. 
The primary outcome was an objective biomarker, rather than a potentially 
subjective, clinically defined outcome, which may have reduced information 
bias. Furthermore, since more than nine out of ten patients with postoperative 
troponin elevation are asymptomatic and only one quarter have 
electrocardiographic or echocardiographic evidence of ischaemia, previous 
	
	182 
studies using clinically defined outcomes are likely to have underestimated the 
incidence of postoperative myocardial injury, which my analysis should have 
avoided.95 Conversely, my analysis used data from a Roche 4th generation 
troponin assay, which will underestimate the incidence of myocardial injury 
compared to newer highly sensitive assays. Thus, I would like to repeat this 
study using highly sensitive troponin assays. The detailed nature of the VISION 
database allowed the analysis to be adjusted for confounding factors using 
multivariable regression modelling, including pre-existing atrial fibrillation.  
 
This analysis also has some limitations. I cannot exclude the influence of 
unmeasured confounding. For example, the use of intraoperative cardiac 
medication, the presence of cardiac pacemakers and the incidence of 
preoperative troponin elevation are all unknown, although the frequency of 
these is likely to be low.114, 356 The association between elevated heart rate may 
have been confounded by the presence of preoperative atrial fibrillation. I 
corrected for this by including pre-existing atrial fibrillation in the multivariable 
models and through a sensitivity analysis. Additional sensitivity analyses that 
excluded cases of emergency surgery, and patients receiving preoperative 
beta-blockers or rate limiting calcium channel antagonists were also performed. 
Continuous measurements of intraoperative heart rate and blood pressure were 
not recorded as part of this study; therefore the analysis was limited to summary 
data for intraoperative heart rate and blood pressure based on pre-defined 
consensus thresholds. Since measurements of heart rate or blood pressure 
were not time-stamped, analyses of combinations of abnormal heart rate and 
blood pressure did not necessarily constitute simultaneous or contemporaneous 
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episodes. Future computational research using continuously recorded heart 




Intraoperative tachycardia and extremes of systolic blood pressure are 
associated with increased risk of myocardial injury after non-cardiac surgery. In 
addition, the duration of intraoperative hypotension and tachycardia are also 
associated with perioperative myocardial injury. Further targeted interventional 
studies using intraoperative heart rate and/or blood pressure thresholds that I 
have identified may help identify strategies to reduce perioperative cardiac 




Chapter six  
Cardiopulmonary and autonomic impairment 
 
Elevated preoperative heart rate is associated with 




This chapter has been published in the British Journal of Anaesthesia (2017) 
119 (1): 87-94 
 
6.1  Introduction 
I have previously found that elevated intraoperative heart rate and elevated 
preoperative heart rate were associated with myocardial injury and mortality 
after non-cardiac surgery, in chapters five and three respectively.273, 274 These 
findings are consistent with an oxygen supply-demand imbalance model of 
perioperative myocardial injury, where transient mismatch between oxygen 
delivery and oxygen consumption in the myocardium causes cellular injury, 
detectable as troponin release.96 While it is plausible that tachycardia could 
promote myocardial injury via this mechanism, there is insufficient evidence to 
support a causal link. Meanwhile, evidence that elevated resting heart rate 
before surgery is associated with myocardial injury raises the question of 
whether tachycardia may be a marker of an underlying pathological process or 
disease state that could cause or contribute to myocardial injury.273, 387  
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In the general population, elevated resting heart rate is an independent risk 
factor for the subsequent development of heart failure.158, 159, 394 In the 
perioperative setting, patients with a confirmed diagnosis of heart failure 
syndrome are twice as likely to die within 30 days after non-cardiac surgery, 
compared to patients without heart failure.349, 350 Cardiopulmonary exercise 
testing (CPET) can identify cardiopulmonary and/or autonomic impairment and 
has been used for prognostication in patients with confirmed heart failure.70, 71, 
179 CPET is also used for surgical risk assessment in one third of UK hospitals, 
where, on preoperative testing, similar patterns of CPET variables can be 
observed as in patients with confirmed heart failure.1, 57, 58 Therefore, elevated 
heart rate before surgery may indicate underlying sub-clinical heart failure, 
which may be detectable with CPET. This could generate several plausible 
pathophysiological mechanisms that may contribute to perioperative myocardial 
injury and mortality.96, 273, 281, 395   
 
I hypothesised that elevated preoperative resting heart rate (>87 bpm) 273 was 
associated with impaired cardiopulmonary and/or autonomic function consistent 
with sub-clinical cardiac failure. I tested this hypothesis by evaluating 
cardiopulmonary and autonomic factors derived from preoperative 
cardiopulmonary exercise testing that are known to be associated with clinical 








This was a secondary analysis of prospectively collected data from the 
Perioperative Morbidity – Heart Rate (POM-HR) study, a multi-centre 
observational cohort study of high-risk patients undergoing non-cardiac surgery. 
I have described the methods in chapter two and data from the study has been 
published previously.396, 397 Patients were aged 45 years or more, scheduled for 
major surgery predicted to last for more than two hours, and were referred for 
cardiopulmonary exercise testing (CPET) as part of their routine preoperative 
assessment. These criteria are very similar to the eligibility criteria for the 
VISION study.16 Researchers collected a standardised data set before, during 
and after surgery from patients and their medical records.  
 
6.2.1 Cardiopulmonary exercise testing (CPET) 
All participants underwent preoperative symptom-limited CPET, which was 
carried out at each participating hospital in designated CPET laboratories. I 
have described the procedures for cardiopulmonary exercise testing in detail in 
chapter two (methods).397 The anaerobic threshold (AT) was determined by two 
independent assessors according to published guidelines using the modified V-
slope method and confirmed by ventilatory equivalents for oxygen (VE/VO2) and 
carbon dioxide (VE/VCO2). Oxygen consumption (ml/kg/min) was measured at 
the anaerobic threshold and at peak exertion. The ventilatory equivalent for 
carbon dioxide (VE/VCO2) was measured at the anaerobic threshold and 
presented as a ratio. Resting heart rate was defined as heart rate measured 
before each test after 30 seconds in the sitting position. Peak heart rate was 
defined as maximal heart rate achieved during exercise. Heart rate recovery, 
was calculated as the difference between peak heart rate and heart rate one 
	
	187 
minute after the end of peak exercise, thus representing the change in heart 
rate during the one minute after exercise in bpm. Peak oxygen pulse (ml/beat), 
a surrogate marker for cardiac stroke volume,398 was calculated as peak 
oxygen consumption (ml/min) divided by peak heart rate (bpm). 
	
6.2.2 Exposure of interest  
The exposure of interest was preoperative resting heart rate >87 bpm. I have 
previously identified this threshold as associated with postoperative myocardial 
injury and mortality in chapter three.273 
	
	
6.2.3 Outcome measures 
The primary outcome measures were three CPET-derived variables that are 
established and independent predictors of mortality in patients with confirmed 
heart failure: ventilatory equivalent for carbon dioxide (VE/VCO2) ≥34, heart rate 
recovery ≤6 bpm and peak oxygen consumption (VO2) ≤14 ml/kg/min.70 
Secondary outcome measures were other CPET-derived cardiopulmonary and 
autonomic variables known to be associated with postoperative clinical 
outcomes or cardiovascular morbidity in the general population: preoperative 
pulse pressure, oxygen consumption at the anaerobic threshold, peak oxygen 
pulse and peak heart rate. Full details for the original papers detailing the 












6.2.4 Statistical analyses 
I planned the analysis before accessing the data. I used STATA version 14 
(StataCorp LP, Texas, USA) to analyse the data. Categorical data were 
summarised as number with percentage. Continuous data with a normal 
distribution were summarised as mean with standard deviation; continuous data 
that do not follow a normal distribution were summarised as median with 
interquartile range. Missing data were handled by list-wise deletion. I 
dichotomised the sample according to heart rate >87 bpm and summarised 
descriptive physiological variables for each group.273 I used a t-test to identify 
differences in continuous variables between groups and a chi-squared test to 
identify differences in categorical data between groups. I used logistic 
regression analysis to test for association between elevated preoperative heart 
rate >87 bpm and each outcome measure, first using univariable analysis. 
Then, I tested whether pre-existing cardiovascular medication (beta-blockers, 
calcium channel antagonists, diuretics, nitrates, anti-platelet agents, statins or 
angiotensin converting enzyme inhibitors/receptor blockers) were associated 
with heart rate >87 bpm.  I subsequently used multivariable analysis to correct 
for potential confounding by age (>75 years), gender and cardiovascular co-
morbidity as determined by Revised Cardiac Risk Index (RCRI) >2.16, 20 I chose 
to include RCRI as this is routinely used as a risk score to predict perioperative 
cardiovascular complications and as a comparator with new risk stratification 
tools (e.g. preoperative coronary computed tomographic angiography).3 The 
results of logistic regression analyses were presented as odds ratios with 95% 





6.2.5  Preoperative left ventricular stroke volume 
I wanted to test the hypothesis that preoperative resting heart rate >87 bpm was 
associated with a heart failure phenotype in a separate data set and using a 
different method. Therefore, I undertook a post-hoc analysis of data from the 
OPTIMISE and POM-O trials. These trials have been described in chapter two 
and the principal findings and methods published previously.279, 281, 397 I 
assessed whether preoperative resting heart rate >87 bpm was associated with 
impaired left ventricular stroke volume in patients undergoing major abdominal 
surgery. The analysis was restricted to haemodynamic data collected from 
cardiac output monitors before and during surgery, which provided detailed 
beat-by-beat measurements of heart rate, cardiac output and stroke volume. 
The cohort was dichotomised according to a mean preoperative heart rate 
threshold of >87 bpm and compared mean beat-by-beat preoperative left 
ventricular stroke volume between groups using a t-test. Logistic regression 
analysis tested for association between mean preoperative heart rate >87 bpm 
and impaired preoperative stroke volume <57ml, defined according to previous 
research in patients with heart failure, corrected for age >75 years, gender and 




6.3  Results 
1,572 surgical patients underwent CPET at one of five participating United 
Kingdom hospitals. Cases that were missing complete CPET data or pre-
defined covariates were excluded, leaving 1,250 patients for the final analysis 
(figure 6.1). Patient characteristics are presented in table 6.2. Resting 
preoperative heart rate >87 bpm was recorded in 399/1250 (31.9%) patients. 
Age, body mass index, cardiovascular risk factors (as defined by Revised 
Cardiac Risk Index) and resting systolic blood pressure were similar for patients 
with heart rate >87 bpm compared to those with heart rate ≤87 bpm (table 6.2). 
52/1250 (4.2%) patients had an established diagnosis of heart failure and 









Table 6.1. Baseline patient characteristics. Descriptive data stratified by resting heart 
rate >87 bpm, presented as frequencies with percentages (%) or mean (standard deviation; 
SD). Heart rate (HR) data in >87 bpm, blood pressure data in millimetres of mercury (mmHg). 
Other units as indicated. Hypothesis testing using t-test for continuous data and chi-squared 
test for categorical data. Angiotensin converting enzyme inhibitor (ACEi), Angiotensin receptor 
blocker (ARB). 
 
Characteristic HR >87 HR ≤87 
bpm 
p-value 
Number of patients 399 851 - 
Age (SD) 66.8 (10.0) 68.5 (9.6) <0.01 
Female gender (%) 139 (34.8) 231 (27.1) <0.01 
Body Mass Index (SD) 27.7 (5.6) 27.4 (4.9) 0.33 
Diabetes mellitus (%) 69 (17.3) 111 (13.0) 0.05 
Revised Cardiac Risk Index  
  
<0.01 
1 170 (42.6) 296 (34.8) - 
2 204 (51.1) 433 (50.8) - 
3 21 (5.2) 101 (12.3) - 
4 4 (1.0) 19 (4.8) - 
Type of surgery (%) 
  
<0.01 
Colorectal 133 (34.5) 283 (34.3) - 
Upper gastrointestinal 70 (18.1) 115 (14.0) - 
Vascular  33 (8.5) 126 (15.3) - 
Urology 74 (19.2) 186 (22.6) - 
Hepatobilliary 25 (6.5) 53 (6.4) - 
Maxillofacial 26 (6.7) 38 (4.6) - 
Gynaecological 9 (2.3) 1 (0.1) - 
Other 16 (4.1) 22 (2.7) - 
Preoperative medication (%) 
  
 
Beta-blocker 38 (9.5) 208 (24.7) <0.01 
Calcium channel antagonist  65 (30.4) 107 (22.2) 0.02 
Diuretic 31 (14.5) 63 (13.1) 0.62 
Nitrate 13 (3.3) 50 (5.9) 0.05 
Anti-platelet 52 (24.3) 166 (34.5) 0.07 
Statin 77 (19.3) 199 (23.5) 0.09 
ACEi/ARB 119 (30.0) 246 (29.1) 0.75 








6.3.1  Primary analysis 
Of 1250 patients 438 (35%) had VE/VCO2 ratio ≥34, 200 (16%) had heart rate 
recovery ≤6 bpm, and 396 (32%) had peak VO2 ≤14 ml.kg-1min-1. The results of 
the logistic regression analyses for heart rate >87 bpm against the primary 
outcome measures are shown in table 6.2. After correcting for potential 
confounding factors, heart rate >87 bpm was associated with peak VO2≤14 
ml/kg/min (odds ratio (OR) 1.69 [1.12-3.55]; p=0.01) and heart rate recovery ≤6 
bpm (OR 2.02 [1.30-3.14]; p<0.01). However, heart rate >87 bpm was not 






Table 6.2. Logistic regression analysis. Univariable (unadjusted) analysis and multivariable analysis including variables significantly associated with the 
outcome measure in univariable analysis and age >75 years, male gender and Revised Cardiac Risk Index (RCRI) >2. The dependent variable was heart rate >87 
bpm. Results presented as odds ratios with 95% confidence intervals, with p-value. 
 
 
Univariable analysis Multivariable analysis 
Characteristic Odds ratio p-value Odds ratio p-value 
Age >75 years 0.78 (0.59-1.04) 0.09 0.87 (0.59-1.28) 0.48 
Male gender 0.70 (0.54-0.90) <0.01 0.79 (0.54-1.16) 0.23 
Revised Cardiac Risk Index >2 0.41 (0.26-0.64) <0.01 0.56 (0.30-1.03) 0.06 
Peak oxygen consumption ≤14 
ml.kg.minute-1 
1.39 (1.08-1.78) 0.01 1.69 (1.12-3.55) 0.01 
VE/VCO2 at anaerobic threshold ≥34 1.59 (1.24-2.03) <0.01 1.31 (0.92-1.87) 0.14 
Heart rate recovery ≤6 bpm 1.96 (1.44-2.67) <0.01 2.02 (1.30-3.14) <0.01 
Preoperative medications     
Beta-blocker 0.32 (0.22-0.47) <0.01 0.37 (0.22-0.61) <0.01 
Calcium channel antagonist  1.52 (1.06-2.19) 0.02 1.71 (1.15-2.55) <0.01 
Diuretic 1.12 (0.71-1.79) 0.62 - - 
Nitrate 0.54 (0.29-1.00) 0.05 0.37 (0.12-1.17) 0.09 
Anti-platelet 0.61 (0.42-0.88) <0.01 0.75 (0.49-1.15) 0.19 
Statin 0.78 (0.58-1.04) 0.10 - - 
ACEi/ARB 1.04 (0.80-1.36) 0.75 - - 





6.3.2 Secondary analysis 
Patients with heart rate >87 bpm had lower peak oxygen consumption, oxygen 
consumption at the anaerobic threshold and (VE/VCO2) ratios (table 6.3). Peak 
oxygen pulse, a measure of left ventricular stroke volume, was lower in patients 
with heart rate >87 bpm.398 Heart rate >87 bpm was not associated with oxygen 
consumption at the anaerobic threshold <11.1 ml/kg/min (OR 1.24 [0.98-1.59]; 
p=0.08) using univariable analysis. However, heart rate >87 bpm was 
associated with peak oxygen pulse <12 ml/beat (OR 2.80 [2.19-3.58]; p<0.01). 
Patients with heart rate ≤87 bpm had near normal predicted oxygen pulse, 
when expressed as a percentage of population-specific normal values (94.9% 
[93.0-96.9]). By contrast, percentage predicted peak oxygen pulse was (15.2% 
[12.3-18.1]) lower in patients with heart rate >87 bpm (p<0.01).  Patients with 
heart rate >87 bpm exhibited higher peak heart rates during CPET. Heart rate 
recovery, the longer duration of which reflects impaired parasympathetic 
reactivation following cessation of peak exercise, was prolonged in patients with 
heart rate >87 bpm.  
 
6.3.3 Sensitivity analysis 
In patients with heart failure and receiving beta-blockers, the prognostic 
threshold for peak oxygen consumption (≤12ml/kg/min) is lower than in patients 
not receiving beta-blockers. I performed a sensitivity analysis by repeating the 
primary univariable logistic regression using the lower threshold in patients 
taking beta-blockers (247/1250). However, association between impaired 





Table 6.3. Physiological and cardiopulmonary exercise test variables. Data stratified by resting heart rate >87 bpm, presented as frequencies 
with percentages (%) or means with standard deviations (SD). Hypothesis testing with t-test for continuous data and chi-squared test for categorical 
data. Heart rate (HR) data in >87 bpm, blood pressure data in millimetres of mercury (mmHg), rounded to the nearest whole number. Other units are 
shown. Oxygen consumption (VO2), carbon dioxide production (VCO2). 
 





Preoperative haemodynamic variables 
    Resting heart rate (bpm) 81 (16) 99 (10) 73 (10) <0.01 
Systolic blood pressure (mmHg) 146 (23) 147 (23) 145 (23) 0.23 
Diastolic blood pressure (mmHg) 82 (13) 84 (12) 81 (13) <0.01 
Pulse pressure (mmHg) 63 (20) 62 (20) 65 (19) 0.09 
Mean arterial pressure (mmHg) 102 (14) 104 (14) 101 (15) <0.01 
Preoperative CPET variables 
    VO2 at the anaerobic threshold (ml/kg/min) 11.3 (3.0) 11.2 (2.7) 11.4 (3.1) 0.21 
Peak oxygen consumption (ml/kg/min) 17.3 (5.0) 16.8 (4.8) 17.6 (5.1) <0.01 
VE/VCO2 at anaerobic threshold 31.6 (5.9) 32.7 (5.7) 31.1 (5.9) <0.01 
Peak oxygen pulse (ml/beat) 13.1 (3.4) 11.6 (2.9) 13.8 (3.5) <0.01 
Peak heart rate (bpm) 134 (23.0) 145 (19) 128 (23) <0.01 
Heart rate increase (bpm) 53 (21) 46.1 (20.3) 55.8 (21.1) <0.01 
Heart rate recovery (bpm) 16 (14) 13 (15) 18 (13) <0.01 






6.3.4 Preoperative left ventricular stroke volume 
I further examined cardiac function in a separate cohort of patients. 181 patients 
with mean age 68 years (SD 9) that underwent major surgery in the OPTIMISE 
and POM-O trials had complete beat-by-beat cardiac output monitor data 
available for analysis (figure 6.3). From both trials, patients with preoperative 
heart rate >87 bpm had lower mean preoperative stroke volume (mean 
difference 23.5 [8.0-38.9] ml; p=0.03). Preoperative heart rate >87 bpm was 
associated with impaired preoperative stroke volume <57ml (OR 3.21 [1.26-
8.20]; p=0.01), taking into account patients with an established preoperative 




Figure 6.2. STROBE diagram showing patients from the POM-O and OPTIMISE 
trials that were included in the post-hoc analysis of left ventricular function. 
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Table 6.4. Logistic regression analysis of patients in the POM-O and OPTIMISE 
trials. Univariable (unadjusted) and multivariable (adjusted) analyses for heart rate >87 bpm 
against impaired stroke volume (<57ml) and sub-clinical impaired stroke volume (impaired 
stroke volume in the absence of an existing diagnosis of heart failure). Multivariable analyses 
are adjusted for age >75 years, male gender and history of ischaemic heart disease. Results 
presented as odds ratios with 95% confidence intervals, with p-value. 
 
Characteristic odds ratio p-value 
Univariable analysis for impaired stroke volume 
 Heart rate >87 bpm  2.45 (1.10-5.47) 0.03 
   Univariable analysis for sub-clinical impaired stroke volume 
Heart rate >87 bpm  2.55 (1.09-5.99) 0.03 
   Multivariable analysis for impaired stroke volume  
Heart rate >87 bpm  3.09 (1.21-7.86) 0.02 
Age >75 years 1.64 (0.69-3.88) 0.26 
Male gender 0.63 (0.29-1.37) 0.24 
History of ischaemic heart disease 0.44 (0.15-1.30) 0.14 
   Multivariable analysis for sub-clinical impaired stroke volume  
Heart rate >87 bpm  3.21 (1.26-8.20) 0.01 
Age >75 years 1.43 (0.60-3.44) 0.42 
Male gender 0.58 (0.27-1.28) 0.18 
History of ischaemic heart disease 0.46 (0.16-1.34) 0.16 





6.4  Discussion 
The principal finding of this analysis is that resting preoperative heart rate >87 
bpm is associated with cardiopulmonary and parasympathetic autonomic 
impairment, compatible with physiologically significant heart failure. This 
pathophysiological phenotype was observed in up to one third of patients. 
However, only 4% of the cohort had a clinical diagnosis of heart failure 
syndrome, suggesting that the majority of these patients have sub-clinical or 
undiagnosed disease causing physiological limitation that is revealed by a 
standardised, incremental ramp exercise test. These findings are supported by 
an analysis of haemodynamic data from two other studies, where preoperative 
heart rate >87 bpm was associated with impaired left ventricular function. These 
data suggest that elevated preoperative heart rate, as observed in chapter 
three, is unlikely to be caused by an acute pathophysiological process, for 
example sepsis, anxiety or inflammation.387  Instead, my results offer a 
plausible explanation of how elevated preoperative heart rate might be related 
to increased risk of perioperative myocardial injury and mortality: through a 
phenotype of cardiopulmonary and autonomic impairment, indicative of sub-
clinical heart failure. This is consistent with previous reports confirming that 
patients with an established diagnosis of preoperative heart failure have 
substantially higher morbidity and mortality after non-cardiac surgery.349 
 
The temporality of the relationship between tachycardia and heart failure is 
unclear. However, evidence from the general population suggests that high 
heart rate might cause heart failure. In apparently healthy men and women, the 
risk of subsequently developing heart failure increases with increasing resting 
heart rate.158, 159 In the EPIC-Norfolk study, a 10 bpm increase in resting heart 
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rate was independently associated with an 11% increase in risk of developing 
heart failure.158 While the Rotterdam Study, which sampled 4768 apparently 
healthy volunteers over a 15-year period, demonstrated that in men each 10 
bpm increase in heart rate was associated with increased risk of developing 
heart failure, within six months after study enrolment.159 Similarly, a study of 
patients with supraventricular tachycardia suggests that sustained elevated 
heart rate can induce heart failure in the absence of structural heart disease.400 
Elevated heart rate also increases the risk of heart failure in the presence of 
established hypertension, coronary artery disease and valvular heart 
disease.401 Thus, elevated resting heart rate appears to be an independent risk 
factor for the development of heart failure in healthy older men in the general 
population. This gender bias mirrors the results of the VISION study, where 
male gender was an independent risk factor for MINS and mortality.  
 
The majority of the evidence in favour of association between heart rate and 
heart failure in the general population is derived from studies of heart failure 
syndrome, which requires a clinical diagnosis. My results suggest that sub-
clinical or undiagnosed physiological heart failure may be eight times more 
common than symptomatic heart failure syndrome. So it is possible that studies 
of apparently healthy volunteers, with results suggesting a causal link between 
tachycardia and heart failure, may have enrolled participants with pre-existing 
sub-clinical heart failure. This is consistent with the so called ‘Will Rogers 
phenomenon’, where the prevalence of a disease increases with introduction of 
a more sensitive diagnostic test, but the severity of the disease reduces due to 
earlier detection, thus giving the illusion of improved survival rates.402 However, 
in this case it is not possible to determine whether or not tachycardia in 
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participants that later developed clinical heart failure syndrome was caused by 
pre-existing sub-clinical heart failure. Or, in other words, the temporality of 
exposure and outcome cannot be determined. 
 
Several pathophysiological mechanisms could link resting heart rate, heart 
failure and perioperative myocardial injury. The predominant causal model of 
perioperative myocardial injury centres on myocardial oxygen supply-demand 
imbalance,96  and it seems intuitive that this could be induced by tachycardia 
through negative effects on coronary blood flow.96 However, my study identifies 
plausible alternative pathological explanations for the development of 
perioperative myocardial injury or mortality. At peak exercise, oxygen pulse is a 
surrogate measure of left ventricular stroke volume.398 Notably, the oxygen 
pulse measurements in patients with HR >87 bpm were similar to patients with 
mild-to-moderate heart failure,22 and data from cardiac output monitors suggest 
impaired left ventricular stroke volume in these patients. This is compatible with 
the hypothesis that heart rate is increased as result of low stroke volume, in 
order to maintain cardiac output - a relationship that is consistently seen in 
patients with heart failure.159 This hypothesis is further supported by the 
observed relationship between elevated heart rate and reduced oxygen 
consumption, which is independent of age, gender and heart disease in medical 
patients.403 Low stroke volume, and hence oxygen delivery, may be 
exacerbated by anaesthesia, leading to intraoperative hypotension and 
associated end-organ hypoperfusion - including myocardial injury.404 
Parasympathetic autonomic impairment can also be linked with cardiac 
ischaemia after non-cardiac surgery. Reduction in heart rate after peak exercise 
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- heart rate recovery - is due to parasympathetic reactivation during the first few 
minutes of recovery.405  
 
Reduced cardiac vagal activity can promote cardiac injury through several 
mechanisms.96, 406 First, inhibition of dorsal vagal motor neuronal stimulation in 
rats and mice reduces cardiac contractility, impairs exercise performance and 
up-regulates G-protein receptor kinase 2 (GRK2) and arrestin, which are also 
up-regulated in patients with heart failure.407 Similarly, baroreflex impairment, 
indicative of parasympathetic dysfunction, is associated with reduced cardiac 
contractility and GRK2 up-regulation in critical illness.186 Second, vagal 
inhibition promotes ischaemia/reperfusion injury and ventricular dysrhythmias, 
compared to low-level vagus nerve stimulation, leading to increased myocardial 
infarction size in dogs and rabbits.408, 409 Increased vagal tone, induced by high-
intensity interval training, reduces ventricular dysrhythmias in patients with heart 
failure.410 Third, vagal stimulation can inhibit the production of reactive oxygen 
species in mice and nicotinic acetylcholine receptor stimulation can inhibit TNF-
alpha, a pro-inflammatory cytokine, in cardiac myocytes.411, 412 
 
Using observations from the VISION study to plan physiological assessment 
using two independent approaches is a major strength of this analysis. The 
large number of patients and multi-centre nature of the POM-HR cohort give the 
results good external validity. Although increasing chronological age is 
associated with declining cardiopulmonary and autonomic function, 
multivariable logistic analysis found that the association between elevated heart 
rate and impaired cardiorespiratory performance was independent of age.413, 414 
There were also significant weaknesses, including the observational design, 
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which cannot, by definition, establish causality. I considered potential 
confounding factors by adjusting for various established clinical risk factors and 
cardiovascular drug therapy, for example beta-blockers, which are known to 
influence heart rate. Heart rate is mathematically coupled with some CPET 
variables, in particular, oxygen pulse at peak exercise is derived by dividing 
peak oxygen consumption by contemporaneous HR – so if HR is high then 
oxygen pulse will, by definition, be decreased.  However, it is notable that I 
have shown an association between raised HR prior to CPET and decreased 
oxygen pulse at peak. Moreover, an association between pre-CPET HR>87 and 
unfavourable CPET measures was also apparent for VO2 and VE/VCO2 at AT, 
variables which are not mathematically coupled to heart rate. There were no 
data regarding intraoperative vasopressor use, which could underestimate the 
extent and/or effect of clinically relevant hypotension on clinical outcomes. My 
results may be confounded by factors that were not measured; for example, I 
am unaware of the incidence of obstructive sleep apnoea in this sample, which 
is known to be associated with autonomic impairment.415, 416 
	
6.5 Conclusion 
In summary, elevated preoperative heart rate is associated with 
cardiopulmonary and autonomic impairment indicative of subclinical heart 
failure. Perioperative myocardial injury might at least partially be explained by 
subclinical cardiac failure. Further research targeting abnormal cardiovascular 
and autonomic phenotypes may improve clinical outcomes, including 




Chapter seven  
Heart rate recovery 
 
Parasympathetic autonomic dysfunction and myocardial injury 
after non-cardiac surgery: results of the METS study 
 
7.1  Introduction 
The pathophysiological mechanism underlying perioperative myocardial injury is 
uncertain. Myocardial injury is more frequent among patients with common 
cardiovascular risk factors, as defined by the Revised Cardiac Risk Index 
(RCRI).20, 95, 273 However, in this group of patients, several treatments for 
myocardial infarction that are routinely used in the non-operative setting do not 
prevent myocardial injury in the perioperative period.100, 101, 166 Similarly, the 
degree of atherosclerosis, measured using computed tomography coronary 
angiogram, correlates poorly with the risk of perioperative myocardial injury.394 
This suggests that while the pathophysiological mechanism responsible for 
perioperative myocardial injury is likely to be associated with the RCRI and its 
constituent risk factors, it is unlikely to be coronary atherosclerosis per se. 
 
I have previously identified that elevated heart rate before and during surgery is 
associated with perioperative myocardial injury, and that resting tachycardia 
before surgery is associated with parasympathetic autonomic dysfunction.273, 
274, 397 Parasympathetic autonomic dysfunction is a plausible candidate 
pathophysiological mechanism for myocardial injury, and is associated  with 
each cardiovascular risk factor in the RCRI, including: diabetes mellitus,179 
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ischaemic heart disease,180 cardiac failure,181 renal impairment182 and stroke.183, 
184 It has been implicated in the development of cardiovascular disease in the 
general population,417 principally due to the loss of cardio-protective vagal 
activity, which is known to increase production of nitric oxide418 and anti-
inflammatory cytokines,419 inhibit the renin-angiotensin axis420 and inhibit 
cardiac dysrhythmia formation.185 In the perioperative setting, two out of five 
high-risk patients are thought to have low baroreflex sensitivity or reduced heart 
recovery after preoperative exercise, suggesting a degree of parasympathetic 
impairment.178, 186 My data from chapter six suggests that one third of high-risk 
surgical patients are at risk of cardiopulmonary and autonomic dysfunction. This 
may be clinically significant, since there is some evidence that parasympathetic 
dysfunction is associated with clinically defined complications after surgery.178  
However, whether or not parasympathetic dysfunction is associated with 
biochemical myocardial injury after surgery remains untested. 
 
Data from previous chapters indicates that elevated preoperative heart rate and 
parasympathetic dysfunction may form part of a phenotype of sub-clinical heart 
failure that is prevalent in patients undergoing non-cardiac surgery, and which 
may promote myocardial injury. However, whether or not parasympathetic 
dysfunction is associated with perioperative myocardial injury has not been 
tested. I hypothesised that parasympathetic autonomic dysfunction, as defined 
by prolonged heart rate recovery after preoperative cardiopulmonary exercise 
testing, was associated with increased risk of myocardial injury after non-
cardiac surgery. I further hypothesised that previously identified CPET-derived 
markers of sub-clinical heart failure were associated with impaired heart rate 
recovery in this cohort. 
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7.2  Methods 
This was a pre-defined secondary analysis of the Measurement of Exercise 
Tolerance before Surgery (METS) study, an international prospective 
observational cohort study of preoperative assessment before non-cardiac 
surgery at twenty-three hospitals in Canada, the United Kingdom, Australia and 
New Zealand. I have described the study methods in chapter two and the study 
protocol was published previously.1 Participants were aged 40 years or older, 
undergoing elective non-cardiac surgery under general anaesthesia and/or 
regional anaesthesia. Researchers at each site collected a detailed and 
standardised dataset directly from participants and their medical records, before 
surgery, and at 30 days and one year after surgery.  
 
7.2.1  Cardiopulmonary exercise testing 
Each participant underwent preoperative symptom-limited cardiopulmonary 
exercise testing (CPET) using a standardised incremental ramp protocol on 
electromagnetically-braked cycle ergometers. The CPET protocol is described 
in detail in chapter two. Investigators at each site interpreted each CPET using 
a standardised case report form. CPET variables of interest included: peak 
oxygen consumption, anaerobic threshold, ventilatory equivalent for carbon 
dioxide, and heart rate recovery during the first minute after the end of exercise. 
Clinicians outside of the research team were blinded to the results of 
cardiopulmonary exercise testing, except where there was a safety concern 






7.2.2  Blood sampling 
Blood was sampled before surgery and on the first, second and third days after 
surgery, as long as the participant remained in hospital. In Canada, Australia 
and New Zealand, serum cardiac troponin (either I or T isoforms) was 
measured in preoperative and postoperative samples at local hospital 
laboratories, according to local policy. In the UK, serum cardiac troponin was 
measured in preoperative and postoperative samples at a single central 
laboratory. A summary of the troponin assays used at each centre is 
summarised in table 7.1. N-terminal pro-B-type natriuretic peptide (NT pro-BNP) 
was measured in all preoperative samples at a single central laboratory.  
 
7.2.3  Exposures of interest 
The exposure of interest was impaired heart rate recovery, defined as reduction 
in heart rate of less than or equal to twelve beats per minute during the first 
minute after the end of preoperative cardiopulmonary exercise testing. This 
threshold was previously identified as an independent predictor of mortality in 
both general and surgical cohorts.90, 186  
 
7.2.4  Outcome measures  
The primary outcome was myocardial injury, defined as postoperative troponin 
measurement greater than the limit of the reference range for any given assay 
(table 7.1), within 72 hours after surgery. Additional pre-defined explanatory 
outcomes were: preoperative NT pro-BNP >300pmol/L, a threshold used to 






Table 7.1. A summary of troponin assays used at each centre. The cut-off value is the limit of the normal range, above which the participant would be 
considered to have myocardial injury. 
 
Assay Cut-off value  Number of centres 
Troponin-I Abbott Architect Immunoassay >70 ng/L 1 
Troponin-I Abbott assay >20 ng/L 1 
Troponin-I Abbott high-sensitivity assay >25 ng/L 2 
Troponin-I Abbott high-sensitivity assay Males >25 ng/L, Females >15 ng/L 3 
Troponin-I Beckman-Coulter assay >30 ng/L 3 
Troponin-I Centaur CP high-sensitivity assay >40 ng/L 8 
Troponin-T Roche high-sensitivity (STAT) assay >14 ng/L 4 
Troponin-T Roche high-sensitivity assay >29 ng/L 1 





7.2.5 Statistical analysis 
The analysis was planned before taking custody of the data. I used STATA 
version 14 (STATACorp LP, Texas, USA). The small number of participants 
without a record of heart rate recovery or missing covariates were excluded. 
The sample was ranked by heart rate recovery at one minute after the end of 
incremental exercise and dichotomised according to a threshold of ≤12 beats 
per minute. This threshold is prognostically associated with subsequent 
cardiovascular morbidity in the general population.90 Baseline characteristics for 
the whole cohort were presented and stratified by heart rate recovery. Normally 
distributed data were expressed as mean ± standard deviation (SD) and non-
normally distributed data were expressed as median ± interquartile range (IQR). 
Binary data were expressed as percentages. 
 
I used univariable logistic regression analysis to test for association between 
impaired heart rate recovery and myocardial injury. Next, using a previously 
published method for stratifying patients at risk of perioperative myocardial 
injury, the cohort were divided into three groups according to Revised Cardiac 
Risk Index (low-risk [RCRI 0 points], intermediate-risk [RCRI 1-2 points] or high-
risk [RCRI 3-6 points]), which represents multiple cardiovascular risk factors 
known to be associated with perioperative myocardial injury.16, 20, 21, 95, 273, 275, 422 
A multivariable logistic regression model for the association between impaired 
heart rate recovery and myocardial injury was constructed and adjusted for 
Revised Cardiac Risk Index, where the low-risk group was considered the 
reference category. Finally, the multivariable logistic regression model was 
adjusted for component cardiovascular risk factors of the RCRI, including: 
coronary artery disease, congestive cardiac failure, diabetes mellitus requiring 
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insulin therapy and preoperative renal impairment (creatinine >177 µmol/L).20, 
422 The results of logistic regression analyses were presented as odds ratios 
(OR) with 95% confidence intervals. The threshold for statistical significance 
was p≤ 0.05. 
 
7.2.6 Secondary analysis 
I presented both mean heart rate recovery and the proportion of participants 
with impaired heart rate recovery for each RCRI group and used univariable 
logistic regression to test for association between RCRI-defined risk groups and 
impaired heart rate recovery, where the lowest-risk group was considered the 
reference category. Mean heart rate recovery and the proportion of participants 
with impaired heart rate recovery stratified by NT pro-BNP were presented, 
using groups identified in the VISION study (unpublished). A relationship 
between impaired preoperative heart rate recovery and sub-clinical heart failure 
was previously described in chapter six.397  To explore whether impaired 
preoperative heart rate recovery is associated with a phenotype of heart failure 
in this cohort, the primary analysis was repeated for the following outcome 
measures, which are biomarkers known to be predictive of poor clinical 
outcome in overt heart failure: NT pro-BNP >300 pg/mL, VO2 peak ≤14 
ml/kg/min and VE/VCO2 at the anaerobic threshold ≥34.397  
 
7.2.7 Sensitivity analysis 
To take account of potential confounding by heart rate limiting medications, the 
primary analysis was repeated including heart rate limiting cardiovascular 
medications (beta-blockers and calcium channel antagonists) as covariates.
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7.3  Results 
1741 patients were recruited into the METS study between February 2013 and 
March 2016. After excluding participants that did not undergo preoperative 
cardiopulmonary exercise testing, did not proceed to surgery or had missing 









Table 7.2. Baseline patient characteristics. Descriptive data stratified by preoperative 
heart rate recovery (HRR) ≤12 beats per minute in the first minute after the end of 
cardiopulmonary exercise testing. Data are presented as frequencies with percentages (%) or 
means with standard deviations (SD). Continuous data are reported to one decimal place and 
categorical data are rounded to the nearest whole number. ASA = American Society of 
Anesthesiologists. 
	
  Whole cohort HRR ≤12 HRR >12 
Number of cases 1325 547 778 
Age 64.2 (10.3) 66.7 (10.0) 62.5 (10.2) 
Male sex (%) 815 (61.5) 314 (57.4) 501 (64.4) 
Pre-existing conditions (%) 
   Atrial fibrillation 49 (3.7) 22 (4.0) 27 (3.5) 
Diabetes 247 (18.6) 125 (22.9) 122 (15.7) 
Hypertension 725 (54.7) 336 (61.4) 389 (50.0) 
Heart failure 17 (1.3) 11 (2.0) 6 (0.8) 
Ischaemic heart disease 152 (11.5) 83 (15.2) 69 (8.9) 
Peripheral vascular disease 37 (2.8) 17 (3.1) 20 (2.6) 
Cerebrovascular disease 54 (4.1) 28 (5.1) 26 (3.3) 
Chronic obstructive pulmonary disease  155 (11.7) 81 (14.8) 74 (9.5) 
Preoperative creatinine >177 µmol/L  100 (7.6) 43 (7.9) 57 (7.3) 
Surgical procedure type (%) 
   Vascular  25 (1.9) 14 (2.6) 11 (1.4) 
Intra-peritoneal or retroperitoneal 434 (32.8) 178 (32.5) 256 (32.9) 
Urological or gynaecological 397 (30.0) 160 (29.3) 237 (30.5) 
Intra-thoracic 30 (2.3) 11 (2.0) 19 (2.4) 
Orthopaedic 312 (23.6) 131 (24.0) 181 (23.3) 
Head and neck 82 (6.2) 34 (6.2) 48 (6.2) 
Other 45 (3.4) 19 (3.5) 26 (3.4) 
High-risk surgery (%) 749 (56.5) 310 (56.7) 439 (56.4) 
ASA grade (%) 
   I 99 (7.5) 33 (6.0) 66 (8.5) 
II 779 (58.9) 302 (55.3) 477 (61.4) 
III 427 (32.3) 203 (37.2) 224 (28.8) 
IV 18 (1.4) 8 (1.5) 10 (1.3) 
Preoperative medication (%) 
   Beta-blockers 215 (16.2) 120 (21.9) 95 (12.2) 
Diltiazem or Verapamil 26 (2.0) 14 (2.6) 12 (1.5) 
Insulin therapy 54 (4.1)  26 (4.8) 28 (3.6)  
Revised cardiac risk index    
0 419 (31.6) 167 (30.5) 252 (32.4) 
1 - 2 870 (65.7) 354 (64.7) 516 (66.3) 
≥ 3 36 (2.7) 26 (4.8) 10 (1.3) 







7.3.1 Primary analysis 
Heart rate recovery ≤12 bpm was recorded in 547/1325 patients (41.3%). 
Across the whole cohort 168/1325 (12.7%) patients sustained myocardial injury 
(table 7.2), compared to 85/547 (15.5%) patients with HRR ≤12 bpm and 
83/778 (10.7%) patients with HRR >12 bpm (odds ratio (OR) 1.54 [1.11-1.23]; 
p<0.01; table 7.3).  
 
Table 7.3. Impaired heart rate recovery and myocardial injury. The independent 
variable was impaired heart rate recovery (≤12 beats per minute within the first minute after the 
end of incremental exercise). The dependent variable was myocardial injury within 72 hours 
after the end of surgery. Results of three separate analyses are presented. First, univariable 
(unadjusted) logistic regression analysis. Second, multivariable logistic regression adjusting for 
Revised Cardiac Risk Index (RCRI) as an ordered categorical variable. Third, multivariable 
logistic regression analyses adjusting for component cardiovascular risk factors of the RCRI, 
which are included as separate terms in the model. Results are presented as odds ratios with 



























7.3.2 Secondary analyses 
The proportion of participants with heart rate recovery ≤12 bpm increased with 
higher Revised Cardiac Risk Index score (Figure 7.2A). Similarly, mean heart 
rate recovery progressively declined in patients with increasing frequency of 
RCRI-defined risk factors (Figure 7.2B).  Participants with three or more RCRI-
defined cardiovascular risk factors were more likely to have impaired heart rate 
recovery compared to those with none (RCRI ≥3: 26/36 [72.2%] versus 
RCRI=0: 167/419 [39.9%]; OR 3.92 [1.84-8.34]; p<0.01). The proportion of 
participants with heart rate recovery ≤12 bpm increased with increasing 
concentrations of preoperative NT pro-BNP (Figure 7.3A). Mean heart rate 
recovery declined in patients with increasing concentrations of preoperative NT 
pro-BNP (Figure 7.3B). Elevated preoperative NT pro-BNP (>300 pg/mL) was 
measured in 207/1325 patients (15.6%), of whom only 11/207 (5.3%) had a pre-
existing clinical diagnosis of heart failure.  
 
Cardiopulmonary performance stratified by heart rate recovery is shown in table 
7.4. Heart rate recovery ≤12 bpm was associated with preoperative NT pro-BNP 
>300pg/mL (OR 1.85 [1.36-2.51]; p<0.01), VE/VCO2 ≥ 34 (OR 2.20 [1.74-2.77]; 
p<0.01) and VO2 peak ≤ 14 (OR 3.11 [2.34-4.13]; p<0.01) adjusted for RCRI 
(table 7.5). Mean heart rate recovery was lower in participants with resting heart 
rate >87 bpm (11.7 [9.7] versus 16.1 [12.7]; p<0.01). Participants with impaired 
heart rate recovery were more than twice as likely to have preoperative heart 









Figure 7.2. Bar charts showing (A) the proportion (%) of participants with heart 
rate recovery (HRR) less than or equal to 12 beats per minute, and (B) mean 
heart rate recovery (beats per minute), stratified by the Revised Cardiac Risk 
Index. Error bars indicate the 95% confidence interval. 167/419 patients with RCRI = 0 had 
heart rate recovery ≤ 12 beats per minute, 354/870 patients with RCRI = 1-2 had heart rate 
recovery ≤ 12 beats per minute and 26/36 patients with RCRI ≥ 3 had heart rate recovery ≤ 12 
beats per minute. The proportion of patients with heart rate recovery ≤ 12 beats per minute was 





Figure 7.3. Bar charts showing (A) the proportion (%) of participants with heart 
rate recovery (HRR) less than or equal to 12 beats per minute, and (B) mean 
heart rate recovery (beats per minute), stratified by NT Pro-BNP concentration. 
263/719 (36.6%) patients with NT Pro-BNP ≤100 pg.mL-1 had heart rate recovery ≤ 12 beats per 
minute, 119/291 (40.9%) patients with NT Pro-BNP 100-199 pg.mL-1 had heart rate recovery ≤ 
12 beats per minute and 165/315 (52.4%) patients with NT Pro-BNP ≤100 pg.mL-1 had heart 




Table 7.4. Cardiopulmonary exercise test variables stratified by impaired heart 
rate recovery. Impaired heart rate recovery was defined as ≤12 beats per minute within the 
first minute after the end of incremental exercise. Continuous variables were presented as 
means with standard deviations and categorical variables were presented as frequency (n) with 
percentage (%). Hypothesis testing for difference in means used a two-tailed unpaired t-test. 
VO2 = oxygen consumption, VCO2 = carbon dioxide production, VE = minute ventilation, RER = 
respiratory exchange ratio.  
 
  Whole cohort HRR ≤12 HRR >12 p-value 
Resting heart rate >87 beats/min, n (%) 310 (23.4) 178 (32.5) 132 (17.0) <0.01 
Oxygen pulse at rest (ml/beat) 4.7 (2.4) 4.4 (2.0) 5.0 (2.6) <0.01 
VO2 peak (ml/kg/min) 19.3 (6.4) 17.1 (5.6) 20.8 (6.5) <0.01 
Heart rate at VO2 peak (bpm) 134 (24) 127 (25) 139 (21) <0.01 
Oxygen pulse at VO2 peak (ml/beat) 12.3 (4.4) 11.6 (4.3) 12.8 (4.3) <0.01 
VO2 at anaerobic threshold (ml/kg/min) 12.7 (4.1) 11.6 (3.4) 13.4 (4.4) <0.01 
VE/VCO2 at the anaerobic threshold 31.8 (5.6) 33.3 (6.2) 30.8 (5.0) <0.01 
VE/VO2 at the anaerobic threshold 29.0 (6.0) 30.3 (6.7) 28.1 (5.3) <0.01 
RER at end of exercise 1.14 (0.14) 1.12 (0.14) 1.16 (0.13) <0.01 








Table 7.5. Impaired heart rate recovery and markers of heart failure. The independent variable was impaired heart rate recovery (≤12 beats per minute 
within the first minute after the end of incremental exercise). The dependent variables were NT pro-BNP >300 pg/mL, ventilatory equivalent for carbon dioxide 
(VE/VCO2) at the anaerobic threshold ≥ 34 and peak oxygen consumption (VO2) ≤ 14ml/kg/minute. Results of univariable (unadjusted) and multivariable (adjusted) 
logistic regression analyses are presented as odds ratios with 95% confidence intervals and associated p-values. Multivariable analyses were adjusted for Revised 
Cardiac Risk Index (RCRI). 
 
	
  NT pro-BNP >300 pg.mL-1 VE/VCO2 ≥34 VO2 peak ≤14 ml/kg/min 
Covariates odds ratio p-value odds ratio p-value odds ratio p-value 
Univariable analysis 
      Heart rate recovery ≤12 beats per minute 1.98 (1.47-2.68) <0.01 2.16 (1.71-2.71) <0.01 3.17 (2.39-4.20) <0.01 
       Multivariable analysis 
      RCRI - - - - - - 
0 (reference) - - - - - - 
1-2 1.23 (0.87-1.72) 0.24 0.86 (0.67-1.10) 0.23 0.97 (0.72-1.32) 0.86 
≥3 6.41 (3.11-13.22) <0.01 0.55 (0.26-1.16) 0.11 1.72 (0.82-3.62) 0.15 
Heart rate recovery ≤12 beats per minute 1.85 (1.36-2.51) <0.01 2.20 (1.74-2.77) <0.01 3.11 (2.34-4.13) <0.01 





7.3.3 Sensitivity analyses 
When I corrected the primary analysis for heart rate-limiting medication, the 
results were similar to the primary analysis (table 7.6).	
 
 
Table 7.6. Impaired heart rate recovery and myocardial injury. Sensitivity analysis 
adjusting for heart rate limiting cardiovascular medications. The independent variable was 
impaired heart rate recovery (≤12 beats per minute within the first minute after the end of 
incremental exercise). The dependent variable was myocardial injury within 72 hours after the 
end of surgery. Results of univariable (unadjusted) and multivariable (adjusted) logistic 
regression analyses are presented as odds ratios with 95% confidence intervals and associated 
p-values. Multivariable analyses were included age >70 years and Revised Cardiac Risk Index 
(RCRI) as covariates.  
	
	
  Myocardial Injury 
Covariates odds ratio p-value 
Univariable analysis 
  Heart rate recovery ≤12 beats per minute 1.54 (1.11-2.13) <0.01 
   Multivariable analysis   
RCRI - - 
0 (reference) - - 
1-2 0.70 (0.50-0.99) 0.05 
≥3 1.40 (0.61-3.20) 0.42 
Preoperative beta-blockers 1.60 (1.07-2.39) 0.02 
Preoperative diltiazem or verapamil 1.66 (0.61-4.50) 0.32 
Heart rate recovery ≤12 beats per minute 1.43 (1.02-1.99) 0.03 





7.4  Discussion 
The principal finding of this analysis was that impaired heart rate recovery after 
exercise, a marker of parasympathetic autonomic dysfunction, was associated 
with myocardial injury within the first 72 hours after non-cardiac surgery. I 
identified parasympathetic dysfunction using a heart rate recovery threshold 
that is associated with cardiovascular morbidity and mortality in the general 
population. These results are consistent with evidence from another surgical 
cohort that impaired heart rate recovery after preoperative exercise is 
associated with poorer postoperative clinical outcomes.178, 186 In addition, 
participants with three or more cardiovascular risk factors, as defined by the 
Revised Cardiac Risk Index, had significantly lower heart rate recovery 
compared to participants with two or fewer cardiovascular risk factors. This 
supports my hypothesis that preoperative cardiovascular risk factors are 
pathophysiologically linked to myocardial injury through a common underlying 
mechanism involving parasympathetic autonomic dysfunction. It may also 
explain why many of these risk factors have been repeatedly associated with 
perioperative myocardial injury, even though the cumulative risk is not 
dependent on the specific variables incorporated into the RCRI.16, 95, 273, 275, 397 
In keeping with my findings from chapter six, parasympathetic dysfunction was 
associated with elevated resting heart rate, as well as CPET and plasma 
biomarker evidence of sub-clinical heart failure.397 This suggests that resting 
tachycardia, parasympathetic dysfunction and sub-clinical heart failure may all 
be part of the same preoperative phenotype. However, I am unable to establish 
the temporality of exposures and since my data are observational in nature, it is 
not possible to define a causal chain.  
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It is possible that tachycardia is the predominant pathophysiological 
mechanism, causing heart failure and myocardial injury. Evidence from cohort 
studies in the general population indicate that elevated heart rate is associated 
with later development of heart failure,158, 159 while sustained tachycardia in 
healthy volunteers and patients with hypertension and ischaemic heart disease 
induces cardiac impairment.400, 401 However, since heart rate is regulated by the 
autonomic nervous system, it seems counterintuitive that tachycardia could 
induce autonomic nervous system dysfunction.85, 423, 424  
 
Alternatively, primary heart failure may cause tachycardia, autonomic 
dysfunction and myocardial injury. Poor left ventricular function can drive 
elevation in heart rate to maintain cardiac output, so it is reasonable to conclude 
that tachycardia is marker of heart failure, sub-clinical or otherwise.60, 75 In 
addition, autonomic dysfunction is common in patients with established heart 
failure and patients with CPET evidence of physiological cardiac impairment.70, 
71 In this chapter I have shown that autonomic dysfunction is associated with 
objective biomarker evidence of heart failure.421  Changes in cardiac vagal tone 
are evident from the very early stages of left ventricular impairment, both in 
terms of ganglionic activity and distribution and concentration of muscarinic 
receptors.185 However, while there is growing experimental evidence that 
autonomic nervous system dysfunction plays an important role in the early 
development of heart failure425 it remains unclear whether autonomic 
dysfunction arises in response to heart failure or causes heart failure.  
Alternatively, the preoperative phenotype I have observed may be multi-factorial 




Parasympathetic dysfunction is a plausible pathophysiological mechanism for 
perioperative myocardial injury, and may offer an explanation of the association 
between elevated preoperative heart rate and myocardial injury (chapter three). 
Parasympathetic dysfunction drives resting tachycardia and is common in 
patients with heart failure.185 It is prevalent in people with cardiovascular 
disease,337, 426, 427 in patients with known risk factors for perioperative 
myocardial injury,179-184  and is associated with subsequent mortality in these 
groups.93 Baroreflex impairment, a marker of parasympathetic dysfunction, 
occurs in over 40% of high-risk surgical patients and is associated with 
postoperative cardiovascular complications.178 Parasympathetic activity, via the 
cardiac vagus nerve, protects the heart through several mechanisms182, 349, 427, 
428 previously discussed in chapter six, including: increased cardiac contractility 
and down-regulation of GRK2186, 407  and arrestin;407 inhibition of dysrhythmias 
and ischaemic/reperfusion injury;408-410 and inhibition of reactive oxygen species 
and pro-inflammatory cytokine production. 411, 412 Loss of this protection may 
predispose patients with cardiopulmonary and autonomic impairment, as I have 
observed, to myocardial injury.213, 363, 427, 428  
 
Parasympathetic dysfunction could cause myocardial injury through at least 
three potential mechanisms. Firstly, vagal activity - regulated by the dorsal 
motor nucleus - is a key determinant of aerobic exercise capacity.407 Inability to 
increase cardiac output during surgery, mediated by the vagus nerve, could 
explain the association between parasympathetic dysfunction and increased 
risk of myocardial injury after surgery.407 In experimental models, impaired 
parasympathetic function is associated with nicotinamide adenine dinucleotide 
phosphate oxidase subunit-2-mediated up-regulation of G-protein-coupled 
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receptor kinase 2 expression in cardiomyocytes, which impairs cardiac 
contractility.186 This may explain, in part, the observed phenotype of sub-clinical 
heart failure in these patients. Secondly, parasympathetic activity may have 
anti-inflammatory effects, limiting myocardial injury in several experimental 
models.429, 430 Since efferent431 and afferent432 vagal nerve activity can reduce 
inflammation, via acetylcholine433 and vasoactive intestinal peptide434 release. 
This is consistent with data from surgical patients with reduced heart rate 
recovery who exhibit elevated neutrophil-lymphocyte ratios, a marker of chronic 
inflammation that is associated with perioperative cardiovascular morbidity and 
mortality.435 Similarly, preoperative baroreflex dysfunction is associated with 
increased risk of infectious complications after major surgery.178 Finally, cardiac 
vagal activity can attenuate the propagation of cardiac arrhythmias, including 
atrial fibrillation, which are associated with plasma troponin elevation.436, 437  
 
This analysis has several strengths. Firstly, the prospective, international, multi-
centre design makes the results generalisable to the majority of intermediate to 
high-risk patients undergoing non-cardiac surgery. Secondly, the primary 
outcome, myocardial injury, is an objective biochemical indicator of myocardial 
injury. The METS study was designed as a pragmatic observational study of 
preoperative assessment and took a pragmatic approach to outcome 
assessment. Thus outside of the UK, where all biomarker measurements were 
carried out at a central laboratory, troponin measurements were carried out at 
each participating hospital. This resulted in a variety of troponin assays being 
used. So while this is reflective of worldwide clinical practice and is likely to 
boost generalisability of the results, the consistency of outcome assessment 
between centres is less robust than for the VISION study, where identical 
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troponin assays were used.  Other limitations of this analysis include the 
observational design, precluding any conclusions regarding causality. 
Cardiopulmonary exercise tests in the METS study were conducted at multiple 
hospitals using a variety of apparatus and interpreted by investigators at each 
hospital, which introduces the potential for measurement error and/or observer 
bias. However, this was mitigated by the prospective use of a standardised 
exercise testing protocol and interpretation guidelines as well as a standard 
case report form for collecting exercise test data.1  The addition of 
intraoperative hemodynamic data would add further insight into the relationship 
between parasympathetic autonomic dysfunction, impaired aerobic capacity 
and hypotension, which is associated with perioperative myocardial injury. 
Although previous studies have established that impaired heart rate recovery is 
strongly associated with other measures of parasympathetic autonomic 
dysfunction, the lack of other autonomic measures in this study limits 




Parasympathetic autonomic dysfunction, characterised by impaired heart rate 
recovery after preoperative exercise testing, is associated with myocardial injury 
after non-cardiac surgery; and globally impaired cardiopulmonary performance 
and elevated plasma NT pro-BNP, indicative of sub-clinical heart failure, which 
was present in 15% of patients. These data suggest that parasympathetic 
autonomic dysfunction is a plausible mechanism that contributes to 





Chapter eight  
Conclusions and future work 
 
In this thesis I set out to identify modifiable cardiovascular risk factors for 
perioperative myocardial injury using epidemiological methods. Observations 
from the general population and from patients with heart failure were tested in 
five perioperative cohorts. While it was possible to identify haemodynamic risk 
factors for perioperative myocardial injury, the preoperative phenotype of 
patients at risk of myocardial injury remains complex. My results suggest that 
elevated preoperative heart rate, impaired autonomic function and subclinical 
heart failure are part of the same preoperative phenotype, which may be 
present in one in six patients undergoing in-patient non-cardiac surgery. 
However, the underlying pathophysiology remains unclear. Further research is 
needed to describe the pathological processes responsible for myocardial 
injury, which may include parasympathetic autonomic dysfunction and/or sub-
clinical heart failure, and to help target novel therapeutic strategies for those 
patients who are most at risk. 
 
8.1  Summary of results 
Myocardial injury occurs in 10-40% of patients undergoing non-cardiac surgery, 
depending on the definition; it is predominantly asymptomatic and without 
diagnostic ischaemic features; and is strongly associated with death.16, 103, 115 
Data from the general population suggest that patients with elevated heart rate 
or blood pressure are at greater risk of major cardiac events and death.152, 153, 
156, 157, 332, 333 Using data from the international, multi-centre VISION cohort, I 
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found that patients with high heart rate before surgery had increased risk of 
myocardial injury and patients with low heart rate before surgery had reduced 
risk of myocardial injury. These findings were replicated using data collected 
during surgery, where patients with high heart rate, or high or low systolic blood 
pressure during surgery were at greater risk of myocardial injury, compared to 
those without heart rate or blood pressure abnormality. Conversely, patients 
with a low heart rate during surgery were at lower risk of myocardial injury. 
These results were independent of potentially confounding factors such as 
urgency of surgery, older age or ischaemic heart disease, and support the 
hypothesis that tachycardia promotes myocardial injury through imbalance 
between myocardial oxygen supply and demand. However, since interventional 
trials of heart rate limiting medication, like beta-blockers, have failed to reduce 
the risk of myocardial injury, it may be more likely that elevated heart rate is a 
marker of another pathophysiological mechanism that causes myocardial injury. 
 
There is uncertainty among anaesthetists and surgeons regarding the 
management of hypertension before surgery, which may result in cancelled 
procedures.92, 189, 190 In the general population elevated arterial pulse pressure 
is associated with cardiovascular complications.147, 213, 370 In chapter four, 
VISION study data were used to identify that elevated preoperative pulse 
pressure was associated with increased risk of perioperative myocardial injury, 
independent of previous history of hypertension and preoperative systolic blood 
pressure. Therefore, patients with elevated pulse pressure may warrant closer 




In the general population, elevated resting heart rate is associated with 
subsequent development of heart failure,158, 159 which is risk factor for 
perioperative morbidity and mortality.349, 350 Cardiopulmonary exercise testing 
can identify cardiopulmonary and/or autonomic impairment, and is used for 
prognostication in patients with heart failure syndrome,70, 71, 438 as well as risk 
assessment before surgery.1 In chapter six, cardiopulmonary exercise testing 
was used to identify cardiopulmonary and autonomic impairment in patients 
undergoing high-risk non-cardiac surgery, identifying that elevated preoperative 
heart rate was associated with impaired cardiopulmonary and autonomic 
function, suggestive of heart failure. However, only a small proportion of these 
patients had a clinical diagnosis of heart failure syndrome. In a separate cohort 
of high-risk patients undergoing abdominal surgery, elevated preoperative heart 
rate was associated with impaired left ventricular stroke volume. Taken 
together, these findings suggest that preoperative tachycardia is a marker of 
subclinical or undiagnosed heart failure. 
 
Approximately one in three high-risk surgical patients have impaired autonomic 
function.178 In the general population this is associated with elevated resting 
heart rate.92 In chapter seven, preoperative cardiopulmonary exercise testing 
was used to identify patients with impaired parasympathetic autonomic function 
in a prospective international multi-centre observational cohort, where 
parasympathetic dysfunction was associated with postoperative myocardial 
injury, elevated resting heart rate and CPET and plasma biomarker evidence of 
heart failure. This suggests that elevated resting heart rate, parasympathetic 




In summary, I have identified that elevated heart rate before and during surgery, 
elevated preoperative pulse pressure, both very high and very low systolic 
blood pressure during surgery, and impaired heart rate recovery after 
preoperative exercise are associated with increased risk of perioperative 
myocardial injury. Furthermore, elevated preoperative heart rate is associated 
with parasympathetic dysfunction and objective evidence of sub-clinical 
physiological heart failure, which mirrors evidence from studies of the general 
population. This suggests that in surgical patients, elevated preoperative heart 
rate, impaired parasympathetic function and subclinical heart failure are likely to 
be part of the same preoperative phenotype, which may be present in 
approximately 15% of patients undergoing non-cardiac surgery. Furthermore, it 
is not possible to determine whether or not the observed associations reflect 
causal relationships. Therefore, further research is needed to characterise the 
underlying pathophysiological mechanism of perioperative myocardial injury 
and to develop novel, and potentially personalised, therapeutic approaches to 
treating these patients.  
 
	
8.2  Strengths and weaknesses 
The research described in this thesis has several strengths. Firstly, the 
explanatory (research question driven) analysis strategy, where analyses were 
planned before taking custody of the data, reduces both analytical and reporting 
biases. In the small number of cases where exploratory analyses were 
undertaken (for example, in some of the analyses of the POM-HR data), these 
were clearly labelled as post-hoc. Secondly, in contrast to the majority of 
previous studies in this field, the primary outcome of interest was myocardial 
injury, defined according to the objective measurement of cardiac troponin, 
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rather than a clinically defined outcome measure. This reduced the influence of 
observer bias due to the subjective assessment and interpretation of clinical 
data. Thirdly, I was fortunate to have access to data from the VISION study, 
one of the largest prospective observational cohort studies in the field of 
anaesthesia and perioperative medicine.16, 115 This was the landmark study that 
identified and defined myocardial injury after non-cardiac surgery (MINS). 
Therefore, when undertaking research into potential risk factors for MINS, it was 
helpful to use the original derivation cohort that was used to initially describe 
this phenomenon. The standardised and detailed nature of the VISION dataset, 
combined with the very large sample size, allowed statistical adjustments for 
potentially confounding factors to be made. This is important because there are 
several factors that could potentially explain the observed relationships between 
the variables of interest and MINS, which have been accounted for. Due to the 
international multi-centre study design, the results are generalisible to a wide 
spectrum of patients undergoing non-cardiac surgery worldwide.  Fourthly, the 
secondary hypotheses relating to sub-clinical heart failure, which further the 
analysis and support my interpretation of the results, were tested in multiple 
datasets, utilising several different diagnostic modalities, including: exercise 
testing, objective measurement of left ventricular stroke volume and objective 
measurement of cardiac biomarkers (NT pro-BNP).  
 
My approach also has several weaknesses. Firstly, the data included here are 
observational in nature. Therefore, it is not possible to draw conclusions 
regarding causative mechanisms. Further research is required to confirm my 
thesis. Secondly, the results are generated from secondary analyses of data 
collected for other purposes. Common limitations of this approach are that 
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important covariates may be absent or that complete data may not be available 
for a sub-population of interest.268 However, due to the standardised and 
detailed nature of case report forms for the studies in question, the risk of this is 
low. In the VISION study, some information regarding intraoperative 
medications and cardiac function were unavailable. However, it is unlikely that 
this adversely affected the interpretation of the results. Furthermore, this 
methodological approach is a principal strength of the analysis, in that it was 
possible to answer the research questions through efficient use of data that 
would otherwise be wasted. Thirdly, the analyses were adjusted for multiple 
potential confounding factors. However, in common with any clinical research, 
there is a risk of further confounding by unmeasured factors. Fourthly, in the 
VISION study, measurements of heart rate and blood pressure were made by 
clinical staff according to local policy at participating hospitals, so were not 
standardised. However, this could be viewed as a strength, since these 
pragmatic data reflect ‘real world’ clinical practice, which increases the external 
validity of the results. Finally, in the METS and POM-HR studies, while 
cardiopulmonary exercise tests were carried out according to standardised 
protocols, the interpretation of the tests was carried out by clinicians at each 
individual hospital and were not standardised. Therefore the results may be 
influenced by inter-observer variation in the interpretation of key exercise test 
variables. However, similar to measurement of heart rate in the VISION study, 
these data reflect local practice at each hospital and increase the external 







8.3 Directions for future research 
I have identified that elevated preoperative heart rate and pulse pressure, high 
or low intraoperative systolic blood pressure, elevated intraoperative heart rate, 
and impaired heart rate recovery after preoperative exercise are all associated 
with increased risk of perioperative myocardial injury. In addition, there is a, 
hitherto unrecognised, group of surgical patients with a phenotype of subclinical 
heart failure. However, before proposing therapeutic strategies for prevention 
and treatment of myocardial injury and subclinical heart failure, further research 
is required in order to better understand the population of patients at risk and to 
investigate the underlying pathophysiology. 
 
The pathophysiological mechanism(s) responsible for perioperative myocardial 
injury are unclear. In the majority of cases it is unlikely to be atherosclerotic 
plaque rupture and subsequent thrombosis, typically seen with acute coronary 
syndrome. Objective measures of atherosclerosis correlate poorly with 
perioperative myocardial injury,394 and standard treatments for acute coronary 
syndrome, for example angioplasty or aspirin, do not prevent perioperative 
cardiac events when given prophylactically.100, 101 Instead, opinion leaders 
support a putative mechanism of oxygen supply-demand imbalance due to the 
combination of a fixed flow limitation in the coronary arteries and increased 
demand in respiring cardiac muscle.96 My results support this hypothesis, since 
tachycardia, hypertension and hypotension could all plausibly contribute to 
increased oxygen demand in the myocardium. However, treatment with the 
negatively chronotropic agents beta-blockers or clonidine fails to reduce the 
incidence of myocardial injury, leaving two explanations. Firstly, 
pathophysiological mechanisms other than tachycardia-induced oxygen supply-
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demand imbalance are involved in the development of perioperative myocardial 
injury. This is supported by data from chapters six and seven, which identify 
that autonomic dysfunction, defined according to impaired heart rate recovery, 
is associated with myocardial injury and that elevated preoperative heart rate is 
associated with a preoperative phenotype of sub-clinical heart failure. However, 
further research is required to understand if, and how, impairment of autonomic 
and cardiopulmonary function contributes to myocardial injury and subsequently 
how this may be exploited as a therapy. The second possible explanation is that 
in the previous trials of negative chronotropes (principally beta-blockers), the 
treatment may not have been targeted with sufficient precision to elicit safe 
treatment effect due to an incomplete understanding of the population of 
patients at risk. This hypothesis seems intuitive since, compared to other 
pathologies, very little is known about perioperative myocardial injury. 
Therefore, it is conceivable that were negative chronotropes to be targeted at a 
narrower subgroup of the surgical population than in previous trials, according 
to a particular ‘at-risk’ phenotype (e.g. elevated heart rate, sub-clinical heart 
failure, parasympathetic dysfunction), a treatment effect may be identified that 
outweighs previously observed side effects. Therefore, further research is 
required to determine whether abnormal heart rate and blood pressure, as 
described in this thesis, represent causal risk factors for myocardial injury, and 
whether these biomarkers could be used to identify patients at risk of 
perioperative morbidity and/or as a target for novel treatments. 
 
The primary outcome of interest was myocardial injury, defined according to 
increased concentrations of cardiac troponins in postoperative blood samples. 
This outcome measure was chosen because it is very common, occurring in 
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approximately one in ten patients undergoing non-cardiac surgery. It is 
predominantly asymptomatic, therefore affecting patients without their 
knowledge or that of their clinicians, and is strongly associated with subsequent 
postoperative mortality.16, 95, 115 For these reasons, there is growing interest in 
routine postoperative screening for myocardial injury.387, 439 However, the 
mechanism of mortality following myocardial injury is unknown and it is unclear 
whether myocardial injury is a causal risk factor for mortality or a marker of 
some, as yet unknown, pathological process. In addition, the long-term 
consequences of myocardial injury in patients that survive the immediate 
postoperative period are unknown. In the absence of these data, it is hard to 
justify a screening programme and to recommend potential therapies for clinical 
trials and ultimately for clinical practice. Therefore, translational research is 
needed to identify the underlying pathology linking myocardial injury and 
mortality, and to develop potential treatments. In addition to this, further 
epidemiological research is needed to determine the long-term impact of 
perioperative myocardial injury, for example on long-term survival, quality of life 
and cardiac function. 
 
Finally, using multiple methods, I have identified a sub-group of surgical 
patients with features of subclinical heart failure. However, other than 
prevalence, little is known about this group of surgical patients. Therefore, I 
propose a prospective observational cohort study to resolve this. A detailed 
preoperative clinical and physiological phenotype would be described using 
biochemical biomarkers of cardiac function, dynamic tests of cardiac function 
using cardiopulmonary exercise testing, and static tests of cardiac function 
using echocardiography. Participants would receive postoperative follow-up to 
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measure clinical outcomes after surgery. Such a study would help to determine 
whether subclinical heart failure is associated with postoperative complications 
as well as mortality, and whether all patients with subclinical heart failure are at 
risk, or whether association is restricted to specific sub-groups, such as patients 
with reduced ejection fraction. 
 
In summary, I have identified that abnormalities of heart rate and blood 
pressure, before and during surgery, are associated with increased risk of 
perioperative myocardial injury. Further to this, elevated preoperative heart rate 
is associated with subclinical heart failure and parasympathetic autonomic 
dysfunction, characterised by impaired heart rate recovery after preoperative 
exercise. The preoperative phenotype of patients at risk of myocardial injury is 
complex, and elevated preoperative heart rate, impaired parasympathetic 
function and subclinical heart failure seem to be part of the same preoperative 
phenotype, present in ~15% of patients undergoing non-cardiac surgery. 
Further research is needed to determine how and why myocardial injury occurs 
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Appendix 1: Researcher development training 
 
  Domain   
  A B C D Total 
  Conference Attendance (Half day) 2.5 1 0 0 3.5 
   Conference Attendance (One day) 19 10 0 0 29 
   Conference Attendance (Three days) 27 18 0 0 45 
   Conference Attendance (Two days) 16 8 0 0 24 
Conference attendance sub-total 18 12 0 0 30 
   CAPD Course 3 5.5 3.5 4 16 
   Core research knowledge or methods course 100 0 0 0 100 
   Other Teaching/demonstrating training 0 1.5 0 1.5 3 
Course/event attendance sub-total 103 7 3.5 5.5 119 
   Fast-track ethical approval 1 0 3 1 5 
Ethical approval sub-total 1 0 3 1 5 
   External funding application >£10,000 15 15 25 15 70 
Funding application sub-total 15 15 25 15 70 
   Conference Presentation (Oral) 9 9 0 12 30 
   Conference Presentation (Poster) 3 3 0 4 10 
Giving presentations sub-total 12 12 0 16 40 
   Representing Research Group at meeting or committee 0 0 11.5 10.5 22 
Meeting/club/reading group attendance sub-total 0 0 11.5 10.5 22 
   Organising Conference (with external speaker(s))  4 0 4 4 12 
Organising events/seminars sub-total 4 0 4 4 12 
   Conference Attendance - internal to QM  3 2 0 2 7 
   Conference Presentation (oral/poster) 3 3 0 4 10 
   Course/event Attendance 90 5 5 13 113 
   Doctoral College Debate 2014 0 1 1 0 2 
   Ethical Approval for Study - Clinical 0 0 10 0 10 
   External course/workshop/event attendance 0 0 5 2 7 
   Organising an event/seminar/conference 9 6 9 16 40 
   Participation in Post-graduate Society events 0 1 0 0 1 
   Presenting - internal to QM 2 2 0 4 8 
Other sub-total 107 20 30 41 198 
   Mentoring/supervising of Project Student 2 1 0 2 5 
   Teaching/demonstrating/marking/preparation 0 12 0 12 24 
Teaching sub-total 2 13 0 14 29 
   Publication - review paper 1 0 0 3 4 
   Refereed Publication (e.g. Journal Paper) acceptance 4 0 0 16 20 
Written publications sub-total 5 0 0 19 24 
Total 267 79 77 126 549 
 
Vitae Researcher Development Framework, where one point represents at least 
one hour of training. Knowledge and intellectual abilities (A), Personal 
effectiveness (B), Research governance and organisation (C) and Engagement, 
Influence and Impact (D). 
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Appendix 3: Additional CPET methods 
  
Contraindications to cardiopulmonary exercise testing 
The ATS/ACCP recommended contraindications to CPET are listed below.272  
	
Absolute contraindications: 
• Acute myocardial infarction within 3-5 days 
• Unstable angina 
• Uncontrolled arrhythmia causing symptoms or haemodynamic 
compromise 
• Syncope 
• Active endocarditis 
• Acute myocarditis or pericarditis 
• Uncontrolled heart failure 
• Acute pulmonary embolus or pulmonary infarction 
• Thrombus of lower extremities 
• Suspected dissecting aneurysm 
• Uncontrolled asthma 
• Pulmonary oedema 
• Room air desaturation ≤85%  
• Respiratory failure 
• Acute non-cardipulmonary disorder that may affect exercise performance 
or be aggravated by exercise (e.g. infection, renal failure, thyrotoxicosis) 







• Left main coronary stenosis or equivalent 
• Moderate stenotic valvular heart disease 
• Severe untreated arterial hypertension at rest (>200mmHg systolic, or 
>120mmHg diastolic) 
• Tachyarrythmias or bradyarrythmias 
• High-degree AV block 
• Hypertrophic cardiomyopathy 
• Significant pulmonary hypertension 
• Advanced or complicated pregnancy 
• Electrolyte abnormalities 
• Orthopaedic impairment that compromises exercise performance 
 
Stopping a CPET 
Since the purpose of a CPET is to determine the participant’s cardiopulmonary 
fitness through exercise to the limit of their tolerance, the most common reason 
for stopping a test was at the request of the participant due to symptom-limited 
fatigue. The ATS/ACCP recommend the following safety criteria for stopping a 
CPET:272 
• Chest pain suggestive of myocardial ischaemia 
• Ischaemic ECG changes 
• Complex ectopy 
• Second or third degree heart block 
• Fall in systolic blood pressure >20 mmHg from highest value during 
CPET 
• Hypertension >250 mmHg systolic or >120 mmHg diastolic 
	
271 
• Severe oxygen desaturation ≤80% when accompanied by symptoms and 
signs of hypoxemia 
• Sudden pallor 
• Loss of coordination 
• Mental confusion 
• Dizziness of faintness 
• Signs of respiratory failure 
 
The METS study standard operating procedure for CPET stipulated the 
following additional stopping criteria:295 
• Pedal rate >50RPM cannot be maintained 
• Participant is fatigued and requests to stop the test 
 
Adverse events during CPET 
The METS study protocol required the following clinical occurrences during 
CPET to be reported as adverse events in line with the adverse event reporting 
standard operating procedure, which I helped to write:440 
• Angina or chest pain suggestive of angina 
• Arrhythmia: sustained ventricular tachycardia or multifocal premature 
ventricular contractions, supraventricular tachycardia, new onset second 
or third degree heart block, new onset atrial fibrillation or flutter, or new 
onset bradycardia 
• Ischaemic electrocardiographic changes: ST segment elevation >1mm in 
leads without diagnostic Q waves (other than V1 or aVR) or excessive 
ST depression >2mm horizontal or down-sloping ST-segment depression 
	
272 
• Hypertensive response (systolic blood pressure >250 mmHg and/or a 
diastolic pressure >120 mmHg) 
• Fall in systolic blood pressure >20 mmHg from the highest value during 
CPET 
• Signs of respiratory failure or severe oxygen desaturation (<80% when 
accompanied by signs or symptoms of severe hypoxia) 
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